The biochemical and biophysical characterisation of p47phox activation. by Hussain, F.
The Biochemical and Biophysical 
Characterisation of p47phox Activation
Farah Hussain
Division of Molecular Structure 
The National Institute for Medical Research 
London, NW1 1AA, UK
January 2008
A thesis submitted in part fulfilment of the requirement of University 
College London for the degree of Doctor of Philosophy
1
UMI Number: U591542
All rights reserved
INFORMATION TO ALL USERS  
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com plete manuscript 
and there are missing pages, th ese  will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U591542
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
DECLARATION
I, Farah Hussain, declare that the work described in this thesis was, except where 
otherw ise indicated in the text, entirely my own.
I have not submitted any portion o f  the work referred to in this thesis in support o f  any 
other qualification at this or any other institute o f  higher learning.
Farah Hussain, January 2008
(Dedicated to my mother Kaneez Hussain)
3
ABSTRACT
The m ulti-com ponent enzym e NADPH oxidase plays a central role in host 
defence against microbial infection, due to its ability to support the production o f  
reactive oxygen species. The enzym e is dorm ant in resting cells where its six hetero­
subunits are separated into cytoplasm ic and membrane compartments. Activation and 
assembly o f  the NADPH oxidase is a complex process that is regulated, in large part, by 
changes in protein-protein and protein-lipid interactions. An important step in the 
activation process is the phosphorylation-induced translocation o f the cytoplasmic 
p40phox-p67phox-p47phox complex to the m em brane-bound heterodimeric p22phox-gp91phox 
complex (flavocytochrome b.sss). This interaction is prevented in the resting state due to 
an intramolecular interaction in p47phox that maintains the protein in an auto-inhibited 
conformation. Phosphorylation o f  eight serine residues in p47phox is essential for 
enzym e activation, o f which five are located in the polybasic region and are known to 
relieve the auto-inhibition. G lutam ate mutants were made to mimic phosphoserine 
residues, and various biochemical and biophysical techniques were used to dem onstrate 
that phosphorylation o f  the rem aining three serine residues, located in the C-term inal 
region, do not contribute to the release o f  auto-inhibition, and hence do not promote 
binding to p22phox. Instead, they weaken the interaction with p67phox. Based on these 
data, a new model for phosphorylation-induced changes in NADPH oxidase assembly is 
proposed.
Binding o f the polybasic region and p22phox to the tandem SH3 dom ains o f
p47phox occurs with high affinity. This affinity is mediated through the formation o f  a 
‘superSH3 dom ain’, which is largely dependent on two structural features: the covalent 
SH3-SH3 linker and a ‘G W W ’ m otif located in the n-Src loops o f either SH3 domain. 
M utant proteins were made and quantitative binding assays were perform ed to 
demonstrate that the chemical nature o f  the linker is more im portant for the 
intram olecular interaction with the polybasic region in the auto-inhibited state, than for 
an interm olecular interaction such as that with p22phox in the active state. Furtherm ore, it 
was shown that the tryptophan residues o f  the GW W  m otif play different roles in the 
stabilisation o f the superSH3 domain conformation. Their precise role depends on 
whether additional interactions between the superSH3 domain and its target can occur 
outside o f  the conserved ligand binding site, as observed in the auto-inhibited state. 
These data suggest that the sequence requirements for the formation o f a superSH3
4
domain are relatively flexible, making it more likely that other proteins containing 
multiple SH3 domains may also form a superSH3 domain.
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ABBREVIATIONS LIST
AG Gibbs free energy
AH Enthalpy
AS Entropy
A.EX Excitation wavelength
A.EM Emission w avelength
3C 3C-precision protease
aa Amino acid
b.p. Base pairs
BSA Bovine serum albumin
CD Circular dichroism
CG Cathepsin G
CGD Chronic granulom atous disease
DPI Diphenylene iodonium
DTT Dithiothreitol
EDTA Ethylenediam ine tetra-acetic acid
FAD Flavin adenine dinucleotide (oxidised form)
fMLp N -form ylated peptide
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H20 2 Hydrogen peroxide
HOCL Hypochlorous acid
IL Interleukin
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K, Association constant
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MAC M embrane attack complex
MBL M annose-binding lectin
MPO M yeloperoxidase
MWCO M olecular weight cut o ff
n Stoichiometry
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PA Phosphatidic acid
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TPR Tetratricopeptide repeats
UV Ultraviolet
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A Ala Alanine
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L Leu Leucine
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1.0 Introduction
The human immune system is com plex set o f  mechanisms, which protects the 
host against infection by invading pathogens such as bacteria, viruses, fungi and 
multicellular parasites. The system involves a whole range o f  proteins, cells, tissue and 
organs, which work in a dynamic manner, discrim inating between self and non-self 
molecules to effectively clear the infection. The human immune system is com posed o f 
two distinct pathways; the innate immune system and the adaptive immune system. The 
former is directed against a wide variety o f  pathogens and is the first line o f  defence 
against microorganisms. However, it does not confer protective or long-lasting 
immunity to the host and in some instances infections cannot be resolved by innate 
immunity alone. The later, although slower to respond is extremely specific and in most 
cases the response provides life long im munity against re-infection from a specific 
pathogen. However, due to the slow response o f  the adaptive immune system (4-7 
days) it is the innate immune response, which is critical in controlling infection in the 
early stages o f infection. Together, the innate and adaptive immune responses act in 
concert to provide an effective system capable o f  preventing and clearing established 
infections (Chaplin, 2006; Hoebe et al., 2004; Janeway, 2001).
1.1 The innate immune response is the first line of
defence
The first line o f defence in the innate immune system involves physical barriers
such as skin and mucosal linings (section 1.1.1). However, if  this immediate defence
mechanism is overcome by the pathogen then non-specific cellular and chemical
responses are activated for the destruction o f  invading pathogens. There are two key
cellular components which mediate an innate im mune response; macrophage and mast
cells (section 1.1.4.2) (Galli, 2000; Gordon, 1995). Both o f these cell types are widely
distributed within the body and respond im mediately when physical barriers are
penetrated by pathogens. M acrophages possess various functions but in innate immunity
its major role is to recruit other effector cells to the site, and in particular phagocytic
neutrophils. Phagocytosis and pathogen destruction by neutrophils is the central defence
weapon in cell mediated innate immunity (Scapini et al., 2000). M ast cells on the other
hand are involved in stimulating local inflamm ation by releasing a cocktail o f
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inflammatory mediators, and enhancing inflamm ation by recruiting further leukocytes 
to the site o f injury. A further key com ponent in the innate im mune system is the 
complement system; a family o f  proteins which react with one another on the surface o f  
pathogens to aid their clearance. Complement activation not only enhances 
phagocytosis and inflamm ation but can also induce cell lysis o f  targets directly (section 
1.1.5) (Morgan et al., 2005; M uller-Eberhard, 1988; Reid, 1986; Reid and Day, 1989; 
Tomlinson, 1993). All o f  these key com ponents involved in the innate immune response 
are described in more detail below (Figure 1).
1.1.1 Surface barriers and mucosal immunity
The body is protected by epithelia tissue such as skin and the mucosal linings o f 
gastrointestinal, respiratory and urogenital tracts. The skin is the fist line o f  defence and 
provides a barrier against invading pathogens, and unless this barrier is com prom ised 
most pathogens cannot penetrate it. Epithelia also actively inhibit microbial growth 
through the secretion o f  microbicidal and microstatic com pounds (B raff and Gallo, 
2006). Oily sebum produced by sebaceous glands in the skin contains lactic acid and 
fatty acids which are toxic to some pathogens. In addition, these substances regulate the 
skins acidic nature (pH < 7.0) which inhibits bacterial growth. Furthermore, the 
presence o f microbial flora on the surface o f  skin prevents pathogens from colonising 
the tissue, by competing with pathogens for nutrients and by producing bacteriocins that 
inhibit their growth (Kitano and Oda, 2006). The mucosal lining o f  gastrointestinal, 
respiratory and urogenital tracts produce mucous which trap invading pathogens and 
prevent them from adhering to the epithelium  (Boyton and Openshaw, 2002). M ucous 
also contains various proteins such as lysozym e which is capable o f destroying bacterial 
cell walls by targeting peptidoglycans, and the iron binding protein lactoferrin. Iron is 
required by all pathogens and the presence o f  lactoferrin competes for free iron, thereby 
depriving the pathogen o f the mineral (Levay and Viljoen, 1995; Rogan et al., 2006). In 
addition, the mucociliary escalator o f the respiratory tract continually moves mucous 
out from the lungs allowing m icroorganisms and debris to be removed by coughing and 
sneezing mechanisms. Other ejection mechanisms include perspiration, nasal secretions, 
saliva and tears. At this point if  a pathogen is successful in overcom ing the physical 
barriers o f the innate immune system then non-specific chemical and cellular responses 
are triggered. These can include inflammation, various cells o f  the innate immune 
response, and activation o f  complement, phagocytosis and destruction o f  the pathogen.
25
Skin 
Mucosal lining
Classical pathway 
Alternative pathway 
MBL pathway
Pain 
Heat 
Swelling 
Fluid leakage
Cells ComplementPhysical barriers Inflammation
Macrophage 
Mast cells 
Neutrophils 
Basophils 
Eosinophils 
Dendritic cells 
Natural killer cells
Innate im m une r e sp o n se
(first line of defence)
Figure 1: Overview of the innate im m une system. The innate immune system is the first line o f
defence against invading pathogens. It involves physical barriers such as the skin and mucosal linings. If 
these barriers are breached or irritated by pathogens, then non-specific chemical and cellular responses 
are activated. These include inflammation which serves to prevent the spread of infection, to destroy the 
pathogen and to subsequently aid in the repair and healing o f damaged tissues. Importantly, innate 
immunity depends on a wide variety o f cell types which i) mediate inflammation and ii) mediate the 
destruction of pathogens. Moreover, both of these processes can be triggered as a result o f complement 
activation. Some of the cell types involved in innate immunity are also involved in triggering an adaptive 
immune response, which provides a more specific defence and results in a life long immunity (Janeway et 
al., 2001).
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1.1.2 Pattern recognition receptors (PRRs) and pathogen-
associated molecular patterns (PAMPs)
One o f  the m ajor problem s o f  the innate immune system is how to distinguish 
between ‘s e lf  and ‘non -se lf. To solve this problem  phagocytic cells have evolved a 
range o f  receptors called pattern recognition receptors (PRRs), which recognise so- 
called pathogen associated m olecular patterns (PAMPs). These are m olecular features 
o f  pathogens that are widely distributed, highly conserved and essential for survival o f 
the pathogen and clearly distinguishable from ‘s e lf  and include viral or bacterial DNA 
or RNA, bacterial carbohydrates such as mannose (found in microbial glycoproteins and 
glycolipids), lipopolysaccharides (gram negative bacterial cell wall com ponent), 
peptidoglycans and lipoteichoic acids (gram positive bacterial wall com ponents), N- 
formylmethionine (bacterial protein com ponent) and zymosan (yeast cell wall 
component). There are two main sub-types o f  PRRs, including endocytic PRRs which 
promote attachment, phagocytosis and pathogen destruction by phagocytes. The second 
sub-type o f PRRs are signalling receptors w hich upon ligand binding trigger a cascade 
o f  downstream processes to initiate the transcription o f various cytokines. Release o f 
these cytokines stimulates local inflamm ation and recruitment o f effector cells.
Endocytic PRRs include mannose receptors and scavenger receptors. The former
2+
belong to the family o f  Ca -dependent lectin family, which bind via their carbohydrate 
binding domains to pathogen cell wall sugars such as mannose and fucose (Ezekowitz et 
al., 1990). These domains are fixed in a specific orientation and bind to residues which 
are found in correct spacing on the surface o f  a wide range o f  pathogenic microbes 
(Apostolopoulos and M cKenzie, 2001; Stahl and Ezekowitz, 1998). Scavenger receptors 
are known to bind low density lipoproteins and various negatively charged ligands on 
gram negative and gram positive bacteria, for example lipoteichoic acid on 
Staphylococci and Streptococci (Dunne et al., 1994).
The group o f signalling PRRs include the family o f  toll-like receptors (TLRs), 
the glycoprotein C D 14, and the family o f  nucleotide-binding oligomerization domain 
(NOD) receptors. At least eleven different TLRs exist o f which some are expressed 
extracellularly and others within endosomes. TLRs recognise a broad range o f  microbial 
products including peptidoglycans, lipopollysaccharides, bacterial lipopeptides and 
various others (Aderem and Ulevitch, 2000; Hayashi et al., 2003; Takeda and Akira, 
2005). Different TLRs can recognise different microbial components. For example
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TLR-4 is important for the recognition o f  lipopolysaccharides (Poltorak et al., 1998), 
where as TLR-2 recognise a wider range o f microbial components including 
peptidoglycans and lipoteichoic acid (Schwandner et al., 1999; Takeuchi et al., 1999). 
On the other C D u can recognise both lipopolysaccharides and peptidoglycans (Antal- 
Szalmas, 2000). In contrast, NOD receptors are cytosolic proteins and recognise for 
example intracellular peptidoglycan com ponents (muramyl dipeptides) o f gram negative 
and gram positive bacteria (in the case o f  N OD I and NOD2) (Bertin et al., 1999; 
Inohara et al., 1999; Ogura et al., 2001).
Secreted PRR proteins also play an im portant role in activating the innate 
immune response. One o f the most im portant is the serum protein, mannan binding 
lectin (MBL) (Ma et al., 2004). MBL recognises mannose containing residues found on 
the surface o f pathogens, which activates the MBL complement pathway to produce 
C3b complement proteins. These bind to the surface o f pathogens thereby opsonising 
them for phagocytosis (refer to section 1.1.5 for details on the MBL com plement 
activation pathway).
1.1.3 Inflammation
Inflammation is the first response to local injury and microbial invasion, which 
occurs to localise infection, to destroy the pathogen, and to aid in the repair o f  damaged 
tissues. Mast cells play a central role in inflam m ation as degranulation o f these cells 
release inflammatory mediators such as histam ine and prostaglandins to induce 
localised vasodilatation; the precursor effect o f inflammation. Vasodilatation causes an 
increase in blood flow (which is associated with the redness and heat observed), which 
increases the delivery o f phagocytes such as neutrophils and com plement proteins to the 
injured tissue. The delivery o f  these com ponents and their actions is associated with the 
pain observed with inflammation. Vasodilatation also causes capillaries to stretch and 
separate thereby increasing permeability, allowing plasm a to escape to surrounding 
areas to induce swelling o f  the affected area. During this process plasma proteins and 
chemotactic factors also escape, further recruiting phagocytes such as neutrophils to the 
site o f injury. Tissue based phagocytic macrophages also play a role in inflammation as 
they secrete various chemokines, which attract further phagocytes to the injured site.
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1.1.4 Cells of the immune system
The cells o f  blood derive from the same progenitor/precursor stem cells o f  the 
bone marrow. Pluripotent hem atopoietic stem cells can differentiate into cells that are 
involved in the immune system, which can be further divided into two types; the 
lymphoid progenitor cells and the m yeloid progenitor cells (Figure 2). The lymphoid 
lineage gives rise to lymphocytes such as B cells and T cells that are prim arily involved 
in the adaptive immune system. The myeloid lineage gives rise to 
monocytes/macrophage, mast cells, polym orphonuclear leukocytes (PM N ’s) and 
dendritic cells; which are involved in the innate immune response although some are 
also linked with the adaptive immune system (Dexter and Spooncer, 1987; Golde, 
1991).
1.1.4.1 Cellular barriers of the innate immune system
A whole variety o f  cells are involved in the innate immune system for the 
effective clearance o f  infection. One o f  the most important cell types are phagocytes 
such as macrophage (Gordon, 1995) but more importantly neutrophils (Scapini et al., 
2000). These cells patrol in search o f  invading pathogens, engulfing foreign particles 
and destroying them. Briefly a pathogen is engulfed into a phagosome, which then fuses 
with a lysosome. These lysosomes possess granules that contain a cocktail o f  
destructive enzymes, and it is the com bined action o f  a respiratory burst producing 
highly reactive oxygen species and the release o f these granular enzymes, which 
ultimately destroys the phagocytosed pathogen. Other cell types important in innate 
immunity include those that mediate inflamm ation such as mast cells and basophils 
(Galli, 2000), and those that activate the adaptive immune response such as macrophage 
and dendritic cells (Banchereau et al., 2000; Palucka and Banchereau, 1999) for longer 
term defence. All o f  these cell types are discusses in more detail below.
1.1.4.2 Macrophage and mast cells
Monocytes continuously circulate the blood and migrate to tissues where they 
differentiate into macrophage. M acrophages are phagocytic and although they represent
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Figure 2: The cellular elements of blood involved in the immune system. Pluripotent
hematopoietic stem cells give rise to lymphoid progenitor cells and myeloid progenitor cells. Lymphoid 
progenitor cells proliferate and differentiate into T lymphocytes and B lymphocytes which are involved in 
the adaptive immune response. One type o f T lymphocyte (Tc) directly destroys pathogens where as the 
other (Th) activates other effector cells such as macrophage or B cells for pathogen destruction. Although 
natural killer (NK) cells derive from the lymphoid lineage they are involved in the innate immune 
response. Myeloid progenitor cells proliferate and differentiate into granulocytes, mast cells, dendritic 
cells and macrophages, all o f which are involved in the innate immune response and some of which are 
involved in regulating the adaptive immune response (adapted from Janeway et al. 2001).
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less than 10 % o f  total leukocytes, they are extremely versatile in their function. They 
are distributed within the body stationed in particular sites where microbial invasion or 
foreign material may accumulate. M acrophages act as scavengers ‘m opping-up’ local 
debris as they continuously phagocytose dead cells and self-proteins in the vicinity 
without evoking an immune response. However, if  a pathogen such as bacteria 
successfully penetrates a physical barrier then it is immediately confronted by tissue 
based macrophages which can mount both an innate and adaptive immune response 
(Gordon, 1995). During innate immunity they engulf and destroy pathogens as briefly 
described above. Importantly, they also play a key role in mediating inflammation, as 
once activated by e.g. microbial lipopollysaccharides they release a complex cocktail o f  
signalling molecules such as interleukin-1 (IL-1) and interleukin-8 (IL-8). Such 
molecules recruit more leucocytes from the blood to the site o f  damage to aid in 
clearing the infection. One o f  the most im portant cell types to be recruited and central to 
cellular mediated innate immunity is the neutrophil (section 1.1.4.3). Neutrophils are the 
most abundant leukocyte and are more efficient killers than macrophage as they produce 
a larger respiratory burst for microbial destruction. In addition activated macrophages 
release various lipid mediators including prostaglandins, which stimulate local 
inflammation. Furthermore, once a m acrophage has digested a pathogen it can initiate 
an adaptive immune response by presenting foreign antigens to T helper cells, which 
stimulate B cells for antibody production. Together this makes the macrophage an 
extremely versatile cell type, linking the innate and adaptive immune responses together 
(Gordon, 1995).
Mast cells mature in tissues and are widely distributed within the body. They 
possess granules which store a whole host o f  inflamm atory mediators such as histamine 
and prostaglandins, thus play a key role in stimulating inflamm atory responses (section 
1.1.3). M ast cells can be activated to release these mediators through various means 
including physical/m echanical trauma, and the binding o f anafylatoxins such as C5a to 
specific cell surface complement receptors (section 1.1.5). Once activated, mast cells 
release chemokines that recruit other leukocytes to the injured site such as eosinophils 
and basophils (1.1.4.3) to further stimulate the inflamm atory response (Galli, 2000; 
Galli et al., 1991; Plaut et al., 1989; W odnar-Filipowicz et al., 1989). Together 
macrophages and mast cells act as effector cells in first line o f host defence.
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1.1.4.3 The polymorphonuclear leukocytes
The polym orphonuclear leukocytes (PM N ’s) include neutrophils, eosinophils 
and basophils, all o f  which circulate the body until they are recruited to sites o f  infection 
and inflammation for pathogen destruction. Examples o f recruitment signals for these 
cell types include N-form ylated peptides e.g. fM etLeuPhe (by products o f bacterial 
sections), cytokines such as IL-1 and IL-8 released by macrophages, histamine released 
by mast cells and basophils, and C3a/C5a produced during complement activation 
(Fernandez et al., 1978; Ryan and Hurley, 1966). The name PM N ’s originates from the 
fact that these cells contain many (poly) differently shaped (morpho) nuclei. These cells 
are also referred to as ‘granulocytes’ due to the presence o f granules within their 
cytoplasm.
Neutrophils are the major cellular com ponent o f  the innate immune system and 
play a fundamentally im portant role in eliminating non-viral infections. They are the 
most abundant leukocyte making up approxim ately 70 % o f  all leucocytes, and are one 
o f  the first cells type to be recruited to sites o f damage (Scapini et al., 2000). 
Neutrophils are professional killers which recognise, phagocytose and destroy ingested 
microorganisms or particles through the action o f  oxygen dependent mechanisms and 
oxygen independent mechanisms. The oxidative pathway involves the activation o f  the 
enzyme, Nicotinamide-adenine dinucleotide phosphate (NADPH oxidase) (refer to 
section 1.3) which produces a respiratory burst o f superoxide radicals (O2 ), and the 
non-oxidative pathway involves the action o f  neutrophil granule proteins. More recently 
it has been shown that these two pathways may in fact merge into one for effective 
microbial killing, as discussed in greater depth in sections 1.2 and 1.3.
Eosinophils make up less than 5 % o f total leukocytes and are predominantly 
involved in eliminating parasites. Once recruited to sites o f  infection they bind C3b 
opsonised parasites (C3b produced during alternative pathway complement activation 
by the parasite), which activates them to release their granule contents. These include 
cationic proteins, major basic protein (M BP), histaminase, arylsulphastase B and 
peroxidase, which together damage the parasite membrane. Eosinophils are phagocytes 
although not very effective ones as many parasites are too large to be engulfed, hence 
the reason why degranulation takes place outside the eosinophil. Eosinophils are also 
associated with inflammation as their granular proteins can dam age host tissues 
(Capron, 1991).
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Basophils on the other hand play more o f  a role in stimulating inflammation, and 
in contrast to neutrophils and eosinophils they are non-phagocytic. Basophils can be 
recruited to and activated at sites o f  dam age through com plement proteins, or by 
chemokines released by tissue based mast cells. A ctivation causes them to release their 
granular contents such as histamine into their surrounding which stimulates 
inflammation. Basophils, mast cells and eosinophils are also associated with allergic 
responses as they carry Fc receptors for IgE. Upon exposure to an allergen, allergen 
specific IgE are produced which bind to these receptors, and upon re-exposure the 
specific allergen binds to IgE on the surface o f  the leukocyte, inducing degranulation 
and inflammation (Galli, 2000; Galli et al., 1991; Plaut et al., 1989; W odnar-Filipowicz 
et al., 1989).
1.1.4.4 Dendritic cells and Natural killer cells
Immature dendritic cells migrate from the blood and reside in most tissues, 
particularly in the skin and mucosal epithelium where they are referred to as 
Langerhan’s cells. Dendritic cells are specialised antigen presenting cells, which initiate 
an adaptive immune response, making them a central com ponent in linking innate and 
adaptive immune responses together. Dendritic cells can bind both bacterial and viral 
particles, and similar to macrophage, they engulf and intracellularly degrade pathogens. 
They then rapidly mature and migrate through lymph to lymph nodes where they 
display foreign antigens to cytotoxic T cells for direct killing, and to helper T cells to 
stimulate B cells for antibody production. In addition to being phagocytic dendritic cells 
are macropinocytic; a receptor independent m echanism  which allows the cell to take up 
large volumes o f fluid and concentrate the m acrosolutes within. In doing so the dendritic 
cell is able to engulf e.g. encapsulated bacteria and virus particles, which do not carry 
common cell surface molecules for phagocytosis by macrophage or neutrophils. Upon 
engulffnent dendritic cells expose pathogenic cell surface features allowing the dendritic 
cell to mature and display the antigen to T cells (Banchereau et al., 2000; Palucka and 
Banchereau, 1999).
Natural killer (NK) cells derive from the lymphoid lineage and are a form o f 
cytotoxic lymphocyte that can destroy viral infected and cancer cells. They carry 
inhibitory receptors such as killer cell im munoglobulin-like receptors (KIR) and 
CD94/NKG2A heterodimers. These recognise cells missing MHC class I expression 
which can occur due to cancer or viral infection, and which are normally expressed on
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most normal cells (Lanier, 1998). NK cells also recognise stress signals such as IF N a 
released from viral infected cells. The cytotoxic activity o f NK cells derives from their 
cytoplasmic granules, which contain various cytotoxic compounds such as perforin and 
granzymes (proteases). Upon activation o f  NK cells these compounds are released 
where perforin forms holes within cell membranes o f  target cells, allowing granzymes 
to enter and induce apoptosis o f  the target. NK cells serve to contain viral infections 
while an adaptive immune response generates cytotoxic T cells that are antigen specific 
to clear the infection (Seino and Taniguchi, 2004; Van Kaer and Joyce, 2005).
1.1.5 Complement activation enhances phagocytosis and
inflammation
The complement system is com posed o f  a family o f proteins that react with the 
surface o f  the pathogen to aid its clearance. The system is composed o f a large num ber 
o f  plasm a proteins, mainly produced by hepatocytes, which circulate in the plasma as 
inactive molecules. Complement activation functions to attract effector cells such as 
neutrophils (which carry com plement receptors) to the site o f  infection via a 
concentration gradient, and to opsonise pathogens for phagocytosis, to stimulate an 
inflammatory response and to directly induce cell lysis o f pathogens by creating pores 
within their membranes (membrane attack com plex) (M organ et al., 2005; M uller- 
Eberhard, 1988; Reid, 1986; Reid and Day, 1989; Tomlinson, 1993).
Complement can be activated via three different pathways; the alternative 
pathway, the classical pathway and the m annose-binding lectin (M BL) pathway (Figure 
3). The alternative pathway is triggered spontaneously by microbial cell surface 
molecules such as lipopolysaccharides on gram negative bacteria, zymosan from yeast 
and fungal cell walls, and some parasitic cell wall molecules. A ntigen-antibody 
complexes typically activate the classical pathway however, it can also be activated by 
some gram negative bacteria, making it an im portant link between adaptive and innate 
immune responses. The MBL pathway is initiated by the binding o f  the serum protein 
‘mannose-binding lectin’ to mannose containing residues found on the surface some 
pathogens (binding o f  MBL to host membrane residues is prevented by the coverage o f  
specific sugar groups such as sialic acid).
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Figure 3: Overview of com plem ent activation. The three pathways through which complement
can be activated are the alternative, the classical, and the MBL pathways. Although these pathways can be 
activated by different molecules they all converge to produce the same effector molecules to opsonise, 
recruit and activate inflammatory cells and ultimately aid in destroying invading pathogens (adapted from 
Janeway et al., 2001).
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Although the three pathways are activated by different molecules they all 
converge to generate the same effector molecules which are used to opsonise pathogens, 
recruit and activate inflamm atory cells, and destroy pathogens (M organ et al., 2005; 
M uller-Eberhard, 1988; Reid, 1986; Reid and Day, 1989; Tomlinson, 1993). W hichever 
way complement is activated they all result in the formation o f  a C3 convertase, which 
splits C3b molecules into C3b and C3a. C3b remains bound to the surface o f  pathogens 
opsonising them for phagocytosis, whereas C3a diffuses away from the pathogen to 
recruit mast cells and basophils for inflammation. In the later events o f  com plem ent 
activation some C3b molecules can bind to C3 convertase to form the C5 convertase. 
C5 convertase captures C5 molecules, which is cleaved into C5a and C5b. C5a diffuses 
away to recruit and activate phagocytes, mast cells and basophils to stimulate 
inflammation. C5b molecules remain attached to the surface o f the pathogen and are 
involved in the assembly o f  the membrane attack complex (MAC). C5b can recruit 
C6, C7, C8 and C9 to the surface where the barrel shaped structure inserts into the lipid 
bilayer o f the pathogen m embrane to form pores, resulting in osmotic lysis and cell 
death (Morgan et al., 2005; M uller-Eberhard, 1988; Reid, 1986; Reid and Day, 1989; 
Tomlinson, 1993).
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1.2 Phagocytosis and microbial destruction
Phagocytes were first recognised by Elie M etchnikoff whilst studying 
transparent starfish larvae. He observed that when splinters and carmine dye particles 
were introduced into the body o f  these larvae, they would become surrounded and 
engulfed by wandering m esodarm al cells (M etchnikoff, 1905). He discovered that these 
cells were phagocytic; a process which plays a central protection m echanism  in the 
immune response, particularly that by neutrophils. The importance o f microbial 
destruction by neutrophils is highlighted in a disease called chronic granulom atous 
disease (CGD). Individuals who suffer from CGD have dysfunctional neutrophils due to 
mutations in NADPH oxidase, which exposes them to recurrent and often life 
threatening bacterial and fungal infections (Thrasher et al., 1994; W inkelstein et al., 
2000) (CGD is described in more detail in section 1.2.7).
The process o f phagocytosis is split into several stages; chem otaxis, recognition 
plus adherence, ingestion (pseudopodium  formation, phagosome formation, phago­
lysosome formation), which is then followed by destruction o f the engulfed pathogen 
(Figure 4). The stage o f  chem otaxis involves the migration o f neutrophils up a gradient 
o f  chemotactic factors produced at the site o f  infection. As described earlier these 
molecules can include com plem ent com ponents such as C5a, bacterial factors such as 
fM etLeuPhe and various chem okines such as IL-8 (Fernandez et al., 1978; Ryan and 
Hurley, 1966; Schiffmann et al., 1975). Once neutrophils have been delivered to the 
injured site they are able to recognise and bind the pathogen, which is mediated through 
an array o f  pattern recognition receptors (refer to section 1.1.2), and it is this process 
which initiates ingestion o f  the pathogen. Ingestion o f  the pathogen involves the 
protrusion o f the membrane to form pseudopodia which folds around the microbe, 
enclosing it within a vacuole known as a phagosome. The phagosome then migrates 
deeper into the cytoplasm where it collides and fuses with cytoplasmic granules to form 
a phagolysosome. The deadly contents o f  the granules are released into the vacuole and 
it is within the phagolysosome structure that destruction o f the engulfed pathogen takes 
place (M oore et al., 1978; Stuart and Ezekowitz, 2005).
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Figure 4: The process of phagocytosis. Illustration showing that phagocytosis takes place in
several stages. 1) The surface o f neutrophils is endorsed with receptors such as the Fc receptor. 2-3) The 
Fc receptor recognises and binds IgG opsonised pathogens. 4-5) Ingestion o f the pathogen is initiated. 
The membrane protrudes out to form pseudopodia which fold around the pathogen to form a phagosome. 
6) As the phagosome moves deeper into the cytoplasm, neutrophil granules fuse to form a 
phagolysosome. 7-8) Degranulation takes place, releasing various antimicrobial agents that destroy the 
enclosed pathogen.
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1.2.1 Neutrophil granules play a central role in microbial killing
Neutrophil granules play a central role in microbial destruction as they contain 
all the components required for killing (Segal, 2005). Two predom inant types o f 
granules are found in the cytoplasm  o f neutrophils: specific granules (secondary 
granules) and azurophil granules (primary granules), as identified through cell 
fractionation, cell staining, biochem ical assays and electron microscopy (Baggiolini et 
al., 1969; Bainton, 1993).
The membranes o f  specific granules contain NADPH oxidase membrane 
subunits (Segal and Jones, 1979), which play a central role in the production o f O2 . 
Furthermore, specific granules contain lysozyme, which hydrolyses polysaccharides 
found in the cell wall pathogens, lactoferrin, which can bind iron and copper (Levay and 
Viljoen, 1995), thereby depriving ingested pathogens o f these growth factors and 
neutrophil gelatinase-associated lipocalin (NGAL), which binds pathogen siderphores 
(Bundgaard et al., 1994). Siderphores are high affinity ion chelators, which are secreted 
by bacteria when iron is not freely available. They have the ability o f extracting iron 
from iron scavenging proteins such as lactoferrin and transferrin and thereby ensure a 
supply o f this vital nutrient (Neilands, 1995). Thus binding o f  NGAL to pathogen 
siderphores inhibits pathogen growth.
Azurophil granules contain a cocktail o f  proteins whose prim ary function is 
microbial destruction. These include defensins, which are small antimicrobial peptides 
that are capable o f forming pores in pathogen membranes to allow efflux. Other granule 
contents include a) proteinases (cathepsin G, elestase and proteinase 3) which hydrolyse 
pathogen proteins, b) lysozyme and c) bactericidal/perm eability increasing protein (BPI) 
which can bind lipopolysaccharides o f  gram negative bacteria. This causes membrane 
damage and results in growth arrest o f the pathogen (Elsbach, 1998). A major 
characteristic component o f  azurophils is myeloperoxidase (M PO) which makes up 
approximately 25 % o f the granule protein. This particular protein has interested 
researcher for many years, as M PO-m ediated halogenation has long been believed to be 
one o f the major killing system in neutrophils (Klebanoff, 1967a; Klebanoff, 1967b; 
Klebanoff, 1968; K lebanoff and W hite, 1969) as discussed is more detail in section 
1.2.3.1. MPO activity, along with a diverse set o f  reactive oxygen species (ROS) is 
thought to be the primary source for microbial destruction. However more recently this 
mechanism o f killing has been challenged by work from Segal and co-workers, who 
argue that ROS are generated to activate granule proteases. Their data suggest that it is
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these activated proteases which destroy the engulfed pathogen, not the direct action o f 
ROS or MPO activity (A hluwalia et al., 2004; Reeves et al., 2002). These mechanisms 
and proposals for microbial destruction are discussed in more detail in section 1.2.4 and 
onwards.
1.2.2 The respiratory burst and ROS
Phagocytosis was first connected with oxygen in 1933 by Baldridge and Gerard 
who observed an increase in oxygen consumption when cocci were mixed with canine 
leucocytes, and smears o f these leucocytes showed that they were loaded with the 
microorganism (Baldridge and Gerard, 1933). Based on these findings it was proposed 
that the increase in oxygen consum ption in a ‘respiratory burst’ was related to an 
increase in energy demand for the process o f  phagocytosis to take place, and this energy 
derived from mitochondria. However in 1959 this theory was proven incorrect by Sbara 
and Kamovsky. W hilst studying phagocytosis o f T. bacilli by monocytes and 
neutrophils, these authors reported that treatm ent o f  mitochondria with inhibitors such 
cyanide and azide did not inhibit the sudden increase in oxygen consumption (Sbarra 
and Kamovsky, 1959). This thereby suggested that the respiratory burst may be 
involved in some other process.
It w asn’t until 1964 when Rossi and Zatti showed that granular fractions from 
phagocytosing genuine pig PM N ’s exhibited a dramatic increase in both NADH and 
NADPH oxidase activities. However granular fractions from resting neutrophils did not, 
and thus it was proposed that NADPH oxidase was responsible for the respiratory burst 
(Rossi and Zatti, 1964). In 1973 Babior and colleagues reported that the function o f the 
respiratory burst was to produce O 2 . This was shown through mixing human leucocytes 
with latex particles and cytochrome c, and measuring cytochrome c reduction at 550 
nm. Reduction was abolished by superoxide dismutase (SOD) verifying that O 2 ’ 
generation indeed took place (Babior et al., 1973).
The respiratory burst relies on the enzyme NADPH oxidase for w hich the core 
component; flavocytochrome bs.ss is present in both the neutrophil plasm a membrane 
and the membrane o f specific granules (Segal and Jones, 1979). Localisation o f the 
cytochrome was determined by resolving neutrophil homogenates, along with organelle 
markers by analytical fractionation on sucrose gradients. Two sucrose fractions were 
found to absorb at 430 nm and 560 nm in dithionite difference spectra, thus suggesting 
that the cytochrome may be located in two separate compartments. One o f  these peaks
40
coincided with the peak activity o f  the specific granule markers; lactoferrin and vitamin 
B 12 binding protein, thus suggesting that cytochrome b is found in specific granules. 
The second peak coincided with the light membranous organelles, thus suggesting that 
it may be located in the plasm a membrane. The presence o f cytochrome b was further 
confirmed when upon addition o f  pyridine, a sharp shift from 560 nm to 557 nm was 
observed in the spectrum (characteristic o f a 6-type cytochrome) (Segal and Jones, 
1979).
Upon phagocytosis the cytochrome is incorporated into the vacuole through 
which electrons are pumped from NADPH in the cytosol, and donated to m olecular 
oxygen at the other side in the vacuole. This one electron reduction generates 
superoxide anions (O2’ ) (Babior et al., 1973), which can be inter-converted by SOD to 
generate hydrogen peroxide (H 2O 2) (Iyer et al., 1961). From here potentially a whole 
host o f other ROS can be generated, for example hypochlorous acid (HOC1) may be 
produced in the presence o f  Cl', MPO and H 2O 2. Hydroxyl radicals (OH«) can 
potentially be generated from the com bination o f  H2O 2 and O 2 ', which requires the 
presence o f Fe2+ or Cu2+. It is clear that both O 2'' and H2O 2 are produced by neutrophils, 
however whether the other ROS described above are also generated is controversial and 
is described in more detail later.
The importance o f the respiratory burst in host defence, generated by the 
NADPH oxidase was highlighted in 1967 by Holmes and colleagues. These authors 
examined the metabolic changes that took place during the phagocytosis o f  latex 
particles by leucocytes o f  CGD patients (Holmes et al., 1967). They reported that the 
increase in oxygen consumption by phagocytosing CGD leucocytes was significantly 
lower than normal cells, as determined using an oxygen monitor. They also reported 
that glucose metabolism in CGD leucocytes was abnormal, as determined by the 
absence o f a normal increase in the formation o f 14CC>2 from glucose-3,4 -14C. In 
addition they showed that production o f H 2O 2 was absent in CGD leucocytes, as 
determined by measuring the production o f 14C from the oxidation o f  form ate-14C by 
H2O2 (Holmes et al., 1967). Based on these results the authors proposed that the 
defective microbicidal activity o f  neutrophils in CGD patients was associated with the 
absence o f a respiratory burst to produce ROS. This led researchers to believe that ROS 
were directly involved in promoting microbial destruction, which was further supported 
by the finding that destruction o f  aerobic organisms such as S. aureus, E. coli and K. 
pneumoniae by neutrophils under anaerobic condition was com prom ised (M andell, 
1974).
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1.2.3 The initial proposal -  ROS and MPO activity are directly
involved in microbial destruction
ROS are toxic as they can react with biological molecules such as DNA, RNA 
and lipids, and thus exposure to excessive amounts can cause significant structural and 
functional damage. Sources for ROS include environment factors such as herbicides, 
radiation and cigarette smoke. Fortunately, the body’s antioxidant defences which 
include superoxide dismutase, glutathione, catalases, vitamin C and E scavenge such 
free radicals to help combat free radical damage. However the ROS to which we are 
exposed do not all derive from environm ent factors, but are also generated as a natural 
byproduct o f  normal metabolism (m itochondrial respiration). Importantly, some free 
radicals are generated for signalling processes and others are produced deliberately by 
phagocytes for microbial clearance (Finkel, 2003).
Originally it was believed that O 2'' generated by neutrophils was directly 
involved in pathogen destruction. Babior and colleagues reported that incubating S. 
epidermidis or E.coli with xanthine oxidase; an enzyme which can produce O 2 ', resulted 
in death o f these organisms (Babior et al., 1975) (as determined by the pour pate 
method). However these experiments were conducted in the absence o f  the substrate 
xanthine. Moreover, killing was not abolished in the presence o f superoxide dismutase 
(SOD), suggesting in fact that the organisms were destroyed via some other m echanism  
and not 0 2 ’’. Since then various other studies have come to surface, which have shown 
that O 2'' is not directly involved in pathogen killing. For example, K lebanoff showed 
that adding SOD to a reaction m ixture containing E.coli, xanthine, xanthine oxidase, CF 
and MPO did not inhibit killing o f  the organism (Klebanoff, 1974).
However, although O2’' itself may not be particularly bactericidal, it acts as a 
precursor for the generation o f  other, much more reactive oxygen species. Indeed, 
already in 1961 Iyer and colleagues showed that the respiratory burst produced a large 
amount o f H2O 2 (measured the production o f 14C from the oxidation o f form ate-l4C by 
H2O2) and that a product o f  this respiratory burst was implicated in antimicrobial 
activity (Iyer et al., 1961).
1.2.3.1 MPO and H2O2 mediated killing
Based on the following points K lebanoff proposed that M PO may play a key 
role in the killing process: i) the prim ary function o f  neutrophils is phagocytosis plus
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microbial destruction, ii) H2O 2 is implicated in microbial killing and iii) H2O 2 can be a 
potential substrate for MPO. K lebanoff tested this hypothesis in vitro in collaboration 
with Hirsch (1961-1962). However, their results were at first rather disappointing. They 
found that mixing E.coli with M PO and H2O 2 at pH 5.0 had no effect on cell viability, 
as determined by the pour plate method. However theoretically it was possible that 
MPO may kill organisms indirectly by converting a substance with little microbicidal 
effect to one with a higher microbicidal effect. Indeed in 1967 K lebanoff reported that 
when H2O 2 and iodide (a non-toxic ion present at low concentrations in the plasma) 
were added to the reaction mixture, an extensive microbicidal effect was observed. He 
reported a reduction in bacterial viability from 6.2 x 106 to zero. Based on these results, 
K lebanoff proposed that MPO and H2O 2 are required to oxidise iodide for the formation 
o f the antibacterial agent iodine, which then prompted him to investigate iodination o f 
E.coli by the MPO system (Klebanoff, 1967a). Iodination experiments involved 
measuring iodine incorporation into a trichloroacetic acid (TCA)-precipitable form, 
where a typical reaction mixture (pH 5.0) consisted o f E.coli, I131, MPO and H:0 2. 
K lebanoff reported that significant iodination (36.1 m pm oles) o f E.coli took place in the 
presence o f  MPO and H2O 2, in contrast little or no iodination was observed in the 
absence o f  either component (0.1 m pm oles and 0.2 m pm oles; respectively) and in the 
absence o f both components sim ultaneously (0.6 mpm oles). Under similar conditions 
he also investigated iodine incorporation by neutrophils that had phagocytosed L. 
acidophilus. He reported that iodine fixation was apparent in these smears but was 
absent in smears where L. acidophilus was not included. Based on these results 
K lebanoff proposed that MPO and H2O 2 are required for iodine incorporation which 
may be important for pathogen destruction by neutrophils (Klebanoff, 1967a). This 
report was soon followed by another in 1968 where K lebanoff showed through similar 
in vitro experiments, that although iodide was the most bactericidal against E. coli, other 
halides such as bromide and chloride were also inhibitory (Klebanoff, 1968). Chloride is 
the most abundant o f  the three anions in biological fluids and oxidation o f this halide 
can produce the highly reactive agent hypochlorous acid (HOC1), an agent typically 
found in household bleaches. M any researchers believe that the major function o f 
neutrophil M PO-mediated halogenation o f bacteria is to produce HOC1 for microbial 
killing.
The role o f  MPO mediated destruction by neutrophils was further supported by 
the finding that that M PO-mediated halogenation was defective in CGD patients 
(K lebanoff and White, 1969) (incubated cells with 125I and used autoradiography to
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demonstrate iodination). In the same year it was found that patients whose neutrophils 
lacked MPO may also be immunodeficient (Lehrer et al., 1969). Furthermore, in 1983 it 
was reported that catalase (breaks down H2O2) negative organisms very rarely cause 
infection in CGD patients (Gallin et al., 1983). It was suggested that these pathogens 
may be capable o f generating their own H2O 2 enough to catalyse their own MPO 
mediated halogenation.
In addition various in vivo studies have also reported that MPO activity may be 
important for host defence against both fungi and bacteria, and that killing may be 
species specific (Aratani et al., 1999; Aratani et al., 2000). More specifically, Aratani 
and colleagues showed that intratracheal challenge o f MPO knock out mice with C. 
albicans increased their susceptibility to pneumonia and death. Approxim ately 500 
times more viable fungi were cultured from the lungs o f MPO knock out mice in 
comparison to wild-type mice, and 18 o f the 27 test animals died after 5 days o f  
injection. These authors also investigated HOC1 generation indirectly by measuring the 
chlorination o f monochlorodim edon (M CD) to form dichlorodimedon. Their results 
showed that neutrophils from wild-type mice generated HOC1 at a level o f  0.47 
nmol/min/106 cells, where as HOC1 generation from MPO deficient mice was 
undetectable. The authors suggested that the MPO knock out mice were unable to 
destroy C. albicans as they were unable to generate HOC1 (Aratani et al., 1999). Aratani 
and colleagues also investigated the effects o f  S. aureus on MPO knock out mice, and 
interestingly these mice were able to clear the infection effectively and to sim ilar levels 
as wild-type mice. Based on these results the group proposed that MPO mediated killing 
may be species specific and that S. aureus may be destroyed by other ROS such as O2*', 
which is rather surprising as O 2’' itself is not a particularly reactive species (Babior et 
al., 1975; Klebanoff, 1974). A sim ilar article was published the following year which 
reported that MPO knock out mice were susceptible to C. albicans, C, tropicalis, T. 
asahii and P. aeruginosa, but not C. glabrata, S. aureus and S. pneumoniae (Aratani et 
al., 2000).
1.2.4 The controversy - Do ROS and MPO activity really kill?
More recently Segal and colleagues have argued that previous experiments 
where ROS and MPO activity were shown to destroy ingested pathogens, were not 
carried under conditions which truly reflect the conditions o f the vacuole. For example 
the pH o f the phagocytic vacuole during the respiratory burst is approxim ately 7.4-8.0
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(Cech and Lehrer, 1984; Reeves et al., 2002; Segal et al., 1981), where as many o f  the 
previous experiments were conducted at pH 5-5.5 (Klebanoff, 1967a; K lebanoff, 1968). 
More importantly, these latter experiments were carried out in the absence o f  granule 
proteins, which when ejected onto the ingested pathogen make up approxim ately 30 % - 
40 % o f the vacuolar content (Hampton et al., 1998). It has been estimated that these 
proteins may be present at a concentration as high as 500 mg/ml (Reeves et al., 2002).
With the above vacuolar conditions in mind Reeves and colleagues re-exam ined 
the bactericidal effects o f O2 ', H 2O 2, HOCL and M PO-induced iodination in vitro 
(Reeves et al., 2002). The results o f  their study contradict those previously reported, and 
propose a more important role for granule proteases in microbial destruction. It was 
found that O 2*' was non-toxic to S. aureus, furthermore high concentrations (100 mM) 
o f H2O 2 were required to reduce the survival o f  S. aureus and E.coli by 50 %, an effect, 
which disappeared in the presence o f  only 25 mg/ml granule proteins. Similarly it was 
reported that although 1-5 pM  HOC1 was bactericidal to S. aureus and E. coli the effects 
disappeared in the presence o f  granular proteins, although the amount o f  granule 
proteins used in these experiments was 20-fold less than what is normally found in the 
phagocytic vacuole. This suggests that under true vacuolar conditions ROS are not 
capable o f  destroying pathogens, and may indeed be consumed by granular proteins.
The notion that MPO mediated iodination constitutes an im portant killing 
mechanism is also challenged by the work o f  Segal and colleagues. In their report from 
2003 they examined which proteins became iodinated upon phagocytosis o f  S. aureus. 
Briefly, they used a reaction mixture consisting o f  neutrophils, 125I and IgG opsonised 
bacteria which was taken into 10 % TCA to precipitate out iodinated proteins. These 
were separated on 2D gels and iodinated proteins were detected autoradiographically. 
These proteins were excised, trypsin digested and identified by M ALDI mass 
spectrometry. The authors reported that rather than bacterial proteins, the majority o f the 
proteins that incorporated 125I belonged to azurophil and specific granules such as 
lactoferrin and lysozyme, along with various cytoskeletal proteins such as actin (Reeves 
et al., 2003). These results were supported by an earlier study which used analytical 
subcellular fractionation o f  neutrophils that had been stimulated by PMA, to show that a 
large proportion o f 131I was distributed with neutrophil granules (Segal et al., 1983).
Further support for this model is given by the observation that, although MPO 
deficient individuals were thought to be im munodeficient (Lehrer et al., 1969) and that 
MPO knock-out mice were susceptible to infection (Aratani et al., 1999; Aratani et al., 
2000), in fact 1 in 2000 individuals are MPO deficient but are nevertheless not unduly
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prone to infection (Nauseef, 1988). In addition, the theory that catalase negative 
organisms rarely infect CGD patients because they may be capable o f generating their 
own H2O 2 enough to catalyse their own MPO mediated halogenation, has also been 
questioned. Chang and colleagues reported that injecting catalase deficient A. nidulans 
into p47phox CGD mice was as equally virulent as wild-type catalase positive A. nidulans 
(Chang et al., 1998). Similar results were reported by M essina and colleagues who 
investigated the virulence o f  catalase positive and negative strains o f S. aureus in CGD 
(Messina et al., 2002).
1.2.5 A new proposal - Granule proteases kill pathogens not
ROS or MPO activity
Based on the results described above it was proposed by Segal and co-workers 
that ROS and MPO activity are not sufficient to kill bacteria and fungi, and that in fact 
granular neutral proteases play a more direct role in microbial destruction. To test this 
hypothesis gene targeting techniques were used to develop mice in which neutral 
proteases such as neutrophil elastase (NE) and cathepsin G (CG) were knocked out, and 
the effects o f  subjecting these animals to pathogenic organism were exam ined 
(Belaaouaj et al., 1998; Reeves et al., 2002; Tkalcevic et al., 2000).
Specifically, Belaaouaj and colleagues reported that intraperitoneal challenge o f 
K. pneumonia into N E' ' mice reduced their survival to 50 % by 16 hrs and by 48 hrs all 
N E "  mice were dead. In addition significant bacterial burden was observed in the 
peritoneal cavities, the bloodstream and vital organs (particularly the lungs) o f  NE*' 
mice in comparison to NE+/+ mice. Using electron microscopy it was shown that after 2 
hrs o f injecting K. pneumonia the organism was actively being degraded by N E+/+ 
neutrophils. In contrast, the phagosome o f NE ' neutrophils contained intact 
intracellular bacteria, some o f  which were actively dividing. Similar experiments using 
E. coli were carried out and showed that NE was also required for destroying this 
organism (Belaaouaj et al., 1998). Tkalcevic and colleagues reported that although over 
time wild-type, single NE ' and single C G '' mice resisted intravenous challenge with a 
small dose o f  A. fumigatus (80,000 viable spores), 60% o f dual protease knock out mice 
(NE "CG' ') did not survive. M oreover, histopathological studies showed that in 
comparison to wild-type mice, N E ' 'CG^ mice carried a substantial load o f  the organism 
in the kidneys, which was not due to a defect in infiltrating neutrophils to the site o f 
infection. These results suggest that both NE and CG are required to fully protect
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against A. fumigatus, and that both proteases may act synergistically with other granule 
proteins to enhance the bactericidal effect. More importantly these authors reported a 
normal respiratory burst by N E‘ 'C G ' '  neutrophils, as determined using flow cytometry 
(measured the oxidation o f  dihydro-rhodam ine to rodamine, by product o f  the 
respiratory burst) (Tkalcevic et al., 2000).
Reeves and colleagues reported that C G " mice were more susceptible to 
intravenous challenge by S. aureus but not C. albicans, where as N E "  mice were more 
susceptible to infection by C. albicans but not S. aureus. However, both organism s were 
significantly virulent in the absence o f both proteases, suggesting that both NE and CG 
are required for full protection against invading pathogens. A mirror image o f  these 
results was observed in vitro by protease deficient mice neutrophils (Reeves et al., 
2002). A cocktail o f protease inhibitors and the oxidase inhibitor diphenylene iodonium 
(DPI) was further used to highlight the importance o f  neutral proteases for microbial 
destruction. Addition o f either o f  these components to a suspension o f  purified human 
neutrophils and S. aureus severely affected microbial destruction, and to similar levels 
as that observed for CGD cells. M ore importantly, the authors showed that production 
o f  a respiratory burst as determined by measuring cytochrome c reduction, and MPO 
activity as determined through iodination by neutrophils was normal in the protease 
knock out mice.
Altogether, the results o f these mouse knock out studies indicate that neutral 
proteases play a fundamental role in microbial destruction. However, there is also no 
doubt that deficiency in NADPH oxidase activity as observed in CGD results in 
defective microbial killing. This suggests that both factors may be required for effective 
clearance o f  infection, and furthermore that they may work in concert; a concept 
investigated by Reeves and colleagues. Using electron microscopy they followed the 
impact o f NADPH oxidase activity on neutrophil granules. They exam ined the 
morphology o f phagocytic vacuoles from neutrophils o f  a normal patient, o f an X- 
linked CGD patient and o f a variant X- linked CGD patient (Reeves et al., 2002). 
Although in the latter two patients NADPH oxidase is defective, X-linked variant CGD 
patients still exhibit 10-12 % oxidase activity. Electron micrographs showed that > 90 
% o f neutrophil granules were uniformly dispersed in normal neutrophils. In contrast < 
30 % and < 20 % were dispersed in X-linked CGD and variant X-CGD cells; 
respectively (granules appeared clumped). These results suggest that NADPH oxidase 
activity may actually influence neutrophil granules by causing them to disperse their 
contents. With this observation on hand and the facts that not only is a large amount o f
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O2 ' generated during the respiratory burst (approxim ately 4mol I '1 ), and that the 10-12 
% (0.5 mol I '1 ) o f 0 2 ' generated in X-linked variant CGD neutrophils is not sufficient 
for pathogen destruction, led Segal’s group to hypothesise that O2 * generation within 
the phagocytic vacuole may influence neutrophil granules, rather than directly killing 
pathogens or producing the substrate for MPO. In fact, Reeves and colleagues presented 
evidence to suggest that O 2 ' generation influences granules by altering the vacuolar pH 
and ion concentrations, and propose that these conditions activate neutrophil proteases 
and it is these proteases, which destroy ingested pathogens (Reeves et al., 2002).
1.2.5.1 Killing is mediated by phagosomal pH and ion concentrations
It is well established that NADPH oxidase is electrogenic as the transfer o f 
electrons across the vacuolar membrane to produce O 2 ' causes a charge imbalance 
(Henderson et al., 1987). This was shown through using the membrane potential 
indicator oxonol V. The absorbance o f oxonol from un-stim ulated cytoplasts gave a 
resting membrane potential o f -100 ± 6.8mV, which rapidly increased upon addition o f 
the oxidase activator PMA. M embrane potential depolarisation was connected to 
oxidase activity as PMA stimulated cytoplasts showed a 120-fold increase in O 2 ’ 
production, as determined by reduction o f cytochrome c. Furthermore both, membrane 
depolarisation and O2 ’ generation in PM A stimulated cytoplasts, were inhibited in the 
presence o f the oxidase inhibitor DPI (Henderson et al., 1987). In order to prevent 
membrane depolarisation and to maintain NADPH oxidase function, the influx o f 
electrons has to be compensated for i.e. a balance in charge movement has to take place 
with either a positive charge moving into the vacuole or a negative charge moving out 
o f the vacuole. This charge balance is generally believed to be bought about by the 
influx o f  protons into the vacuole, as membrane depolarisation has shown to be 
enhanced in the presence o f Cd2+ ions (block H+ currents) (Henderson et al., 1987). 
However, O 2 ' generation in the vacuole ultimately leads to the production o f  H2O 2; a 
process which consumes protons and increases the vacuolar pH from 5.5-6.0 to 7.8-8.0 
despite the release o f acid granule proteins. Segal and co-workers argue that if  only 
protons are involved in charge compensation then this would cause a buffering effect 
(neutral pH) and does not explain the observed rise in vacuolar pH. In support o f their 
argument they have shown that blocking proton channels with Zn2+ and Cd2+ (proton 
channel inhibitors) did not block NADPH oxidase activity (Ahluwalia et al., 2004), thus 
suggesting that ions other than protons may be involved in charge compensation. More
48
specifically, they presented evidence to suggest that part o f  the charge is compensated 
for by K+ influx. This not only increased the vacuolar pH but to also activated granule 
proteases for microbial destruction (Ahluwalia et al., 2004; Reeves et al., 2002). These 
findings are discussed in more detail below.
The involvement o f  K+ was shown through various experiments including a 
quantitative assay where secretion o f  Rb from vacuoles was measured (Reeves et al., 
2002). 86Rb+ is a marker com monly used in K+ transport studies (Rb+ belongs to the 
same atomic family as K+). Reeves and colleagues reported that transport o f  86Rb+ from 
stimulated neutrophils was suppressed in the presence o f DPI (Reeves et al., 2002), 
suggesting that NADPH oxidase may in fact require K +. Furthermore Ahluw alia and 
colleagues reported that large conductance Ca2+ activated K 4 (BKca) channels were 
involved in hC flux. These channels were identified by western blotting to be present in 
the cell membranes o f  neutrophils and in the membranes o f  cytoplasmic granules. 
Blocking o f these channels with iberiotoxin or paxilline (selective and potent BKca
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channel inhibitors) not only inhibited the secretion o f Rb but also prevented vacuolar 
alkalinization as well as inhibiting the destruction o f S. aureus, S. marcescens and C. 
albicans. The vacuolar pH was determined from the excitation spectrum o f fluoresceine 
labelled IgG-coated S. aureus, which was compared with a calibration curve produced 
from bacteria in buffers o f  differing pH values. Moreover, neutrophil iodination and 
oxidase activity were not affected in the presence o f these BKca channel inhibitors. 
Altogether these results suggest that K+ flux is important for effective microbial 
destruction, and that ROS and M PO activity are not as directly involved as previously 
believed. This then raises the question o f  how K 4 is involved in destroying ingested 
pathogens.
1.2.5.2 The link between K+ influx and neutral proteases
The findings by Segal’s group that K+ flux and granular proteases are required 
for pathogen destruction, led to the proposal that K+ may be involved in solubilising the 
anionic sulphated proteoglycan matrix, within which the proteases are tightly bound 
(Kolset and Gallagher, 1990). Surface plasmon resonance measurements showed that 
the binding affinities for the interaction between the matrix protein heparin and purified 
cathepsin G, elastase and MPO are 5.3 nM, 8.9 nM and 20.4 nM; respectively (Reeves 
et al., 2002). The acidic environm ent (pH 5.0) within granules keeps these proteases 
inactive (Styrt and Klempner, 1982), while the influx o f K4 raises the pH and thereby
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produces the optimum conditions for these proteases to function at. Furthermore, these 
authors showed that K+ is linked with microbial destruction as incubating isolated 
granules with S. aureus and 200-400 mM KC1 was bactericidal, and this effect was 
partially inhibited in the presence o f  protease inhibitors. In the absence o f  KC1 the 
granules were not bactericidal. Finally, Reeves and colleagues suggested that H2O 2 
generation may be a mere by-product o f the respiratory burst and that the prim ary role 
o f MPO may be to protect proteases against oxidative damage. They reported that in 
their preliminary studies cathepsin G was sensitive to oxidation by H2O 2, and that it was 
rendered inactive in neutrophils treated with azide, which inhibits MPO (Reeves et al.,
2002).
1.2.6 Final conclusions on microbial killing by neutrophils
Based on studies by many groups, including those o f Babior and K lebanoff it 
became generally accepted that ROS and MPO activity were directly involved in 
pathogen destruction by neutrophils. However, more recently it has been argued by 
Segal and colleagues that ROS and MPO activity are not sufficient to kill ingested 
pathogens. Instead a new model has been put forward, in which it was proposed that O 2 ’ 
is produced to ‘m op-up’ free protons and induce K+ influx, which elevates the vacuolar 
pH to levels that are optimum for the function o f granule proteases. In addition, in this 
model K+ influx solubilises the anionic sulphated proteoglycan matrix to release 
granular proteases and peptides, rendering them active for microbial destruction. In 
spite o f the fundamental differences in these models for the mechanism o f  pathogen 
destruction by neutrophils, it is im portant to keep in mind that there is no doubt at all 
that NADPH oxidase activity is absolutely essential for the killing o f pathogens to take 
place.
1.2.7 Microbial destruction is defective in chronic 
granulomatous disease
Chronic granulom atous disease (CGD) is a rare genetic disorder affecting 
approximately 1:200,000 - 1:250,000 individuals (W inkelstein et al., 2000). It manifests 
in early childhood and predominantly effects boys. CGD is caused by mutations 
including missence, nonsense, insertions, deletion and splice site mutations, in the genes
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encoding the NADPH oxidase subunits (described in detail in section 1.3). These 
mutations result in the complete absence or severely reduced levels o f the affected 
protein, either because the gene is com pletely or partially deleted or the protein is 
unstable. In turn this results in the inability to produce or produce sufficient amounts o f 
O 2 ’ to clear infections effectively (Dinauer, 2005; Heyworth et al., 2003; M eischl and 
Roos, 1998; Segal, 1996). The exact locations o f  these mutations can be found in a 
range o f extensive databases (Cross et al., 1996a; Cross et al., 1996b; Heyworth et al., 
1997; Roos et al., 1996). M utations in human CGD have allowed researchers to gain 
invaluable information about the NADPH oxidase subunits, their functional domains 
and their modes o f interaction to form the active NADPH oxidase complex. M utations 
in the CYBB gene which encodes for gp91phox (Xp21) gives rise to the X -linked CGD 
form and is the most common form o f the disease, which accounts for approxim ately 65 
% o f all cases. O f all the non-X linked autosomal recessive forms o f CGD, mutations in 
the NCF-1 gene (7q 11), which encodes for p47phox are the most common which 
accounts for approximately 25 % o f all CGD cases. M utations in the NCF-2 gene 
(lq25), which encodes for p67phox and the CYBA (16q24) gene, which encodes p22phox 
are infrequent, each accounting for approximately 5 % o f all cases. CGD associated 
mutations in the NCF-4 gene w hich encodes for p40phox (22q 13.1) have not been 
reported as o f yet. CGD predisposes patients to recurrent bacterial and fungal infections 
which can often be life-threatening. These infections are typically characterised by 
pneumonia, lymphadenitis, abscesses in subcutaneous tissues, bones and vital organs 
such as lungs and liver. Comm on infecting pathogens in CGD patients include C. 
albicans, S. aureus and A. fumigatus which can cause pneumonia and is the most 
frequent cause o f death in CGD patients. Treatment for CGD patients includes 
prophylactic antibiotics and interferon-y (IFN—y) therapy, and bone marrow transplants 
and gene therapy potentially offers a future resolution (Dinauer, 2005; Heyworth et al., 
2003; Meischl and Roos, 1998; Segal, 1996).
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1.3 The NADPH oxidase complex
The NADPH oxidase is a tightly regulated multi-component enzyme composed 
o f six subunits termed the phox proteins (phagocytic oxidase). It is found in an inactive 
and active state, and in the inactive state the enzyme subunits are kept in different 
subcellular locations to prevent inappropriate activation and assembly (Figure 5). Two 
o f the enzyme components are integral membrane proteins (gp91phoxand p22phox) and 
form a heterodimer known as flavocytochrome bsss, named after an absorption 
maximum o f the a-band  near 558 nm (also known as cytochrome b .245 after its midpoint 
reduction potential o f  -245V). Flavocytochrome bsss is considered as being the catalytic 
core o f the NADPH oxidase as it contains all the components required for the electron 
transfer reaction to generate superoxide anion (O 2 ) The remaining four subunits are 
located in the cytosol (p47phox, p67phox, p40phox and the small GTPase Rac). Upon 
appropriate activation the cytosolic proteins translocate and associate with the 
membrane-bound cytochrome and Rac (Figure 5C) to form the catalytically active 
NADPH oxidase complex.
1.3.1 Flavocytochrome b558
The existence o f a ‘respiratory burst’ that is required for microbial killing, and 
which is defective in patients with CGD has been known for a long time. However, it 
w asn’t until 1978 that Segal and Jones discovered a novel b-type cytochrome which is 
incorporated into neutrophil phagocytic vacuoles was responsible for this activity. The 
cytochrome was identified when significant changes in the difference spectra o f  purified 
human neutrophil homogenates (activated by PMA or IgG opsonised latex particles) 
were observed, and was confirmed to be a 6-type cytochrome as dithionite (reduces b- 
type cytochromes) difference spectra gave a similar pattern (Segal and Jones, 1978). 
Importantly this cytochrome was shown to be absent in certain CGD neutrophil 
homogenates, thereby indicating that it constitutes the oxidase system that is responsible 
for the microbicidal activity o f  neutrophils (Segal and Jones, 1978).
Purification o f the cytochrome by detergent extraction o f neutrophil membranes 
and subsequent column chromatography yielded a single protein that migrated at an 
apparent molecular weight o f  68-78 kDa on SDS-PAGE (Harper et al., 1984). This 
protein is now known as the gp91phox subunit and was the first NADPH oxidase subunit
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Figure 5: Activation of the NADPH oxidase. A. The resting state o f NADPH oxidase where the
membrane components (gp91phox and p22phox) are separate from the cytosolic components (p47phox, 
p67pho\  p40phox and Rac). B. At some point after cell stimulation some p47phox binds dimeric p67phox- 
p40phox to form the p47phox-p67phox-p40phox trimeric complex. C. The active state o f NADPH oxidase 
where the cytosolic components translocate and interact with the membrane integrated flavocytochrome 
bssg, resulting in the formation o f the active enzyme complex.
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to be identified. The large m olecular w eight distribution o f  this protein on SDS gels was 
shown to be due to its heavy glycosylation, and removal o f  carbohydrates by 
endoglycosidase F resulted in a protein that runs as a sharp single band on SDS gels 
with an apparent m olecular weight o f  55 kDa (Harper et al., 1985).
The second NADPH oxidase component to be discovered in human neutrophils 
was p22phox. In 1987 Segal reported that throughout chromatographic purification and 
sucrose gradient centrifugation gp91phox was found tightly associated with a 23 kD 
protein, which was subsequently named p22phox (Segal, 1987). A similar purification 
strategy combining column chromatography with sucrose density gradients used by 
Parkos and colleagues confirmed the presence o f the p22phox subunit, which unlike 
gp91phox was shown not to be glycosylated (Parkos et al., 1987). Further support for an 
association o f gp91phox with p22phox was provided by the fact that both subunits are 
absent in the neutrophils o f X-linked CGD patients, as determined by w estern blot 
analysis (Parkos et al., 1987; Segal, 1987).
The stoichiometry o f the gp91phox-p22phox complex was shown to be 1:1 using a 
range o f different techniques, including densitometry o f Coomasie stained protein bands 
o f  SDS-PAGE separated cytochrome, and absorbance measurements o f each subunit 
after chromatographic separation under denaturing conditions (W allach and Segal, 
1996). In addition, Huang and colleagues used direct peptide sequencing o f purified 
cytochrome to determine the ratio o f  gp91phox to p22phox. In this work the authors 
performed automated Edman degradation on the flavocytochrome, which released two 
amino acids in each cycle that corresponded to the reported sequences o f  gp91phox and 
p22phox. Quantification o f the am ount o f  amino acids released in each cycle (corrected 
for different recovery efficiencies o f  different amino acids) clearly pointed towards a 
1:1 ratio o f gp91phox to p22phox (Huang et al., 1995).
The observation that mutations found in some CGD patients that interfere with 
the expression o f one o f the two cytochrome subunits, often lead to the absence o f the 
other (Parkos et al., 1989; Segal, 1987) further supports the notion o f  a tight association 
o f the two subunits, and importantly suggests that each other's presence may be required 
for mutual stabilisation or folding. This idea is further supported by the fact that co­
expression o f  both subunits in COS-7 or NIH-3T3 cells (used because they lack 
endogenous p22phox, which otherwise is present in many different cell types) 
significantly increased the amount o f  mature gp91phox (Yu et al., 1998). Furthermore, 
DeLeo and colleagues showed that during biosynthesis o f the flavocytochrom e the 
uncomplexed subunits were susceptible to proteasomal degradation (DeLeo et al.,
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2000). Nevertheless, it should be noted that p22phox is found in many different cell 
types, even in the absence o f  gp91phox and hence that there are clear differences in the 
stability o f these proteins depending on the cell type.
1.3.1.1 Gp91phox
The gp91phox subunit (also called the p-subunit) o f flavocytochrome bsss consists 
o f  570 amino acids. The N-terminal portion o f the protein is hydrophobic and predicted 
to contain six transmembrane helices, where as the C-terminal region is hydrophilic and 
located in the cytosol (Royer-Pokora et al., 1986) (Figure 6). Gp91phox binds all the 
cofactors required for the electron transfer reaction process to take place; nam ely two 
heme molecules, FAD and NADPH (discussed in more detail below). Electrons are 
transferred from NADPH via FAD to the two heme groups to reduce O2 to O 2 " in the 
vacuole. The two heme molecules are coordinated by histidine residues in the N- 
terminal membrane spanning region o f gp91phox, while the binding sites for FAD and 
NADPH are located in the cytoplasmic region. This region shows some degree o f 
sequence homology with the family o f  ferredoxin-NADP reductases, which enabled 
Taylor and colleagues to suggest a model for the three-dimensional structure o f  this 
domain, based on the known structure o f  ferredoxin-NADP reductase (Taylor et al., 
1993). Currently this is the only available structural information o f this subunit.
It was first suggested in 1977 that the superoxide-generating enzyme o f 
neutrophils was a flavoprotein, as an increase in O 2 " production was observed when 
FAD was added to a system containing broken cell preparations from zym osan-treated 
normal neutrophils. The involvement o f  FAD was further supported by the fact that 
FAD failed to support O2 generation in a system containing particles from zymosan- 
treated CGD neutrophils (Babior and Kipnes, 1977). In addition, the authors o f  this 
study reported that FAD was the preferred cofactor over many others, including flavin 
mononucleotide (FMN), riboflavin, adenosine 5 ’-diphosphate (ADP) and adenosine 5 ’- 
monophosphate (AMP) (Babior and Kipnes, 1977).
The fact that the cytochrome itself is the FAD binding com ponent has been 
established independently by three groups in 1992. A combination o f  sequence analysis, 
reconstituted NADPH oxidase assays in the absence or presence o f FAD, and the 
measurement o f FAD content in the membranes o f resting and activated neutrophils 
clearly showed that the FAD binding site is located within the gp91phox subunit, and that
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Figure 6: Flavocytochrome b558. Model showing the predicted domain structures o f gp91phox
(purple) and p22phox (green). The FAD and NADPH binding sites in gp91phox are shown in red and blue; 
respectively. The heme binding sites are shows as blue diamonds. The PXXP m otif in the cytoplasmic tail 
o f p22phox that interacts with the tandem SH3 domains o f p47phox is shown in yellow. The regions in 
gp91phox that are believed to interact with p47phox in the active state are shown as red dots (taken and 
adapted from Groemping and Rittinger, 2005).
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FAD is present even before activation o f  the oxidase (Rotrosen et al., 1992; Segal et al., 
1992; Sumimoto et al., 1992). Based on sequence com parisons presented in these 
studies it was suggested that the gp91phox subunit could also contain the binding site for 
NADPH. This has been confirm ed by photoaffinity labelling o f  neutrophil membranes 
with 2-azido-NADP+ (Segal et al., 1992).
The number and location o f  the heme groups present in the cytochrome has been 
controversial, and it was initially suggested that the heme-binding com ponent o f 
flavocytochrome bsss was p22phox. Yamaguchi and colleagues chromatographically 
purified flavocytochrome bssg to yield a 20 kDa subunit as determined by SDS-PAGE. 
Oxidised spectra o f the protein showed an absorption maximum at 413.5 nm and the 
reduced spectra showed absorption maxima o f  426 nm, 529 nm and 558 nm, thus 
suggesting that the 20 kDa subunit o f the flavocytochrome was the heme bearing 
component. However, their proposal has since been rejected as not only was gp91phox 
absent in their final product but the amino acid sequence o f  the purified 20 kDa protein 
was markedly different from that predicted for p22phox (Yamaguchi et al., 1989). It 
quickly became apparent that in fact flavocytochrome bsss contained 2 heme groups 
with midpoint redox potentials (Em) o f -225 mV and -265 mV (Cross et al., 1995), yet 
their precise location remained unclear for some time. For example Quinn and 
colleagues reported the presence o f  hemes in both subunits based on the separation o f 
the cytochrome components by LDS-PAGE followed by heme staining using 
tetramethylbenzidine (TMBZ) (Quinn et al., 1992). It was suggested that one o f the 
heme molecules may be shared with p22phox, which was supported by the finding that 
not only does p22phox contain a histidine at position 94 (His94) which aligns exactly the 
same as the heme coordinating histidine in myoglobin, but that the region surrounding 
His94 also resembled that o f  a heme bearing region o f  mitochondrial cytochrome c 
oxidase (Parkos et al., 1988).
However since these reports, there has been overwhelm ing evidence to suggest 
that histidine residues in the N-terminal hydrophobic portion o f gp91phox coordinate 
both hemes. Yu and colleagues conducted studies where they spectrophotometrically 
examined the membranes o f  transgenic COS7 cell lines expressing gp91phox, p22phox or 
both. They reported that cell lines expressing gp91phox or both gp91phox and p22phox had 
a heme spectrum similar to that o f  human neutrophil flavocytochrom e bsss- However, 
this spectrum was absent in cell lines only expressing p22phox. In addition, cell lines 
expressing gp91phox alone exhibited mid-point potentials o f -233 mV and -264 mV, 
supporting the hypothesis that gp91phox is the sole bearer o f  the two heme groups (Yu et
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al., 1998). The heme-coordinating histidine residues have been suggested to be located 
in predicted helices III and V: 101:209 and 115:222, based on mutational studies by 
Biberstine-Kinkade and colleagues. These authors reported that mutation o f either o f  the 
histidine residues to leucine significantly reduced the heme spectrum and O2 " 
generation (Biberstine-Kinkade et al., 2001). In addition, missense mutations in any o f 
these histidine residues have been associated with X-linked CGD.
1.3.1.2 P22ph0x
The p22phox subunit (also called the a-subunit) o f  flavocytochrome bssg consists 
o f 195 amino acids. Secondary structure and hydropathy analysis o f  p22phox predicts the 
N-terminal, hydrophobic portion o f the protein to contain three transm embrane a -  
helices (Parkos et al., 1988) (Figure 6). The C-terminal cytoplasmic region does not 
contain any predicted secondary structure and is believed to be highly flexible. The 
only recognisable m otif within this region is a proline-rich (PR) or PxxP m otif that is 
known to be the target sequence for the Src-homology 3 (SH3) domains.
By now it is well established that this PR m otif w ithin the cytoplasmic portion 
o f p22phox constitutes the docking site for active p47phox. One o f the early studies, which 
provided evidence for this was by Sumimoto and colleagues who used a monoclonal 
antibody that specifically recognizes p47SH3 to show a direct interaction between 
p47phox SH3 domains and p22phox (Sumimoto et al., 1994). Similar evidence for a 
p22phox-p47phox interaction was provided by Leto and colleagues using biotinylated 
p47phox SH3 domains to probe nitrocellulose membranes blotted with p22phox (aa 127- 
195) (Leto et al., 1994). The importance o f this interaction has been highlighted by the 
mutation o f proline 156 to glutamine that has been identified in a p22phox deficient CGD 
patient (Dinauer et al., 1991). Loss o f  proline 156 completely abolishes the translocation 
o f  the cytosolic component p47phox to the membrane and prevents NADPH oxidase 
activity (Leto et al., 1994; Leusen et al., 1994a).
1.3.2 Cytosolic components
In the resting state o f the NADPH oxidase the subunits p47phox (Segal et al., 
1985) p67phox (Leto et al., 1990), p40phox (W ientjes et al., 1993) and the small GTPases 
Rac (Abo et al., 1991) are located in the cytosol. Their discovery and characterisation 
has been aided immensely by the development o f cell-free assays for reconstitution
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studies which was originally developed in 1984 (Bromberg and Pick, 1984; Heyneman 
and Vercauteren, 1984), and production o f specific antibodies against the different 
subunits. Briefly, cell-free assays involve recovering membrane and cytosolic fractions 
from resting neutrophils and activating the NADPH oxidase by mixing the subcellular 
fractions with activators such as protein kinase C (PKC), the bacterial peptide fMLP, 
the PKC activator phorbol myristate acetate (PMA) or sodium dodecyl sulfate (SDS) 
which is believed to mimick phosphorylation by providing negative charges (Abo et al., 
1994; Bromberg and Pick, 1984; Heyneman and Vercauteren, 1984; Park et al., 1992). 
In contrast, whole cell assays involves the activation o f intact cells followed by 
recovering membrane and cytosolic fractions, and subsequent detection o f  NADPH 
oxidase components by immunoblot assays (Abo et al., 1994; Heyworth et al., 1991; 
N auseef et al., 1991).
Many researchers believe that during the resting state o f the NADPH oxidase 
some cytosolic p47phox exists in com plex with p67phox and p40phox, as a tight hetero- 
trimer o f  approximately 240-300 kDa. Evidence for this has been provided using 
chromatographic purification and im munoprecipitation o f resting neutrophil cytosols 
followed by immunoblot assays (Park et al., 1992; Someya et al., 1993; W ientjes et al., 
1993). Lapouge and colleagues further employed analytical ultracentrifugation, dynamic 
light scattering and isothermal titration calorimetry to show that the large apparent 
molecular weight o f the p47phox-p67phox-p40phox complex detected by gel filtration is due 
to its extended non-globular structure, rather than the presence o f  multiple copies o f  the 
components as previously believed (Lapouge et al., 2002).
However, more recently this model has been challenged by Brown and 
colleagues, who developed a new assay for studying NADPH oxidase activation, in 
which they permeabilised resting neutrophil membranes with Streptolysin-O to allow 
the cytosolic contents to gently leak out into the surroundings, whilst m aintaining the 
intracellular structure as verified by electron microscopy (Brown et al., 2003). As 
determined by gel filtration chromatography and immunoblot assays, under these 
conditions it was found that only p40phox-p67phox co-eluted and that p47phox eluted 
separately. M oreover im muno-depletion o f  p47phox from resting cytosols did not lead to 
depletion o f p67phox or p40phox, thus suggesting that p47phox associates at a later stage to 
form the hetero-trimeric complex, which translocates to the membrane (Brown et al.,
2003). The authors o f this study argue that the experimental conditions used by previous 
researchers, in which cells were ruptured to separate membranes from cytosols, were 
physically harsh and may have accidentally activated/forced the formation o f the
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trimeric complex. They suggest that their approach is less manipulative and that the 
results obtained using this novel assay are a true representation o f the neutrophil resting 
state. In this new model p47phox would exist separately from the p67phox-p40phox complex 
in the resting state, and formation o f  the trimeric complex would in fact constitute the 
first step along the activation pathway.
Not enough data are currently available to fully understand the conflicting 
observations made, and to decide what truly constitutes the resting state o f the NADPH 
oxidase. Further studies are now required to gain a better insight into this aspect o f  the 
activation process. However, it is clear that neutrophil stimulation causes a trimeric 
complex consisting o f p47phox-p67phox-p40phox to translocate to the membrane and 
associate with the flavocytochrome to form the active NADPH oxidase enzyme. It is 
also important to note that there is an excess o f free cytosolic p47phox, however the 
physiological significant o f this is not understood at present.
1.3.2.1 P47Ph0*
P47phox consists 0f  390 amino acids and has a m olecular w eight o f 
approximately 47 kDa. It possesses two different types o f protein interaction domains 
(interaction domains are described in more detail in section 1.4): two adjacent SH3 
domains and a phox (PX) homology domain. In addition it contains a proline-rich 
region (PR) and an auto-inhibitory polybasic region (rich in arginine, lysine and serine 
residues) (Figure 7). P47phox was initially identified by Segal and co-workers from 
autosomal recessive CGD neutrophils, as a phosphoprotein in which enhanced 
phosphorylation was absent. This was determined by measuring the rate o f 32P- 
incorporation in PMA activated whole cells (Segal et al., 1985). The Babior group 
further highlighted a possible link between p47phox phosphorylation and the respiratory 
burst. They reported that when normal neutrophils were incubated with 32P and 
activated by either PMA, fMLP or arachidonic acid, that p47phox was able to take up the 
label. However, this uptake was not observed when p47phox deficient CGD neutrophils 
were used, thus suggesting that phosphate uptake by p47phox may be involved in 
NADPH oxidase activation (Hayakawa et al., 1986). Various groups further verified the 
importance o f p47phox in NADPH oxidase activity in the late 1980’s. For example Nunoi 
and colleagues showed that when p47phox purified form normal neutrophils was added to 
cell-free assays containing p47phox deficient CGD neutrophils, O 2 ' generation was 
restored (Nunoi et al., 1988). In support o f this Lomax and colleagues used recom binant
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Figure 7: Domain arrangements and amino acid sequences of the cytosolic NADPH oxidase
proteins p47ph01 and p67pho\  The domain arrangement for p47phox and p67phox are shown with the 
corresponding amino acid sequences. P47phox phosphorylation sites (serine residues) are highlighted in 
orange in the amino acid sequence, and shown as sticks in the domain arrangement. Boundaries o f the 
individual domains were obtained from the Pfam database (Bateman et al., 2004) and the Prosite database 
(Hulo et al., 2006).
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p47phox to show that NADPH oxidase activity was restored in a system containing 
p47phox deficient CGD neutrophils (Lomax et al., 1989). These studies clearly show that 
p47phox is absolutely required for O 2 ' generation by the NADPH oxidase.
Park and colleagues showed using cell-free assays that activation o f resting 
neutrophils with SDS was accompanied by generation and translocation o f a large 
protein complex comprising o f p47phox and p67phox, from the cytosol to the membrane. 
This translocation however was not observed if  membranes lacked flavocytochrome 
b558, as observed using neutrophil membranes from X-linked CGD patients (Park et al., 
1992). Similar results were reported using whole cell assays activated by PMA or fMLP 
(Heyworth et al., 1991; N auseef et al., 1991). These results suggest that upon neutrophil 
activation the entire cytosolic complex translocates and associates with the membrane 
bound flavocytochrome bsss to form the active NADPH oxidase. Furthermore, 
Heyworth and colleagues showed that, although in p47phox deficient CGD neutrophils 
the levels o f p67phox were the same as wild-type cells (as determined by immunoblot 
assays), p67phox did not translocate to the membrane upon PMA activation. However in 
p67phox deficient CGD neutrophils, p47phox was detected in membrane fractions 
(Heyworth et al., 1991), clearly suggesting that o f the three cytosolic proteins ( p40phox 
had not been discovered at the time) that comprise the trimeric complex, p47phox is 
responsible for mediating membrane translocation.
Taken together the results from numerous studies by many different groups it is 
now well established that p47phox is a key player at two crucial stages in the regulation 
o f the NADPH oxidase, and functions simultaneously as a regulator o f  NADPH oxidase 
activity as well as an adapter protein that facilitates the formation o f  the active complex. 
Firstly, during the inactive state o f the NADPH oxidase p47phox exists in an 
autoinhibited conformation and thereby enforces a cytoplasmic location o f  the p47phox- 
p67phox-p40Phox complex (section 1.3.2.1.1). Secondly upon activation, p47phox is 
responsible for translocating this complex to the membrane and bringing p67phox and 
p40phox into close proximity to the flavocytochrome and Rac. M embrane translocation is 
achieved by the specific recognition o f  the cytosolic portion o f p22phox by p47phox, as 
well as the interaction between the p47phox PX domain and membrane lipids. Additional 
interactions with the cytoplasmic region o f gp91phox, as described in more detail below, 
may further contribute to the stabilisation o f the active enzyme complex.
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1.3.2.1.1 The inactive state of p47phox
The first insight into the mechanistic basis o f the regulation o f  NADPH oxidase 
activity by p47phox, came in 1994 when Sumimoto and co-workers showed that 
activation o f the NADPH oxidase involved the interaction between the SH3 domains 
located in the central region o f  p47phox and p22phox. Importantly, in this work the authors 
showed that the SH3 domains appear to be masked in the resting state and that 
activation in vitro by agents such as arachidonic acid or SDS relieves these 
autoinhibitory interactions (Sumimoto et al., 1994), thereby paving the way for the 
notion that NADPH oxidase activity is regulated by reversible intra- and interm olecular 
protein-protein interactions.
Regulation o f protein function through intramolecular, auto-inhibitory 
interactions is a common mechanism that is found in many different systems. For 
example the Src family o f  non-receptor protein-tyrosine kinases (including Src, Lck, 
Hck, Fyn, Blk, Lyn, Fgr, Yes and Yrk) (Hofmann et al., 2005) contain regulatory SH3 
and SH2 domains, a kinase domain, and a conserved tyrosine residue in the C-terminal 
tail o f the protein. In the inactive state, kinase activity is inhibited due to an 
intramolecular interaction between the SH2 domain and the conserved phosphotyrosine 
in the C-terminal tail. In addition, the SH3 domain interacts with the SH2 domain- 
kinase linker region and thereby contributes to the inhibition o f  kinase activity (Sicheri 
et al., 1997; Williams et al., 1997; Xu et al., 1997). Similarly in the resting state o f  the 
NADPH oxidase enzyme, activity is prevented due to an auto-inhibited conform ation o f 
P47phox.
The fact that SH3 domains can bind PR sequences and that p47phox itself 
contains a PR stretch in the C-terminal region, led to the suggestion that that during the 
inactive state o f p47phox the SH3 domains may be masked by the C-term inal PR region 
o f  p47phox in an intramolecular fashion (Sumimoto et al., 1994). The model in which 
intramolecular interactions within p47phox prevent binding to p22phox was supported by a 
number o f studies including that by Hata and colleagues, who showed through in vitro 
GST pull-down assays that full-length wild-type GST-p47phox could not bind its 
membrane target p22phox. However, truncated p47phox where the C-terminal region was 
absent bound to p22phox as strongly as the isolated p47phox SH3 domains (p47SH32), as 
determined by western blot analysis. These results were in good agreement with in vivo 
binding assays using the yeast-2-hybrid system (Hata et al., 1998). The study also 
suggested that the region in p47phox recognised by the SH3 domains does not involve the
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PR region, which instead mediates the interaction with p67phox. Similar results were 
reported by Ago and colleagues using both in vivo (yeast-two hybrid assay) and in vitro 
(pull-down assays using purified proteins) methods. The authors o f this study showed 
that while full-length wild-type p47phox was unable to bind p22phox, full-length mutant 
p47phox carrying either the P299Q/P300Q or R301E/R302E mutations (located in the 
polybasic region) was able to bind p22phox. This observation further supports the model 
that an intramolecular interaction between the SH3 domains o f p47phox and the region C- 
terminal to these domains prevents binding to p22phox, and that the binding site for 
p22phox only becomes accessible after this intramolecular interaction is disrupted (Ago 
et al., 1999).
More recently this model has been verified by crystal and solution structures o f 
inactive p47phox which clearly show that the ligand binding sites o f  the tandem SH3 
domains are masked by an intramolecular interaction with the polybasic region 
(Groemping et al., 2003; Yuzawa et al., 2004a; Yuzawa et al., 2004b) (Figure 8). The 
crystal structure o f  the auto-inhibited core o f  p47phox (aa 156-340) shows that the two 
SH3 domains cooperate and that their conserved ligand binding sites are juxtaposed in 
such a fashion that they form a novel, single ligand binding site, a conformation now 
called the superSH3 domain (Groemping et al., 2003) (superSH3 domains are described 
in more detail in section 1.6). The polybasic region is bound to this novel ligand binding 
site via the non-consensus sequence 296RGAPPRRSS304 (Figure 8). The core 
297GAPPR301 region adopts a PPII conformation (section 1.4.1), and makes contacts 
with both the S H 3 a and SH 3 b domains. In addition, extensive contacts are also made by 
the remainder o f the polybasic region, which interacts with both SH3 domains and the 
linker connecting the two domains. To investigate the importance o f these additional 
contacts Groemping and colleagues carried out quantitative binding studies using 
isothermal titration calorimetry (ITC). They showed that a peptide with the sequence 
296RGAPPRRSS304 bound to the tandem SH3 domains, but not the individual SH3 
domains, with an affinity o f 29 pM . However, when the peptide was extended to include 
an additional 26 residues (296-330), the affinity for the tandem SH3 domains was 
increased to 1.5 pM  (Groemping et al., 2003). These results suggest that additional 
contacts outside the core binding region significantly contribute to the maintenance o f 
the auto-inhibited state. Furthermore, these studies support the notion that the region 
containing amino acids 156-340 is sufficient to maintain the auto-inhibited state. This 
region will be referred to as the "auto-inhibited core".
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5315
p47phox
Figure 8: Structure of p47pho* in the auto-inhibited state. The tandem SH3 domains (blue) are
masked by an intramolecular interaction with the polybasic region (green). Phosphorylation sites in the 
polybasic region are shown as sticks (S303, 304, 3 15, 320 and 328). The linker connecting SH3A and 
SH3b is shown in yellow. PDB identifier 1NG2 (Groemping et al., 2003). The figure was prepared using 
the program Molscript.
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1.3.2.1.2 P47phox phosphorylation relives the auto-inhibited conformation
The phosphorylation o f  p47phox plays a key role in the activation process o f  the 
NADPH oxidase, and was first linked with NADPH oxidase activity when it was shown 
that that phosphorylation o f this protein was abnormal in p47phox deficient CGD patients 
(Hayakawa et al., 1986; Segal et al., 1985). P47phox is the most extensively 
phosphorylated subunit o f  the NADPH oxidase and so far eleven serine residues have 
been shown to become phosphorylated. Interestingly, they are all located in the region 
C-terminal to the tandem SH3 domains (S303, 304, 310, 315, 320, 328, 345, 348, 359, 
370 and 379). Many o f the sites have been identified by Babior and collaborators using 
tryptic phosphopeptide mapping. Briefly, neutrophils or Epstein-Barr virus (EBV)- 
transformed B lymphoblasts were loaded with 32P. The cells were activated and p47phox 
was immunopurified using antibodies against the C-terminal portion o f  p47phox. 
Fractions containing phosphorylated p47phox were then characterised by SDS-PAGE 
followed by autoradiography, and identified as a single radioactive band m igrating at 
~47 kDa. The band was excised, digested and phosphopeptides detected by 
autoradiography, which were HPLC purified and phosphorylation sites identified by 
Edman degradation (el Benna et al., 1994; El Benna et al., 1996). To examine the 
importance o f  p47phox phosphorylation in NADPH oxidase activation Babior’s group 
subsequently used PM A activated EBV-transformed lymphoblasts deficient in p47phox 
which were transfected with different p47phox serine to alanine mutants,. These studies 
showed that a mutant protein where all eleven serine residues between S303 and S379 
were substituted for alanine was i) not phosphorylated and ii) almost com pletely failed 
to support O2'' generation (Faust et al., 1995). These results clearly suggest that p47phox 
phosphorylation is essential for normal NADPH oxidase activation.
Several approaches were used to identify the kinases responsible for 
phosphorylation o f p47phox. For example El-Benna and colleagues used 
immunoprecipitated p47phox from resting neutrophils, and incubated it with [y-32P]ATP 
and either protein kinase C (PKC), protein kinase A (PKA) or mitogen activated protein 
kinase (MAP). They then em ployed tryptic phosphopeptide mapping to identify which 
p47phox phosphorylation sites were phosphorylated by which kinase. Peptide mapping 
revealed that PKA only phosphorylated Ser320 and Ser328 and/or the Ser359/370 
peptides, and MAP kinase only phosphorylated the Ser345/348 peptide. However, PKC 
phosphorylated all the p47phox peptides other than that corresponding to Ser345/348, 
thus suggesting that PKC may be a key kinase for phosphorylation o f  p47phox (El Benna
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et al., 1996). There is now a great deal o f evidence supporting a positive role for PKC in 
NADPH oxidase activation; for example N auseef and colleagues showed that 
staurosporine which is a potent PKC inhibitor prevented i) PMA activated O2'* 
generation ii) p47phox phosphorylation as determined by autoradiography and iii) p47phox 
membrane translocation as determined by immunoblot assays (N auseef et al., 1991). 
Altogether this suggests that p47phox phosphorylation by PKC is associated with 
membrane translocation o f p47phox, and the assembly o f active NADPH oxidase 
complex.
The contribution o f individual p47phox serine residues to NADPH oxidase 
activation has been studied extensively, and many o f these studies have made use o f 
phosphorylation mimics, where serine residues have been substituted with either 
aspartate or glutamate residues. These amino acids are the closest in conformation to a 
phosphoserine (Figure 9). Based on a number o f studies it appears as phosphorylation o f 
only eight p47phox serine residues is sufficient for NADPH oxidase activation, as 
described in more detail below. These include serine residues 303, 304, 315, 320, 328, 
which are located in the polybasic region and form part o f  the auto-inhibitory region. 
Further phosphorylation sites required for activation includes serine 359, which is 
located N-terminal and serine residues 370 and 379, which are located C-terminal to the 
PR region, a segment that otherwise mediates the interaction with p67phox. Ago and 
colleagues used the yeast two-hybrid system to show that the simultaneous substitution 
o f serine residues 303, 304 and 328 by either aspartate or glutamate was sufficient to 
disrupt autoinhibitory, intramolecular interactions and allow binding to p22phox. 
Furthermore, the authors o f  this study showed that these mutations supported O2'' 
generation in cell-free systems without the need o f activators such as arachidonic acid 
or SDS (Ago et al., 1999), strongly indicating that these residues play a key role in 
NADPH oxidase activation. This suggestion is further supported by the observation that 
the substitution o f  all serine residues known to become phosphorylated (S303, 304, 310, 
315, 320, 328, 345, 348, 359, 370 and 379) by either aspartate or glutamate except 
either one o f S303, S304 or S328 produced mutant proteins that failed to interact with 
p22phox, thus further highlighting the importance o f phosphorylation o f  p47phox serine 
residues 303, S304 and S328 for p22phox binding and NADPH oxidase activation (Ago 
et al., 1999).
Additional support for the importance o f these serine residues was provided by 
Groemping and colleagues who quantified the contribution o f  individual residues to the
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Figure 9: Side-chain structures of phosphorylation mimics. The side-chains of the amino acids
serine (S), phosphoserine (pS), aspartate (D) and glutamate (E). Glutamate is closest in conformation to 
phosphoserine.
activation process by fluorescence spectroscopy using a fluoresceine-labelled p22phox 
peptide and p47phox recom binant proteins (Groemping et al., 2003). They showed that 
the double substitution o f S303 and S304 to glutamate or the single substitution o f S328 
alone allowed only weak binding o f p47phox to p22phox (93 pM  and 590 pM, 
respectively). However, the effect o f substituting these residues was cumulative and a 
triple mutant, S303/304/328E bound with an affinity o f 17.8 pM  to the p22phox-derived 
peptide. A slightly higher maximum binding affinity o f  8 pM was achieved when all the 
serine resides within the polybasic region had been substituted by glutamate residues 
(S303/304/315/320/328E) (Groemping et al., 2003). These observations can be 
rationalised by the crystal structure o f  auto-inhibited p47phox, which shows that Ser303 
forms a hydrogen bond with Glu241 and hence that introduction o f negatively charged 
phosphates in this region would lead to charge repulsion and possibly cause steric 
clashes. Ser328 in the C-terminal portion o f the polybasic region forms a hydrogen bond 
with Arg267, and it seems likely that the introduction o f a bulky phosphate group in this 
position would also lead to a steric clash (Groemping et al., 2003).
In a complimentary study Ago and colleagues showed by yeast two-hybrid 
assays that full-length p47phox carrying simultaneous S359, 370 and 379D substitutions 
failed to interact with p22phox, suggesting that these C-terminal serine residues may not 
be directly involved in the disruption o f the intramolecular interaction (Ago et al., 
1999). However phosphorylation o f  these residues has been implicated in NADPH 
oxidase activation by other authors, who proposed that they may facilitate 
phosphorylation o f the remaining serine residues. Babior’s group employed cell-free 
assays using p47phox deficient B lymphoblasts expressing the double mutant p47phox 
S303A/S304A to show that although upon PMA activation, membrane translocation o f 
the mutant was not affected (as determined by im munoblot assays) it nevertheless 
almost completely failed to support O2 ’ generation. Enzyme activity was restored when 
the alanines were replaced with glutamates, thus suggesting that phosphorylation o f 
S303 and S304 is essential for NADPH oxidase activation but not for translocation 
(Inanami et al., 1998). However, in a similar assay p47phox S359A/S370A or 
S359K/S370K mutants caused a dramatic reduction in O 2 ' generation and prevented 
phosphorylation o f other serine residues, as well as prevented membrane translocation. 
Although oxidase activity was still reduced when these mutations were replaced by 
aspartate or glutamate residues (S359D/S370D or S359E/S370E), these mutant proteins 
translocated to the membrane in a normal m anner and phosphorylation o f other serine 
residues was restored (Johnson et al., 1998). Based on these results the Babior group
69
proposed that phosphorylation o f  S359 and/or S370 takes place first, which is then 
followed by phosphorylation o f S379 and then S303 and/or S304. S379 is believed to 
play a central role in p47phox activation in this model as Faust and colleagues showed 
that in comparison to other p47phox serine residues, mutation o f  S379 to alanine alone 
resulted in the most significant loss in p47phox translocation and consequently O2 ' 
generation (Faust et al., 1995). However, this model is contradictory to other data which 
clearly show that phosphorylation o f serine residues 303, 304 and 328 are sufficient for 
membrane translocation o f the trimeric complex and O2'' production (Ago et al., 1999). 
Further studies are now required to fully understand the biological significance o f 
phosphorylation o f serine residues 359, 370 and 379, and to establish if  phosphorylation 
o f p47phox occurs in a sequential manner that requires phosphorylation o f  a particular 
serine residue to allow further phosphorylation events.
1.3.2.1.3 p4 7 Phox tandem SH3 domains bind the cytoplasmic region of p22phox
The studies described above clearly show that p47phox activation induces 
conformational changes within the protein, which disrupt an intramolecular interaction 
and expose the SH3 domains allowing them to bind to p22phox. While the im portance o f 
a p47phox-p22phox interaction has been generally accepted there were conflicting data 
concerning the requirement o f one or both SH3 domains o f p47phox. These were mostly 
due to the fact that different techniques had been used to investigate this interaction (for 
example immunoblot, pull-down or yeast two-hybrid assays), which may have 
underestimated the contribution o f  both domains to complex formation (de M endez et 
al., 1997; Sumimoto et al., 1996). However, the simultaneous requirement for both SH3 
domains o f p47phox to form a tight complex with p22phox has since been confirm ed by 
the structure o f the tandem SH3 domains o f p47phox bound to a peptide derived from 
p22phox (which is thought to mimick the active state o f p47phox). This structure shows 
that the tandem SH3 domains adopt a superSH3 domain conformation as previously 
observed in the autoinhibited protein, and interact with the consensus PXXP m otif 
( 154N P P P R P 159) located in the cytoplasmic tail o f p22phox (Figure 10) (Groemping et al., 
2003). Although SH 3a is the dom inant component in the interaction with p22phox, the 
cooperation o f both, SH 3a and SH3b is required to achieve tight complex formation with 
p22phox, as highlighted by ITC experiments that show that whilst isolated SH 3a is able 
to bind to p22phox on its own with an affinity o f  3.4 pM , the strength o f this interaction
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Figure 10: Structure of an active form of p47ph0* in complex with a p22pho*-derived peptide.
The tandem SH3 domains are shown in blue, and the linker connecting SH3A and SH3B in yellow. The 
p22phox peptide is shown in green stick format, and key residues o f the PXXP motif are highlighted 
(R158, P I57 and P I55). PDB identifier 10V3 (Groemping et al., 2003). The figure was prepared using 
the program Molscript.
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is greatly increased to 0.19 pM  by the presence o f S H 3 b (Groemping et al., 2003). 
Furthermore this structure also provides a molecular basis for the observation that 
substitution o f proline 156 in p22phox by glutamine causes CGD, by highlighting the 
extensive contacts made between this residue and p47phox.
1.3.2.1.4 p4 7 phox p x  domain binds PtdIns(3,4)P2
Phosphoinositide 3-kinases (PI3K) are a family o f enzymes which belong to 
either class I, class II or class III. Class I PI3Ks are activated by a range o f  cell surface 
receptors that operate via protein-G, and tyrosine kinase transduction pathways 
(Hawkins et al., 2007). They are believed to phosphorylate PtdIns(4,5)P2 in the plasma 
membrane giving rise to PtdIns(3,4,5)P3, which in turn can be dephosphorylated by 3- 
proteases to generate PtdIns(4,5)P2 and 5-phosphatases to form PtdIns(3,4)P2. Class II 
PI3Ks are less well studied where as Class III PI3Ks are believed to phosphorylate 
Ptdlns to generate PtdIns(3)P. Various Ptdlns are formed in the plasm a and/or 
phagosomal membrane during phagocytosis and can regulate NADPH oxidase 
activation at several steps. These include activation o f Rac via phosphoinositide- 
dependent guanine nucleotide exchange factors (GEFs) such as P -R exl, 
phosphorylation o f p47phox via phosphoinositide-dependent kinases such as protein 
kinase B (Akt/PKB), or direct interaction with cytosolic sub-units such as p47phox and 
p40phox, as described in more detail below (reviewed by Hawkins, 2007).
The products o f PI3Ks are well established signalling molecules which interact 
with a range o f protein interaction domains including the PX domain (for details see 
section 1.4.4). The N-terminal regions o f p47phox and p40phox both contain a PX domain 
and binding o f  these domains to Ptdlns contributes to subcellular localisation and 
membrane association. The lipid specificity o f PX domains and specifically o f  the PX 
domain within p47phox was established by Kanai and colleagues, who carried out 
protein-lipid binding assays using so-called PIP-arrays, in which various 
phosphatidylinositols were spotted onto nitrocellulose membranes. These were 
incubated with either p47phox or p40phox PX domain GST-fiision proteins and binding 
was detected using anti-GST antibodies (Kanai et al., 2001). The authors o f  this study 
showed that the p47phox PX domain bound strongly to PtdIns(3,4)P2 but weakly to 
various other Ptdlns including Ptdlns (3,5)P2, PtdIns(3)P and PtdIns(3,4,5)P3. In 
contrast the p40phox PX domain specifically only bound to PtdIns(3)P. This suggests that 
the p47phox PX domain has a strong preference for Ptdlns (3,4)P2, where as the p40phox
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PX domains has a preference for PtdIns(3)P. This observation was verified by a number 
o f other in vitro assays including ultracentrifugation assays for lipid-vesicle binding (see 
Materials and Methods). Furthermore this study showed that mutation o f R42Q in the 
PX domain o f  p47phox, which is found in some CGD patients completely eliminated 
binding to Ptdlns (3,4)P2, thus further highlighting the importance o f lipid binding for 
full NADPH oxidase activity (Kanai et al., 2001).
Karathanassis and colleagues furthered our understanding o f the lipid binding 
activity o f the p47phox PX domain, by carrying out more quantitative binding studies 
using surface plasmon resonance (SPR) with lipid vesicles coupled to sensor chips 
(Karathanassis et al., 2002). They showed that in the absence o f PtdIns(3,4)P2, purified 
recombinant p47phox PX domain had a low affinity (>20 pM ) for vesicles only 
containing phosphatidylcholine (PC) or phosphatidylethanolamine (PE). However when 
PtdIns(3,4)P2 was included the affinity dramatically increased to 38 nM. Furthermore, 
mutations in the PtdIns(3,4)P2 binding pocket such as R43Q and R90A decreased the 
affinity by 245-fold and 84-fold; respectively (Karathanassis et al., 2002). These results 
clearly show that the p47phox PX domain binds with high affinity to PtdIns(3,4)P2. 
Interestingly, the crystal structure o f  the p47phox PX domain shows that it contains a 
second, smaller lipid binding pocket which might possibly accommodate small anionic 
lipids (Figure 17). This is supported by the observation that in the presence o f 
phosphatidic acid (PA) the affinity for PtdIns(3,4)P2 in increased 63-fold, while the 
presence o f phosphatidylserine (PS) increased the affinity 25-fold. These results indicate 
that simultaneous binding in the presence o f an anionic phospholipid, preferentially PA, 
may synergistically increases membrane affinity (Karathanassis et al., 2002).
1.3.2.1.5 p4 7 Phox phosphorylation relieves the PX domain for PtdIns(3,4)P2
binding
During the resting state o f  the NADPH oxidase, binding o f the p47phox PX 
domain to Ptdlns appears to be m asked (in the context o f the full-length protein). Using 
SPR Karathanssis and colleagues showed that the binding affinity for PtdIns(3,4)P2 was 
34-fold weaker (1.3 pM ) than that for the isolated PX domain (38 nM), suggesting that 
in the resting state o f the enzyme the PX domain is not fully accessible (Karathanassis 
et al., 2002). Ago and colleagues similarly showed using liposome binding assays (for 
details see Material and Methods) that full-length recombinant GST-p47phox was unable 
to bind liposomes containing PtdIns(3,4)P2, where as isolated GST-p47phox PX domain
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bound effectively (Ago et al., 2003). A subset o f PX domains contain a consensus PxxP 
motif, which is typically known to bind SH3 domains, leading to the suggestion that 
intramolecular PxxP-SH3 domain interactions in p47phox may be responsible for 
inhibition o f lipid binding. This model originated from a study by Hiroaki and 
colleagues who showed through NM R chemical shift perturbation assays, that the 
p47phox PX domain was able to bind the p47phox SH 3 b domain with an affinity o f  around 
50 pM  (Hiroaki et al., 2001). However, the crystal structure solved by Groemping and 
colleagues has since shown that during the resting state, the polybasic region already 
occupies the binding surfaces o f  the tandem SH3 domains, which are thus not available 
to interact with the PX domain (Groemping et al., 2003).
Interestingly though, certain mutations in p47phox that interfere with auto­
inhibition and lead to NADPH oxidase activation have been shown to restore lipid 
binding. For example Karathanssis and colleagues used SPR to show that mutation o f 
the conserved S H 3 b residue W263 (W 263R) in full-length protein increased the affinity 
for lipid vesicles by 560-fold, in comparison to full-length wild-type p47phox. Similar 
observations were made using in vitro liposome binding assays (Ago et al., 2003). 
Importantly, it has emerged that phosphorylation o f the same serine residues that induce 
activation o f p47phox exposes the PX domain and thereby allows interaction with Ptdlns. 
For example, Ago and colleagues used the whole-cell system where they transfected 
either wild-type full-length p47phox or a full-length mutant carrying the S303/304/328A 
substitution into K562 cells (leukemic cell line transduced with gp91phox and p67phox) 
(Ago et al., 2003). They showed that when these cells were stimulated with PMA the 
triple mutant did not translocate to membranes as determined by immunoblot assays, 
and failed to support 0 2 ’ generation. However wild-type p47phox supported both, thus 
indicating that phosphorylation o f  S303, 304 and 328 is required to induce a 
conformational change in p47phox, which renders the PX domain free for Ptdlns binding. 
This was further supported by the observation that full-length GST-p47phox, which was 
phosphorylated in vitro by PKCpiI bound to Ptdlns liposomes, however full-length 
GST- p47phox S303/304/328A did not. M ore importantly, the p47phox phosphorylation 
mimic carrying S303/304/328D substitutions was capable o f binding Ptdlns liposomes 
without treatment with PKC (Ago et al., 2003). Similarly Karathanassis and colleagues 
showed through SPR analysis that a quintuple full-length p47phox phosphorylation 
mimic carrying S303, 304, 328, 359 and 370E substitutions, bound to PtdIns(3,4)P2 
lipid vesicles with an affinity 100-fold greater than wild-type p47phox (Karathanassis et 
al., 2002).
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Although it is not clear how phosphorylation o f  the C-terminal serine residues 
359 and 370 may contribute to the exposure o f the PX domain, it is well accepted that 
phosphorylation o f the serine residues located within the auto-inhibited segment (S303, 
304 and 328) plays a key role. Overall, the studies carried out so far leave no doubt that 
the p47phox PX domain is masked in the full-length protein. Nevertheless the exact 
binding target o f the PX domain is unknown, and will most likely involve the complete 
auto-inhibitory core rather than solely the SH 3 b domain o f p47phox as initially suggested.
1.3.2.1.6 Active p47phox may interact directly with gp91phox
In addition to the interaction between p47phox and p22phox it has been proposed 
that active p47phox may also directly interact with gp91phox at potentially three different 
sites (Figure 6). One o f these was identified by Leusen and colleagues using neutrophils 
from an X-linked CGD patient carrying the gp91phox N500G mutation. Using PMA 
activated cell-free assays they reported that neutrophils from this patient failed to 
support O2 ' generation and that membrane association o f p47phox was strongly reduced 
(determined by immunoblot assays) (Leusen et al., 1994b). M oreover this failure was 
corrected when membranes were replaced with those from normal neutrophils, 
suggesting that p47phox directly interacts with gp91phox at position 500 in the extreme C- 
terminal region. This proposal was further confirmed by the observation that pre­
incubation o f  normal neutrophil membranes in cell-free assays with a synthetic wild- 
type peptide spanning gp91phox at amino acids 491-504 interfered with both, p47phox 
membrane translocation and O 2 * generation. However, a mutant peptide carrying the 
N500G substitution was 10-fold less potent than the wild-type peptide (Leusen et al., 
1994b). DeLeto and colleagues used random-sequence peptide phage display library 
analysis o f  recombinant p47phox, to further identify potential sites o f  interaction between 
p47phox and flavocytochrome bsss. They mapped two additional sites encompassing 
amino acids 450-457 (close to the NADPH binding site) and amino acids 86-93 (in the 
first cytosolic loop o f gp91phox) and reported that synthetic peptides to these regions also 
inhibited 02’’ generation (DeLeo et al., 1995). Furthermore, peptide walking 
experiments have been used to map possible regions in p47phox that may bind gp91phox. 
Briefly, overlapping peptides spanning p47phox were added to a cell free system and 
their ability to inhibit NADPH oxidase activity determined. Results o f  such studies 
identified the region spanning residues 301-339 in p47phox as a possible gp91phox binding 
site (Morozov et al., 1998).
75
These proposed multiple interactions between p47phox and gp91phox may take 
place to correctly position p67phox for interaction with gp91phox, or may induce 
conformational changes in flavocytochrome bssg. However the molecular details o f such 
an interaction are unknown.
1.3.2.2 p67phox
P67phox consists o f 526 amino acids and has a m olecular weight o f 
approximately 60 kDa. It contains three different types o f protein interaction domains: a 
tetratricopeptide repeat (TPR) domain, consisting o f  four repeats, two SH3 domains and 
a PB1 domain. In addition it contains a PR region (Figure 7). P67phox was initially 
identified through immunoblot assays as a protein missing in neutrophils from patients 
with a form o f autosomal recessive CGD (Volpp et al., 1988). Its importance for 
NADPH oxidase activity was highlighted by Leto and colleagues using cell-free assays, 
where the authors showed that purified recombinant p67phox was able to partially restore 
NADPH oxidase activity in p67phox deficient CGD neutrophils (Leto et al., 1990). In the 
resting state o f the oxidase p67phox interacts simultaneously with p40phox and p47phox (for 
detailed descriptions refer to section 1.3.2) and acts as a bridge that connects these two 
proteins (section 1.5). After activation and translocation to the membrane p67phox 
interacts with the membrane bound flavocytochrome bssg, and with Rac. The possible 
functional significance o f these interactions are discussed in detail below.
1.3.2.2.1 P67phoxis absolutely required for NADPH oxidase activity
Heyworth and colleagues showed that p67phox failed to migrate to the membrane 
in p47phox deficient CGD neutrophils stimulated with PMA, thus suggesting that 
membrane translocation o f p67phox is dependent on the presence o f p47phox (Heyworth et 
al., 1991). However, using cell-free assays Freeman and Lambeth showed that as long 
as p67phox and Rac were present at high concentration, p47phox was not essential for 
generating large amounts o f O2 ’ Nevertheless, if  either p67phox or Rac were omitted 
from the system then no NADPH oxidase activity was observed, even in the presence o f 
high concentrations o f p47phox (Freeman and Lambeth, 1996). This highlights the 
importance o f p67phox in NADPH oxidase activity, and suggests that although p47phox 
plays an important role as an adaptor protein it is p67phox and Rac, which are essential 
for O2 " generation. These authors go on to suggest that p67phox and/or Rac may be
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directly involved in regulating NADPH oxidase activity (Freeman and Lambeth, 1996) 
as discussed in more detail in section 1.3.2.4.5.
M olecular details o f the involvement o f p67phox in regulating NADPH oxidase 
activity were beginning to emerge in 1998 when Han and colleagues reported that 
truncated p67phox (1-198) failed to support O2 ’ generation in cell-free systems. Shorter 
truncations (1-235, 1-221, 1-216 and 1-210) generated O 2 ' similar to wild-type p67phox, 
however any p67phox construct shorter than 210 amino acids failed to support enzyme 
activity. Based on these results the authors proposed that p67phox contained an 
‘activation dom ain’ in the region spanning residues 199-210. They further defined the 
activation domain by making single amino acid mutations (converted to alanine or 
leucine), and examining the effects these mutations had on O 2 ' generation. They 
showed that the mutations significantly reduced the ability o f p67phox to support 
NADPH oxidase activity, and based on these results the authors proposed that the 
p67phox activation domain may directly interact with flavocytochrome bssg to regulate 
enzyme activity. In addition the authors reported that mutations in the activation domain 
did not affect binding o f p67phox to Rac, as determined by fluorescence spectroscopy. 
Based on these results and the fact that Rac is absolutely essential for NADPH oxidase 
activity, the authors proposed that the role o f  Rac in the NADPH oxidase system may be 
to correctly orientate p67phox so that the activation domain is juxtaposed with gp91phox 
for the electron transport reaction to take place (Han et al., 1998).
Using cell-ffee assays Nisimoto and colleagues measured the reduction o f  FAD 
by NADPH fluorophotometrically (Nisimoto et al., 1999). The authors o f  this study 
showed that adding NADPH to the system gradually reduced FAD over the course o f  
the measurement, which corresponded to the observed increase in O 2 ' generation. 
However, when p67phox was omitted from the system the flavin was almost completely 
oxidised and O 2 ' was not generated. Such a complete loss was not observed when 
p47phox was omitted from the system, thus suggesting that p67phox is crucial for the 
reduction o f FAD and hence NADPH oxidase activity. They further reported that 
truncated p67phox (1-198) where the activation domain was absent, resulted in a very low 
level o f FAD reduction and failed to support detectable levels o f O2 ’ production. Similar 
results were observed with p67phox activation domain mutants (V204A and V205A), 
thus suggesting that the activation domain o f  p67phox may be involved in regulating the 
reduction o f FAD by NADPH (Nisimoto et al., 1999). The results o f this study were 
further supported by a similar article published a year later (Han and Lee, 2000).
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Ultimately a direct interaction between p67phox and the gp91phox subunit o f  the 
membrane flavocytochrome was shown by Dang and colleagues using three different 
approaches (Dang et al., 2001). An overlay assay was used in the first approach where 
neutrophil specific granules (source o f  flavocytochrome bssg) from a normal patient and 
from a gp91phox CGD patient were resolved and transferred to a nitrocellulose 
membrane. The membranes were incubated with phosphorylated p67phox (32P) and 
analysed by autoradiography. Their results showed that p67phox recognised a band 
running at ~91 kDa in normal neutrophils, but was not recognised in gp91phox deficient 
neutrophils. They confirmed that this 91 kDa band was indeed gp91phox through 
immunoblot assays using antibodies against gp91phox. The second approach used dot- 
blot assays where binding o f p67phox to purified flavocytochrome bsss was detected 
using antibodies against p67phox. Their third approach used affinity precipitation where 
GST-p67phox was incubated with flavocytochrome bsss, to which glutathione-sepharose 
4B beads were added. The beads were pelleted and immunoblot assays were carried out 
to show binding between p67phox and gp91phox using antibodies against the latter. 
Altogether their result concluded that indeed p67phox does interact directly with gp91phox, 
and such a direct interaction could explain the observation that p67phox is absolutely 
required for enzyme activity. These authors also provided evidence for the importance 
o f Rac in the NADPH oxidase system. They showed through affinity precipitation 
assays and scanning densitometry, that binding o f p67phox to gp91phox was enhanced in 
the presence o f R acl, thereby suggesting that the role o f R acl is to prom ote the 
interaction between p67phox and flavocytochrome b558 (Dang et al., 2001).
In addition it has been suggested that p67phox may also contain a binding site for 
NADPH. Smith and colleagues showed that treating neutrophil cytosol with a 2 ’, 3'- 
dialdehyde derivative o f NADPH, inactivated O2 " generation which was reversed upon 
addition o f  NADPH (but not NADP, NAD or GTP). Chromatographic purification o f 
the cytosol yielded fractions containing the dialydehyde sensitive component, as 
determined by its ability to restore the loss in NADPH oxidase activity. This component 
was identified by immunoblot assays to be p67phox, suggesting that p67phox may be the 
NADPH dialydehyde sensitive component (Smith et al., 1996). In further support o f  this 
proposal the authors showed that adding purified recom binant p67phox to NADPH 
dialydehyde treated cytosol was capable o f restoring NADPH oxidase activity. In 
addition affinity labelling studies using radioactive NADPH dialydehyde showed that 
only p67phox was labelled, and this labelling was reduced by NADPH. Although it is 
generally accepted that gp91phox contains all the catalytic machinery necessary for
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oxygen reduction, based on these data Smith and colleagues proposed that NADPH 
oxidase may contain two separate catalytic NADPH binding sites; one in gp91phox and 
the other in p67phox. They speculate that upon translocation o f  p67phox to the membrane, 
the two NADPH binding sites may cooperate to form a single NADPH catalytic unit. 
Dang and colleagues provided further evidence for this model. The authors o f this study 
made the following truncated forms o f p67phox: p67phox (1-243), p67phox (1-210), p67phox 
(1-199) and p67phox (244-526). Using fluorescence spectroscopy they showed that the 
fragments o f p67phox that contained the N-terminal portion o f  the protein bound NADPH 
whereas the C-terminal fragment did not, thus suggesting that the N-terminal portion o f 
p67phox may contain the NADPH binding site (Dang et al., 1999). Furtherm ore the 
authors showed that p67phox (1-119), which contains the TPR domain, bound to NADPH 
with a IQ o f 6.4 pm which was similar to that o f full-length p67phox (7.2 pm). Based on 
these results Dang and colleagues proposed that p67phox may bind NADPH via its TPR 
domain (Dang et al., 1999). However, such an interaction could not be reproduced by 
other groups (unpublished data) and further work is required to gain a better 
understanding about this possible p67phox-NADPH interaction.
1.3.2.3 P40phox
P40phox consists o f 339 amino acids and has a m olecular w eight o f 
approximately 39 kDa. P40phox was the last NADPH oxidase subunit to be discovered 
and was identified via its co-purification with p67phox (Someya et al., 1993; W ientjes et 
al., 1993), P40phox contains three different types o f protein interaction domains; a PX 
domain, a SH3 domain and a PB1 domain (Figure 11). P40phox is tightly associated with 
p67phox and its presence in the cytosol o f patients with p67phox deficient CGD is 
markedly reduced, leading to the suggestion that the interaction between p67phox and 
p40phox may have a stabilising effect on the individual proteins. In contrast, there are no 
reports o f a reduction in p40phox levels in patients lacking p47phox (W ientjes et al., 1993).
To date there are no reported cases o f p40phox linked CGD, and the exact role o f 
p40phox is controversial as it has been seen to both inhibit and stimulate NADPH oxidase 
activity. For example, Sathyamoorthy and colleagues showed that when p40phox was 
added to neutrophil membranes plus p47phox, p67phox and Rac, O2 * generation was 
inhibited by 35 %. Furthermore, the isolated SH3 domain o f  p40phox had an even greater 
effect by reducing NADPH oxidase activity by 60 %, thus suggesting that p40phox may
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Figure 11: Domain arrangement and amino acid sequence of the cytosolic NADPH oxidase
protein p40pho\  Boundaries of the individual domains were obtained from the Pfam database (Bateman et 
al., 2004) and the Prosite database (Hulo et al., 2006).
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down-regulate NADPH oxidase activity. Based on these observation and yeast-two 
hybrid screens that showed an interaction between the p40phox SH3 domain and the C- 
terminal PR region o f p47phox (Fuchs et al., 1996), Sathyamoorthy and colleagues 
proposed that p40phox may compete with p67phox for binding to p47phox and thereby 
down-regulate NADPH oxidase activity (Sathyamoorthy et al., 1997). Further support 
for a potential interaction between p40phox and p47phox, and hence for this model comes 
from gel filtration and small angle neutron scattering experiments (Grizot et al., 2001), 
and the affinity-bead method using recombinant proteins coupled to Hitrap columns 
(Wientjes et al., 1996). However p40phox only binds weakly to p47phox with an affinity in 
the range o f 5 pM , as estimated based on small angle neutron scattering studies (Grizot 
et al., 2001) and analytical ultracentrifugation (Lapouge et al., 2002). W hile the 
interaction between the C-terminal PR region o f p47phox and the C-terminal SH3 domain 
o f p67phox occurs with a high affinity, between 20-40 nM as determined by ITC and 
surface plasmon resonance (Lapouge et al., 2002; W ientjes et al., 1996), thus making a 
direct competition unlikely.
At the same time there is overwhelming evidence to suggest that p40phox may be 
a positive regulator o f NADPH oxidase activity. For example Tsunawaki and colleagues 
reported that mixing resting neutrophil cytosol with antibodies against the C-terminal 
region o f  the p40phox (which binds p67phox) prevented co-im munoprecipitation o f 
P67ph0\  as determined by immunoblot assays and importantly reduced O 2 ' generation 
by up to 55 % (Tsunawaki et al., 1996). Kuribayashi and colleagues used K562 cells 
(which express functional flavocytochrome bss%, p47phox and p67phox) and tested the 
reaction o f these cells upon stimulation with PMA in the presence or absence o f  co­
transfected p40phox. These experiments showed that in cells that did not express p40phox, 
p47phox and p67phox were able to translocate to the membrane in a time-depended 
manner, as determined by immunoblot assays. However, the presence o f p40phox not 
only increased membrane translocation 2-3 fold but also O2 " generation. Thus 
suggesting that binding o f p40phox to PtdIns(3)P may aid the recruitment o f  p67phox, 
which does not contain a PX domain to the membrane flavocytochrome. Furthermore, 
the authors o f this study reported that this enhancement was dependent on the 
interaction between p40phox and p67phox, as cells expressing p40phox with the mutation 
D289A (residue important in the interaction between p40phox and p67phox) was not 
capable o f enhancing O f ' generation (Kuribayashi et al., 2002). Finally, Ellson and 
colleagues used p40phox mouse knock-out models to show that neutrophils from these 
mice produced 69-84 % less O2 * than wild-type mice. These p40phox deficient mice also
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presented severe deficiency in destroying S. aureus both in vitro and in vivo, thus 
suggesting that p40phox is essential for pathogen destruction (Ellson et al., 2006).
1.3.2.3.1 p40phox p x  domain binds PtdIns(3)P
The PX domain o f p40phox shows a very strong preference for binding 
phosphatidylinositol 3-phosphate (PtdIns(3)P), as determined using a variety o f 
methods including protein-lipid overlay and liposome binding assays (Ago et al., 2001; 
Kanai et al., 2001) as well SPR (Ellson et al., 2001). The molecular basis o f this 
specificity could be explained by the crystal structure o f  the isolated PX domain bound 
to PtdIns(3)P (Bravo et al., 2001), and more recently the structure o f full-length p40phox 
bound to PtdIns(3)P (Honbou et al., 2007) (for further details see section 1.4.4). 
PtdIns(3)P which is a product o f PI3K signalling pathways becomes abundantly 
available in the phagosomal membrane during phagocytosis, and thus may act as a 
signalling molecule to direct the NADPH oxidase complex by binding to p40phox (Ellson 
et al., 2001). The functional integrity o f the PX domain seems crucial for the positive 
regulatory role o f p40phox, as transgenic mice with a mutation in the PX domain (R58A) 
are severely impaired in their ability to kill S. aureus, and neutrophils derived from 
these mice show a reduced production o f O2 ’ upon stimulation (Ellson et al., 2006), thus 
further supporting a positive regulatory role o f  p40phox.
All in all there are now an increasing number o f reports that support a positive 
role for p40phox in NADPH oxidase regulation. However the m olecular basis o f  such a 
positive regulatory role is still not understood and further studies are required to fully 
bring to light the precise role o f this subunit
1.3.2.4 Rac
Rac belongs to the Rho family o f small GTPases, which are approximately 20 
kDa in size and constitute a subfamily o f the Ras superfamily o f small GTPases. Two 
closely related Rac isoforms exist; Racl and Rac2, which primarily differ in their C- 
terminal region which is more basic in R acl than Rac2. Racl is ubiquitously expressed 
whereas Rac2 is only expressed in hem atopoietic cells. Like all small GTPases R acl 
and Rac2 carry a lipid modification in their C-terminus; a geranylgeranyl group which 
anchors these proteins to the membrane.
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Members o f  the Rho family o f small GTPases play important roles in the 
regulation o f a large wide variety o f cellular processes including cell growth and 
differentiation, cytoskeletal organisation, lipid vesicle transport and O2 ‘ generation. 
They act as molecular switches only relaying signals when in their active form (Figure 
12). Specifically, Rac alternates between an inactive GDP-bound state and an active 
GTP-bound state. Binding o f  an extracellular ligand to a specific cell surface receptor 
causes Rac-specific guanine-nucleotide exchange factors (GEFs) such as the PIP3- 
dependent Rac exchanger (P-R exl) to catalyse the dissociation o f  GDP from Rac, 
thereby allowing GTP, which exists in much higher concentration within the cell, to 
bind. This GTP-bound Rac recognises and binds specific downstream proteins (Figure 
12) and thereby induces a specific cellular response, either through inducing a 
conformational change in the effector protein, a change in its subcellular localisation or 
by inducing the assembly o f large, multi-protein complexes as observed in NADPH 
oxidase. The signal is terminated by GTPase activating proteins (GAPs), which bind 
activated GTPases and increase the rate o f GTP hydrolysis by several orders o f 
magnitude, switching it from the GTP-bound form to the inactive GDP-bound (Takai et 
al., 2001). In addition, Rho family proteins associate with guanine-nucleotide 
dissociation inhibitors (GDIs) while in their GDP bound form. GDIs contain a 
hydrophobic pocket that is able to accommodate the geranylgeranyl group, and thereby 
extract the GTPase from the membrane and keep it cytosolic in its inactive state 
(Hoffman et al., 2000; Scheffzek et al., 2000).
Like all small GTPases, Rac contains the so-called switch I region (aa 30-40)
and switch II region (aa 60-67) in its N-terminal portion. These regions are the only part 
o f the molecule that change their conformation upon switching between the inactive and 
active form, and are those regions that are recognised by downstream effectors as well 
as regulatory proteins. In addition, Rac contains a so-called insert region, also called
insertion helix, which is specific to Rho-family GTPases, but whose function is not
really understood at present (see below).
1.3.2.4.1 Rac is involved in activating the NADPH oxidase
Several groups first suggested the involvement o f a small GTPase in the 
regulation o f the NADPH oxidase in the late 1980’s. For example a study by Ishida and 
colleagues showed that SDS activated cell-free systems containing membrane bound
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Figure 12: Regulation of small G-protein activity. Illustration shows that small GTPases act as
molecular switches, alternating between an inactive GDP-bound state and an active GTP-bound state. 
Binding of guanine-nucleotide exchange factors (GEFs) catalyse the conversion from GDP to active GTP 
bound forms. The GTP-bound form recognises and binds specific effector proteins to induce downstream 
signals. The signal is terminated by GTPase activating proteins (GAPs) by binding and converting the 
active GTP bound form to the inactive GDP form (taken and adapted from Takai et al., 2001).
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flavocytochrome b558, and cytosolic p47phox and p67phox were not sufficient to support 
NADPH oxidase activity. However when GTP or GTP-yS (a non-hydrolysable GTP 
analogue) were added, 0 2‘ generation was increased several fold. This effect was 
decreased when GDP was added, thereby suggesting that a guanine nucleotide 
regulatory protein may be involved in regulating NADPH oxidase activity (Ishida et al., 
1989). This protein was subsequently identified to be R acl or Rac2, which were shown 
to be absolutely required for full NADPH oxidase activity, as discussed in more detail 
below.
W hen Abo and colleagues chromatographically purified guinea pig macrophage 
cytosol they observed two bands running at 22 kDa and 26 kDa on SDS-PAGE (Abo et 
al., 1991). Based on immunoblot assays they suggested that the smaller band was most 
likely R acl. In addition, sequence analysis o f trypsin digested peptides o f the 22 kDa 
and 26 kDa proteins showed that they shared sequence homology with R acl and 
RhoGDI, respectively. In further support o f their proposal for the involvement o f  Rac 1 
they showed that adding recom binant R acl to a cell-free system increased 0 2' 
generation by three-fold. However, this increase in activity only occurred when Racl 
was pre-incubated with GTP-y-S but not with GDP-pS. This suggested that not only 
was Rac essential for NADPH oxidase activity, but that it was kept inactive when bound 
to RhoGDI, and only became active when in a GTP-bound form (Abo et al., 1991). 
Similar experiments were carried out by Knaus and colleagues, however in that study 
cytosol from human neutrophils was used, and sequence analysis subsequently 
identified the small GTPase involved to be Rac2 (Knaus et al., 1991).
Since then there have been numerous in vitro and in vivo studies to show that 
Rac is absolutely required for 0 2' generation. For example Freeman and Lambeth 
showed through cell-free assays that when Rac was omitted from the assay, 0 2‘ 
generation could not be detected (Freeman and Lambeth, 1996). Furthermore, Roberts 
and colleagues showed a significant reduction in the amount o f 0 2" generation from 
bone marrow-derived neutrophils from Rac2 deficient mice. These Rac2 deficient mice 
also showed increased mortality upon challenge with A. fumigatus (Roberts et al., 
1999), suggesting that Rac is essential for normal NADPH oxidase activity.
1.3.2.4.2 Rac2 is the predominant isoform in human neutrophils
Heyworth and colleagues reported that both, recombinant R acl and Rac2, were 
capable o f supporting 0 2" generation to comparable levels in human neutrophil cell-free
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systems, where the cytosol was replaced by recom binant p47phox and p67phox and 
supplemented with GTP-yS or GTP (Heyworth et al., 1993). This result is not surprising 
as both isoforms share 92 %  sequence homology (Didsbury et al., 1989). However, it 
has been shown by various groups that the predom inant Rac isoform involved in 
activating the NADPH oxidase in human neutrophils is in fact Rac2. For example a 
study by Knaus and colleagues showed that an antibody against the C-terminus o f Rac2 
significantly inhibited O2 ’ production in neutrophil cell-free systems, while an antibody 
against the C-terminus o f R acl had a much lower inhibitory effect (Knaus et al., 1991). 
In support o f these findings, Abo and colleagues chromatographically purified the 
cytosol o f resting neutrophils and immunoblot assays using antibodies against R acl and 
Rac2 showed that the cytosol predominantly contained Rac2 (Abo et al., 1994). 
Furthermore, Heyworth and colleagues quantitated the relative amounts o f Rac by using 
highly purified neutrophil Rac2 as a standard, alongside neutrophil cytosol which was 
diluted so that the final concentration was within the linear range o f the standard curve. 
This was followed by immunoblotting to show that > 96 % o f Rac present in neutrophils 
was indeed Rac2 (Heyworth et al., 1994).
The physiological importance o f  Rac2 in NADPH oxidase activity has been 
highlighted by the discovery o f a case o f  CGD where Asp57 located N-term inal to the 
switch II region was substituted for Asn (Rac2D57N). Neutrophils from this patient could 
not support O2'" generation in vitro (Ambruso et al., 2000). The equivalent mutation in 
Ras (D57N) has previously been shown to act in a dominant negative m anner where it 
preferentially bound GDP and formed a stable complex with GEFs thereby interfering 
with activation o f Ras (Jung et al., 1994). Ambruso and colleagues showed that 
Rac2D57N had a similar effect as recom binant Rac2D57N could bind [3H]GDP but was 
unable to bind [35S]GTP[yS]. Furthermore, recom binant Rac2D57N was unable to support 
O2 " generation in a cell-free system, suggesting that Rac2D57N does indeed act in a 
dominant negative manner thereby preventing NADPH oxidase activation.
1.3.2.4.3 Membrane translocation of Rac
Initially it was believed that Rac would translocate together with p47phox and 
p67phox to the membrane. This idea was based on data from cell-free assays in which 
activation was induced with SDS, and membrane translocation, followed by the 
preparation o f membrane and cytosol fractions and their subsequent analysis by western 
blotting (Abo et al., 1994). In a parallel study Heyworth and colleagues carried out cell-
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free and whole cell assays using CGD neutrophils lacking p47phox or p67phox, to 
determine if  Rac2 translocation was dependent on these cytosolic proteins. Their results 
showed that even in the absence o f  p47phox or p67ph0\  Rac2 was still able to translocate 
and associate with the membrane in a normal manner, thus suggesting that Rac2 must 
translocate to the membrane in an independent fashion (Heyworth et al., 1994). A 
similar study using p47phox and p67phox deficient CGD neutrophils was conducted by 
Dusi and colleagues, who also reported that Rac2 translocated to the membrane 
independent o f either these subunits (Dusi et al., 1996). Since then there has been 
overwhelming evidence to show that Rac indeed translocates to the membrane 
independently.
1.3.2.4.4 The interaction between Rac and p67phox is crucial for NADPH 
oxidase activity
In order to identify the functional target protein for Rac in the NADPH oxidase 
system, Diekman and colleague’s purified recom binant GST-tagged p67phox and p47phox 
and carried out in vitro binding assays using R acl, which was bound to radioactively 
labelled GTP or GDP. These assays showed that Rac only bound to p67phox but not 
p47phox, suggesting that p67phox is the functional target for Rac. Importantly, this 
interaction only took place when Rac was in its active GTP-bound form, suggesting that 
p67phox is a bona fide downstream effector o f Rac (Diekmann et al., 1994). The authors 
o f this study further attempted to define the binding region for Rac within p67phox, and 
using different p67phox truncations in pull-down assays were able to show that Rac binds 
the N-terminal region o f  p67phox between residues 1-199. Simultaneously, the authors 
showed that Rac binds p67phox via its effector region, as three effector region mutants 
(aa 35, 38 and 40 substituted with alanine or lysine) were unable to support O2 ’ 
generation and no loner bound p67phox (Diekmann et al., 1994).
Since then there have been numerous reports, which confirm the proposal that 
Rac supports NADPH oxidase activity by binding the N-terminal region o f p67phox; a 
region which is comprised o f four tetratricopeptide repeats (TPR). An interesting study 
was carried out by Koga and colleagues who introduced mutations into the TPR m otif 
o f p67phox which were expected to disrupt the packing o f the TPR helices. Specifically, 
they substituted small conserved amino acids with bulky Gin residues and deleted a 
conserved residue at position 22 in the TPR motifs, resulting in incorrect packing 
between adjacent TPRs (similar mutations in the p67phox TRP m otif have been reported
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in CGD patients). The effects o f these mutations on Rac2-p67phox binding was examined 
using the yeast two-hybrid system and overlay assays with GST-fusion recombinant 
proteins (Koga et al., 1999). The authors o f this study reported that mutations in the first 
three repeats resulted in defective p67phox-Rac binding and abolished O2 ' generation 
under cell-free conditions, suggesting that only the first three TPRs o f p67phox are 
involved in Rac binding. However, although mutations in the last TPR did not affect 
p67phox-Rac binding, they showed little or no support for NADPH oxidase activity. This 
suggests that the fourth TPR may contribute to enzyme activation possibly by 
interacting with other components such as flavocytochrome bssg. Together the authors 
o f this study proposed that the TPRs o f p67phox are packed in a manner as to provide the 
binding site for Rac2, which plays a crucial role in NADPH oxidase activation (Koga et 
al., 1999). Additional support for the importance o f the Rac-p67phox interaction for 
NADPH oxidase activity comes from the observation that point mutations within switch 
I o f both Racl and Rac2 significantly reduce O2 ’ generation (Freeman et al., 1994; Xu 
et al., 1994).
The importance o f the TPR domain in p67phox for complex formation with Rac 
has been confirmed by the crystal structure o f this domain in complex with Rac-GTP 
(Lapouge et al., 2000) (Figure 15). The structure revealed that the switch I region o f 
Rac-GTP plays an important role in complex formation and further explained the 
molecular basis for the specificity o f  this interaction. In addition, the authors o f this 
study used isothermal titration calorimetry (ITC) to quantify the interaction between 
Rac 1/2 and p67phox and investigate if  the remainder o f p67phox may contribute to 
complex formation. No significant differences were found between R acl and Rac2 or 
between full-length p67phox and the isolated TPR domain. Thus clearly showing that the 
C-terminal portion o f p67phox neither contributes nor is affected by complex formation, 
and that any differences detected in vivo between R acl and Rac2 may be due to 
differences in their affinity for p67phox.
1.3.2.4.5 Models for Rac function in NADPH oxidase regulation
Members o f the Rho-family o f GTPases have the interesting property that they 
contain an insertion o f 12 amino acids at position 123-135, which has been called the 
insertion helix. Although many groups have studied the role o f this insertion helix its 
function is still controversial. In fact, the role o f Rac in NADPH oxidase activity has for 
a long time believed to be the m ost convincing case for a functional role o f  this
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insertion. The crystal structure o f  the p67TPR-Rac.GTP complex (Lapouge et al., 2000) 
(Figure 15) has shown that the insertion helix is distant from the p67TPR/Rac interface 
and not required for complex formation, however, the insertion is exposed and hence 
available for other interactions, for example with the cytochrome. So far mutational 
studies have produced conflicting results concerning the involvement o f  the insertion 
helix in O2 * production, as discussed in more detail in the models that follow. 
Furthermore, there is still controversy about the precise role o f Rac in the regulation o f 
NADPH oxidase activity, whether it acts primarily as an adaptor or is an active 
participant in the catalytic process. These models are described as follows.
The model proposed by Lambeth and colleagues suggests p67phox is the main 
driving force for the electron transport reaction, and that Rac functions solely as an 
adaptor protein. They propose that once Rac becomes activated it is recruited to the 
membrane where it binds p67phox via the switch I region and may bind flavocytochrome 
bssg via the insert-region. They believe that these interactions take place to orientate the 
p67phox activation domain in such a manner that it is aligned perfectly for contact with 
flavocytochrome bssg, to regulate the electron transfer reaction (Lambeth, 2000). In this 
model it is believed that a possible interaction between the Rac insertion helix and the 
flavocytochrome does not directly regulate the electron transport reaction. This is based 
on the observation that mutation o f  single amino acids or deletion o f  the insert region o f 
Racl reduced the affinity o f Rac for the oxidase by 13-25 fold, as determined by the 
EC50 value (effective concentration at 50 % o f  Vmax), but did not effect the maximal rate 
(Vmax) o f O2 ’ generation (Freeman et al., 1996).
Edgar Pick’s group on the other hand have proposed a number o f models, some 
o f  which contradict one another (most likely because they are based on data gained 
using different experimental approaches). Originally the group used peptide walking 
experiments under cell free conditions to show that the Rac insertion helix is important 
for O2 " generation (Joseph and Pick, 1995). However, later they proposed a model 
similar to that by Lambeth where p67phox regulates the electron transport reaction, and 
Rac functions primarily as an adaptor protein. In contrast to Lam beth’s model the Pick 
group propose that Rac does not directly interact with flavocytochrome bssg, and that the 
Rac insertion helix is not important for NADPH oxidase activity. The former part o f this 
model was based on the observation that in cell-free assays prenylated Rac was able to 
bind phospholipid vesicles in both the presence and absence o f flavocytochrome bssg 
(Gorzalczany et al., 2000) whereas non-prenylated Rac could not. Thus indicating that 
the lipid tail is required for membrane association, but more importantly that Rac does
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not depend on the flavocytochrome for this interaction. These experiments involved 
incubating prenylated or non-prenylated Rac.mant-GTP (a fluorescent GTP analogue) 
with recombinant p67phox and p47phox, along with either membrane vesicles containing 
membrane bound flavocytochrome bsss or phosphatidylcholine vesicles. The samples 
were purified by gel filtration and the presence o f free Rac and membrane associated 
Rac was measured spectrofluorometrically. The latter part o f this model was based in 
the observation that a recombinant chimeric protein comprising p67phox( 1-212) fused to 
Racl but which was lacking the insertion helix, fully supported O2 " generation in cell- 
free systems (Alloul et al., 2001), thus suggesting that the insertion helix is not required 
for NADPH oxidase activity.
More recently the same group proposed another model for the involvement o f 
Rac in the regulation o f NADPH oxidase activity. In this model Pick and colleagues 
propose that a) Rac tethers p67phox to the membrane whereby it orientates p67phox with 
respect to flavocytochrome bsss and b) Rac induces conformational changes within 
p67phox thereby activating it (Sarfstein et al., 2004). The former part o f the model is 
based on the observation that mutating six basic residues in the Rac C-terminus 
(residues important for membrane association) o f a chimera comprising p67phox (aa 1- 
212) fused to full-length R acl, failed to support O2 ’ generation in a cell free assay. The 
latter part o f the model is based on the observation that m utating key residues that are 
involved in the p67phox Racl interaction such as R102E (in p67phox-TPR domain), A27K 
and G30S (R acl-sw ith I region) resulted in a severe loss in NADPH oxidase activity. 
The authors suggested that the intrachimeric bonds between p67phox and Rac may be 
important for inducing conformational changes within p67phox (possibly within the 
activation domain). In support o f this theory they showed that enzyme activity was 
resorted when exogenous Racl (Racl-G TPyS) was added to the system, but not when 
exogenous p67phox was added. Altogether, based on the above findings Pick and 
colleagues propose that Rac plays a dual role where it tethers p67phox to the membrane 
and induces conformational changes within p67phox, possibly to increase the affinity o f 
p67phox for gp91phox or to activate electron flow through gp91phox (Sarfstein et al., 2004).
In contrast to the two previous models, Deibold and Bokoch propose that Rac 
plays a direct regulatory role and is important for the two-step electron transfer reaction, 
from NADPH to FAD (1st step) and from FAD to heme (2nd step) and then onto 
molecular oxygen (Diebold and Bokoch, 2001). Their proposal is based on experiments 
using a cell-free assay, which contained recombinant p67phox and p47phox, 
flavocytochrome bsss purified from human neutrophils and prenylated Rac2. They
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measured electron transfer in the 1st step by monitoring reduction o f 
iodonitrotetrazolium violet (INT); an artificial two-electron acceptor, and in the 2nd step 
by monitoring cytochrome c reduction. The authors o f this study generated Rac2 and 
p67phox mutants which were unable to interact with one another and found that both, a 
p67phox mutant (A 178-184) and Rac2 switch I region mutants were able to support INT 
reduction (1st step) to similar levels as wild-type p67phox, but support for cytochrome c 
reduction (2nd step) was significantly reduced. Thus suggesting that i) interaction 
between p67phox and Rac2 was not required for the 1st step, ii) Rac and p67phox 
independently regulate electron transfer from NADPH to FAD and iii) that p67phox and 
Rac2 have to interact for subsequent electron transfer in the 2nd step. Based on these 
results Deibold and Bokoch propose that Rac2 may play a regulatory role in the electron 
transfer reaction o f the NADPH oxidase. Importantly, these authors were able to show 
that the fluorescence intensity o f wild-type fluorescently labelled (mant-GppNHp) Rac2 
increased in the presence o f flavocytochrome bsss, thus suggesting a direct interaction 
between the two components. This interaction was not observed when Rac2 insert 
deletion mutants were used, suggesting that Rac2 may regulate the electron transfer 
reaction by binding the cytochrome via the insertion helix (Diebold and Bokoch, 2001).
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1.4 Protein interaction domains
Regulatory proteins are often constructed in a block-like manner, in which 
multiple protein interaction domains are connected by linkers o f varying length and 
flexibility (Pawson, 1995; Pawson and Nash, 2003). Protein interaction modules are 
independently folding units o f 35-150 amino acids that can be separated into domain 
families based on sequence homology. Individual protein interaction domains normally 
exhibit clearly defined ligand binding properties and can mediate the formation o f 
protein-protein, protein-nucleic acid and protein-lipid complexes. Very often these 
domains are crucial for the formation o f  multi-protein complexes that drive and regulate 
signalling processes. Typical protein-protein interaction modules include the Src- 
homology 3 (SH3) domain, which recognizes proline-rich regions and the Src- 
homology 2 (SH2) domain, which binds phosphotyrosine-containing sequences. 
Examples o f lipid binding modules include the phox homology (PX) domain and the 
pleckstrin domain (PH), both o f which bind membrane lipids (phosphoinositides) with 
varying specificities.
In order to understand the molecular mechanism o f NADPH oxidase regulation, 
it is important to understand the interactions that take place between the various protein 
components during activation and assembly. P47phox? p67phox and p40phox are m ulti­
domain proteins, each containing several protein-protein and protein-lipid interaction 
modules as shown in Figures 7 and 11. The properties o f protein interaction domains 
that are present in p47phox, p67phox and p40phox are described in sections 1.4.1 to 1.4.4.
1.4.1 SH3 domain
SH3 domains were first recognised as non-catalytic homology regions o f
approximately 60 amino acids, in protein kinases related to Src (M ayer et al., 1988).
SH3 domains mediate the formation o f  protein-protein interactions, and are known to be
involved in a range o f biological processes from enzyme regulation via intramolecular
interactions, to mediating the assembly o f multi-protein complexes (Mayer, 2001).
Extensive structural studies (X-ray crystallography and NMR spectroscopy) have shown
that all SH3 domains possess the same basic topology (Lim and Richards, 1994; Noble
et al., 1993; Terasawa et al., 1994; Yu et al., 1992). They contain five or six anti-parallel
P-strands packed at approximately right angles into two sheets with three characteristic
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interconnecting loops: the RT (Arg-Thr) loop, the N-Src loop (neuronal Src) and the 
distal loop (Figure 13A). The N-Src and RT loops form part o f the ligand binding 
surface. The distal loop is located on the opposite face and may interact with other 
regions o f the binding partner (Dalgam o et al., 1997). The first p-sheet is formed by P- 
stands A and E and the first half o f p-strand B. The second p-sheet is formed by the 
second half o f  P-strand B and P-strands C and D. The RT loop separates p-strands A 
and B, the N-Src loop separates p-strands B and C, and the distal loop separates p~ 
strands C and A. A 3i0 helical conformation (4-5 amino acids) is generally observed 
between p-strands D and E, and a type II p-tum  can be seen N-terminal to p-stand B. 
This overall fold brings the most conserved residues o f the SH3 domain close together 
to form a patch o f  aromatic residues on the surface o f  the domain for ligand binding 
(Larson and Davidson, 2000). SH3 domain alignments show that there are several 
conserved positions that are important for ligand binding (positions 8(Y), 10(Y), 35(G), 
36(W), 51(P), 53(N) and 54(Y), numbering according to the consensus sequence), o f 
which positions 36(W) and 51(P) are fully conserved among all SH3 domains (Figure 
13B). SH3 domains also contain a hydrophobic core which is crucial for maintaining 
protein stability (Dill, 1990). The core is made up o f several conserved hydrophobic 
residues (Bashford et al., 1987; Chothia et al., 1998) {positions 4(V), 10(Y), 18(L), 
20(F), 26(1), 28(V), 37(W), 50(F) a n d 55(V)) (Larson and Davidson, 2000).
SH3 domains have a flat hydrophobic ligand-binding surface, consisting o f  three 
shallow grooves (Mayer, 2001). The hydrophobic surface o f  SH3 domains typically 
binds to proline rich sequences, preferentially recognising PXXP as the core-binding 
m otif (P being a proline and X being any amino acid, although aliphatic residues are 
preferred) (Feller et al., 1994; M ayer and Eck, 1995; Ren et al., 1993). The specificity 
and affinity o f SH3 domains for their target ligands are generally low, with affinities 
ranging from 5 pM  to 100 pM  (Chen et al., 1993). However, this can be increased by 
additional contacts made outside o f  the core binding motif, for example by residues in 
the RT and N-Src loops (Feng et al., 1995).
Proline-rich (PR) motifs contain seven to ten amino acids, and often adopt a left 
handed polyproline-II helix (PPII) conformation. In this conformation the helix has 
three residues per turn, meaning that it is triangular in cross section. As a consequence, 
the core proline residues are on the same face o f the helix, separated by two amino acids 
(PXXP). This PXXP m otif lies along the binding site o f the SH3 domain, and adheres to 
the three hydrophobic pockets within the binding surface o f SH3 domains
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Figure 13: The structure of a typical SH3 domain and sequence alignment. A. The SH3
domain (blue) from the sex muscle abnormal protein 5 (SEM5), in complex with a proline-rich peptide 
(type II) from mSos (green). The positions of PXXPXR are indicated. The SH3 domain characteristic 
loops are shown in grey and the p-stands are labelled PA-E. PDB identifier 1SEM (Lim et al., 1994). B. A 
sequence alignment of different SH3 domains. Conserved residues that are involved in ligand binding are 
highlighted in yellow (taken and adapted from Groemping et al., 2003). The consensus sequence as 
defined by Larson and Davidson, 2000 is shown below the alignment. All structural pictures were 
generated in PyMOL (http://www.pymol.org) unless otherwise stated.
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(Mayer, 2001). Two of the binding pockets can accommodate the two conserved 
prolines in the consensus PXXP motif, which are crucial for a high binding affinity. The 
third pocket is more variable but in most cases binds basic residues such as arginine. 
Proline rich motifs fall into two classes, which can bind to the SH3 domain either in a 
forward or reverse orientation. Class I motifs contain the RXXPXXP sequence, where 
the arginine residue is N-terminal to the PXXP motif, and class II motifs contain the 
XPXXPXR sequence, where the arginine is C-terminal to the PXXP m otif (Feng et al., 
1994; Lim et al., 1994; Mayer and Eck, 1995) (Figure 14).
Initially it was thought that PXXP motifs were the only ligands recognised by 
SH3 domains. However, recent studies have shown that there are a number of 
exceptions in which SH3 domains are also able to bind non-canonical sequences. Such 
examples include the SH3 domain o f PIX, which recognises an unusual m otif in p21- 
activated kinase (PPPVIAPRPETKA) (Manser et al., 1998), the SH3 domain o f Eps8 
that recognises a PXXDY m otif (Mongiovi et al., 1999), the SH3 domains o f CIN85 
which bind the consensus m otif PXXXPR (Jozic et al., 2005; Kowanetz et al., 2003) 
and many others.
RT
Class I C lass II
Figure 14: Models of class I and 11 proline-rich ligands. The ligands are shown schematically
where ‘P’ and ‘R’ indicate conserved proline and arginine residues; respectively. ‘X ’ indicates any amino 
acid (taken and adapted from Mayer, 2001).
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1.4.2 Tetratricopeptide repeat (TPR) domain
Tetratricopeptide repeats (TPR) are degenerate 34 amino acid sequences that are 
normally found in tandem arrays o f  3-16 motifs. TPR domains were first identified in 
1990 in the S.cerevisiae protein CDC23 (Hirano et al., 1990) and the S.pombe protein 
nuc2+ (Sikorski et al., 1990), both o f which are involved in mitosis. TPR domains are 
often found in proteins that form scaffolds for the assembly o f multi-protein complexes 
to facilitate protein-protein interactions (Das et al., 1998). The first structure solved o f a 
TPR domain was that o f protein phosphatase 5, which showed that each repeat folds 
into two anti-parallel helices that are arranged in a regular fashion next to one another 
(Das et al., 1998) This regular arrangement o f a-helices leads to the formation o f a 
groove, which was suggested to constitute the ligand binding site. The suggestion was 
supported by the structure o f a complex between the TPR domain o f  the adaptor protein 
HOP and a peptide derived from its ligand Hsp90 (Figure 15A) (Scheufler et al., 2000). 
However, since these studies it has emerged that TPR domains are in fact extremely 
versatile, and can bind their ligands via different binding surfaces. One such example is 
the p67phox TPR domain, where ligand binding occurs outside o f  the groove (Lapouge et 
al., 2000).
P67phox contains four TPR motifs in the N-terminal 200 amino acids, and this 
region has shown to bind the small GTPase Rac (in vitro binding assays, yeast two- 
hybrid assays and fluorescence spectroscopy) (Ahmed et al., 1998; Diekmann et al., 
1994; Han et al., 1998). The crystal structure o f the p67phox TPR domain shows that it 
consists o f nine a-helices, and eight o f these form the TPR m otif (Figure 15B) (Lapouge 
et al., 2000). The additional helix at the C-terminus (helix C) is present in almost all 
TPR structures and has been speculated to be im portant in the stability o f these domains 
(D'Andrea and Regan, 2003). As previously observed each repeat folds into two anti­
parallel a-helices (helix A and B). A twenty amino acid insertion between the third and 
fourth repeats o f p67phox folds into two short anti-parallel P-strands and a 3 io helical 
turn, which is known as the p-hairpin insertion. The p-hairpin insertion together with the 
loops connecting the TPR segments (TR1 with TRP2, and TPR2 with TPR3) form the 
binding surface for the small GTPase Rac.
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AHsp90
Figure 15: The structure of HOP and p67ph01 TPR domains in complex with their ligands. A.
The HOP TPR domain is shown in purple, and the Hsp90 peptide in yellow sticks. PDB identifier 1ELR 
(Scheufler et al., 2000). B. The p67phox TPR domain is shown in purple in complex with Rac.GTP (red). 
The P-hairpin insertion which is crucial for complex formation is highlighted in orange, and the TPR 
repeats are labeled 1-4. The additional helix at the C-terminus is highlighted in white text as ‘C ’. PDB 
identifier 1E96 (Lapouge et al., 2000).
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1.4.3 PB1 domain
The PB1 domain is approximately 85 amino acids in length and contains the 
consensus sequence ^X Y X D ED G D X ^X ^kX SD ED /E^X  (where % is a hydrophobic 
amino acid and X is any residue), known as the octicosapeptide repeat (OPR) 
(Nakamura et al., 1998; Ponting et al., 2002; W ientjes et al., 1993). PB1 domains are 
present in a range o f proteins including M APK kinases (MEK5 or MAPKK5), the 
adaptor protein Par6 and the NADPH oxidase components p40phox and p67phox (Ponting 
et al., 2002). They mediate the formation o f homodimeric and heterodimeric protein 
complexes (Ito et al., 2001; Wilson et al., 2003). The PB1 domain o f  p40phox was 
originally called the PC m otif due to its presence in phagocytic oxidase and cdc24. 
However recently, after sequence analysis it was suggested that in fact PC motifs and 
octicosapeptide repeats should be classified as a single family known as the PB1 
domain. The P B 1 domains o f p40phox and p67phox bind each other with high affinity (4 
nM-10 nM) (Lapouge et al., 2002; Nakamura et al., 1998; Ponting et al., 2002; Wilson 
et al., 2003).
The crystal structure o f  the complex between the p40phox and p67phox PB1 
domains is shown in Figure 16 (W ilson et al., 2003). Both PB1 domains consist o f two 
a-helices and a P-sheet made o f  five p-stands. The surface o f  the p67phox PB1 domain 
contains two basic clusters (B C 1 and BC2) that bind two acidic clusters (AC 1 and AC2) 
present in the p40phox PB1 domain. BC1 contains Lys355, which interacts with Asp289, 
Glu291 and Asp293 o f AC1, and BC2 contains Lys382 and Lys365 which interacts 
with Glu301 and Asp302 o f AC2.
1.4.4 PX domain
The phox homology (PX) domain is approxim ately 125 amino acids in length 
and is found in a variety o f proteins including membrane trafficking proteins such as 
Vam7p and the yeast protein Bern 1 p. It was first discovered in the p40phox and p47phox 
cytosolic proteins o f the NADPH oxidase (Ponting, 1996). Originally it was thought that 
PX domains may bind to SH3 domains due to the presence o f  a proline-rich region in 
many PX domains. Indeed, an NM R study by Hiroaki and colleagues showed that the 
p47phox PX domain could interact with the isolated p47phox C-terminal SH3 domain with 
an affinity o f ~ 50 pM (Hiroaki et al., 2001). However, more recent studies have shown
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Figure 16: The structure of the p40phox and p67pho* PB1 domains. The complex between the
PB1 domain of p40phox (blue) and p67phox (green). Key residues from the basic clusters (BC1 and BC2)- 
p67phox, and acidic clusters (AC1 and AC2)-p40phox, which are involved in complex formation are 
represented as sticks. PDB identifier lOEY (Wilson et al., 2003).
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that PX domains belong to the family o f lipid binding modules along with PH 
(Pleckstrin homology) and FYVE (F ab l, YOTB/ZK632.12, V acl and EEA1) domains, 
and that they interact specifically with phosphoinositides (Corvera et al., 1999; Fruman 
et al., 1999; Prehoda and Lim, 2001; Simonsen and Stenmark, 2001; W ishart et al., 
2001). These protein-lipid interactions are important in recruiting proteins to specific 
cell membranes.
A number o f NM R and crystal structures o f  PX domains have been solved, 
including those o f p47phox and p40phox (Bravo et al., 2001; Hiroaki et al., 2001; 
Karathanassis et al., 2002). They reveal that PX domains are composed o f  three anti­
parallel p-sheets and four a-helices. The structure o f the p40phox PX domain is similar to 
the p47phox PX domain, with the exception o f an additional N-terminal a-helix. The 
crystal structure o f the p40phox PX domain was solved in complex with the soluble 
ligand di-C4-PtdIns(3)P, and shows that the wall o f the binding pocket is formed by 
A rgl05, Arg85 and Tyr59 (Bravo et al., 2001) (Figure 17A). The X-ray structure o f the 
p47phox PX domain was solved in the absence o f a lipid. However, the structure showed 
that the protein had two sulfate ions bound in two distinct basic binding pockets (the 
sulfate ions are believed to mimic phosphate groups). The first binding pocket is larger 
than the second, and is assumed to be the phosphoinositide binding site. This binding 
pocket is formed by Arg43 which makes hydrogen bonds with the sulphate, and through 
van der Waals interactions with Arg90 (Figure 17B) (Karathanassis et al., 2002). 
Mutation o f R43Q has been found in CGD patients and leads to loss o f p47phox 
expression and stability, demonstrating that the p47phox PX domain plays a key role in 
protein integrity (Heyworth and Cross, 2002). The second, shallower basic pocket, 
which has not been seen in any other PX domain structure, has been suggested to bind 
anionic phospholipids such as phosphatidic acid (PA) or phosphatidylserine (PS). The 
walls o f the pocket are formed by the side chains o f Arg70, Lys55 and His51, which 
gives the pocket its basic character. Both the p40phox and p47phox PX domains have 
exposed hydrophobic residues in the vicinity o f the lipid binding pockets, which could 
penetrate into the membrane and thereby synergistically increase membrane affinity 
(Karathanassis et al., 2002).
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Figure 17: The structures of the p40phox and p47phox PX domains. A. The p40phox PX domain in
complex with di-C4-PtdIns(3)P (yellow sticks). The positions of residues forming important contacts with 
the phosphoinositide are shown as blue sticks. PDB identifier 1H6H (Bravo et al., 2001). B. The p47phox 
PX domain bound to two sulfates ions (sulfates shown in CPK representation). The position o f residues 
involved in forming the phosphoinositide and anion binding pockets are shows as blue sticks. PDB 
identifier 107K (Karathanassis et al., 2002). In both figures the J3-sheets are shown in green and a-helices 
in pink.
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1.5 Protein interactions in the resting state of the
NADPH oxidase
Reversible protein-protein interactions mediated through protein interaction 
domains are key in the assembly o f the NADPH oxidase. Extensive studies have been 
carried out to investigate these interactions using a range o f techniques including 
isothermal titration calorimetry, fluorescence spectroscopy, yeast-two hybrid assays, 
phage display, oxidase reconstitution assays and GST pull-down assays. Furthermore, 
crystallography and NM R have been used to solve structures o f various fragments and 
complexes, and have contributed immensely to our understanding o f the molecular basis 
o f NADPH oxidase function. The three cytosolic subunits p40phox, p47phox and p67phox 
are able to form a tight heterotrimeric complex (Figure 18) (for details concerning the 
formation o f this complex refer to section 1.3.2). The m olecular details o f  this complex 
are described in the following section.
1.5.1 The p67phox-p40phox complex
Full-length p67phox interacts with p40phox with a binding affinity o f  10 nM 
(Lapouge et al., 2002), and this binding event is solely driven by their respective PB1 
domains (Ito et al., 2001; Nakamura et al., 1998). This finding has been confirmed by 
the observation that the binding affinity o f  the interaction between the isolated PB1 
domains is similar to that observed for the full-length protein (4 nM) (Wilson et al., 
2003). Figure 16 shows the crystal structure o f  the complex between the PB1 domains 
o f p40phox and p67phox (Wilson et al., 2003). A single point mutation in the p40phox PB1 
domain, D289A, disrupts the interaction with p67phox and thereby prevents membrane 
translocation o f p40phox and O2 " generation (Kuribayashi et al., 2002). However despite 
our current understanding o f the molecular details o f  the p40phox-p67phox interaction, the 
exact biological significance o f complex formation is not clear at present.
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Figure 18: Model for the P47phox-p67phox-p40phox complex in the resting state of NADPH
oxidase. The p47phox C-terminal proline-rich region (shown in blue) interacts with p67phox(SH3)B with a 
binding affinity of 20 nM. P67phox interacts with p40phox via their PB1 domains with a binding affinity of 
10 nM (taken and adapted from Lapouge et al., 2002).
1.5.2 The p47phox-p67phox complex
The interaction between p47phox and p67phox is mediated by the PR region 
located in the C-terminus o f  p47phox and the C-terminal SH3 domain o f  p67phox 
(p67phox(SH3)B), which bind each other with a binding affinity o f 20 nM (Finan et al., 
1994; Lapouge et al., 2002; Leto et al., 1994). The structure o f a complex between 
p67phox(SH3)B and this PR region (aa 359-390) has been solved by NM R spectroscopy 
(Figure 19) (Kami et al., 2002). The structure shows that the p67phox-binding region o f 
p47phox has two binding surfaces: a PXXP m otif (aa 360-370) and a non-canonical m otif 
(aa 368-389) that folds into a helix-tum -helix structure (HTH). The isolated PXXP m otif 
binds to the SH3 domain in a class II orientation (PXXPXR), with an affinity o f 20 pM, 
which is typical for SH3 domain mediated interactions. Disruption o f this interaction via 
mutations o f the core proline residues to alanine (P363A and P366A) reduces the 
affinity by 30-fold and 100-fold, respectively. However, inclusion o f the HTH structure 
(aa 359-390) significantly enhances the binding affinity by ~ 1000-fold to 24 nM. 
Arg368, located in the class II consensus m otif (PXXPXR), is important for this high 
affinity interaction, as mutation o f  this residue to alanine reduces the affinity 625-fold. 
In addition, Ile374 (in helix a l )  and Thr382 (in helix a2) in the HTH structure are also 
important for complex formation. Substitution o f  either o f  these residues to alanine 
reduces the affinity to 3.0 pM and 1.1 pM, respectively.
Interestingly, three phosphorylation sites (serine residues 359, 370 and 379) are 
located in the C-terminal region o f p47phox, adjacent to the PR sequence motif. 
However, the precise function o f these phosphorylation sites is not yet known (for a 
more detailed discussion see section 1.3.2.1.2). In addition to the interaction with 
p67phox, the C-terminal PR region o f  p47phox has also been suggested to be the target o f 
the SH3 domain o f p40phox, which may compete with p67phox for binding to this region. 
However the binding affinity o f this interaction is significantly weaker than the p47phox- 
p67phox interaction, making a direct com petition unlikely.
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Figure 19: C-terminal SH3 domain of p67pho* in complex with the C-terminal region of
p47pho\  The SH3b domain of p67phox is shown in blue. The C-terminal peptide of p47phox is shown as a 
surface representation (grey) with underlying ribbons shown in green. Important residues involved in 
complex formation are shown as sticks (Arg368, Ile374 and Thr382), along with key phosphorylation 
sites (Ser359, Ser370 and Ser379). Pro363 and Pro366 of the PXXP motif are also indicated. PDB 
identifier 1K.4U (Kami et al., 2002).
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1.6 The superSH3 domain as a novel protein-protein
interaction module
Adjacent protein interaction modules can work in coordination with one another 
to increase the affinity and specificity for bivalent targets as seen for example with a 
number o f SH2 domain containing proteins (Ottinger et al., 1998). Alternatively, they 
can form higher ordered structures that may have slightly different ligand binding 
properties than the individual domains (Fedoroff et al., 2004). An example o f  the former 
is seen in p47phox where the tandem SH3 domains work together to bind either the 
polybasic region or p22phox (Groemping et al., 2003; Yuzawa et al., 2004a; Yuzawa et 
al., 2004b). In the free, uncomplexed form o f  p47phox, the linker region connecting the 
two SH3 domains is highly flexible, allowing the two domains to move freely resulting 
in an extended globular structure (Ogura et al., 2005). However, upon ligand binding the 
two adjacent SH3 domains become juxtaposed in both the active (p22phox-bound) and 
auto-inhibited (polybasic region-bound) states. Binding o f the ligand causes the tandem 
SH3 domains to adopt a relatively rigid and com pact structure (Groemping et al., 2003; 
Yuzawa et al., 2004a; Yuzawa et al., 2004b). This structure is referred to as the 
superSH3 domain, and has been proposed to be a novel protein-protein interaction 
module (Groemping et al., 2003). The relative positioning o f  the two SH3 domains with 
respect to one another within the superSH3 domain is im portant to form a single 
binding surface o f high affinity. The formation o f this conformation appears to be 
dependent on two structural features: the covalent linker, which connects the two SH3 
domains, and a conserved ‘G W W ’ m otif located in the n-Src loops, a region where the 
two SH3 domains make contact.
1.6.1 The linker
Other than physically connecting interaction domains together, linkers can be 
important in facilitating protein function. For example, using site-directed deletion 
mutagenesis Govindaraj and Pouolos showed that the length o f  the linker connecting the 
heam and FAD binding sites o f  cytochrome P450BM-3, was important in controlling 
the electron transfer reaction o f  this enzyme (Govindaraj and Poulos, 1995). Hegvold 
and Gabrielsen showed that increasing the flexibility o f  the linker (through proline to 
glycine substitutions) connecting the R2 and R3 repeats in the DNA binding domain o f
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c-Myb protein, affected DNA binding (Hegvold and Gabrielsen, 1996). Linkers have 
also shown to play an important role in proteins where the activity is regulated by auto- 
inhibitory interactions. For example increasing the flexibility o f the SH2-SH3 linker 
(proline to glycine substitution) in Src kinase relieves auto-inhibition and induces kinase 
activation (Young et al., 2001).
Similarly, the activity o f the NADPH oxidase is prevented by an intramolecular 
interaction between the tandem SH3 domains o f p47phox and the polybasic region. The 
linker connecting the two SH3 domains may be important for the formation o f the ‘auto­
inhibited core’, as the crystal structure o f the auto-inhibited p47phox shows that the linker 
region is well ordered and makes a number o f contacts with the rem ainder o f the protein 
(Groemping et al., 2003; Yuzawa et al., 2004a; Yuzawa et al., 2004b). Importantly, the 
linker is absolutely essential for the formation o f the superSH3 domain, as no 
interaction between the individual SH3 domains is observed in free solution 
(Groemping et al., 2003). However, at present it is not clear how factors such as linker 
length, composition and flexibility contribute to the formation and stabilisation o f the 
superSH3 domain.
The p47phox linker makes contacts with the polybasic region at many points 
along its length, as well with the two SH3 domains. The N-terminal region o f the linker 
makes contacts with SH3a, where as the C-terminal region contacts SH3b. Key residues 
o f the linker involved in these interactions include E218, E220 and D221. E218 makes 
hydrogen bonds with Lysl88A and Tyrl6lA- E220 makes hydrogen bonds with Glnl59A 
and Lysl88A. D221 makes a single hydrogen bond with L cu2 6 0 b (Figure 20). 
Interestingly, during the active state the linker does not directly contact p22phox, and 
only residues E220 and D 221 form hydrogen bonds with the SH3 domains (E220 makes 
a hydrogen bond with Try 16 1a, and D221 makes a hydrogen bond with Leu260).
The p4 7 phox [inker is composed o f fifteen amino acids 
(213LDSPDETEDPEPNYA227), and this specific length may be important in maintaining 
the correct distance and orientation between SH3a and SH3b. In addition, the linker of 
p47phox contains three proline residues at positions 216, 222 and 224. The side-chain 
ring o f  a proline is covalently attached to its backbone nitrogen atom, making it a rigid 
structure that strongly influences the conformation o f proline containing sequences. 
Therefore, linker rigidity imposed by these proline residues may also contribute to the 
stabilisation o f the superSH3 domain. However, so far no systematic studies have been 
carried out to investigate the importance o f  p47phox linker specifics (length, composition
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Figure 20: p4 7 Pho* linker interactions with the tandem SH3 domains in the auto-inhibited
state. Schematic representation showing the hydrogen bond interactions between E218, E220 and D221 
and the tandem SH3 domains. All others are backbone interactions. W194A and W264B make hydrogen 
bonds across the domain interface. PDB identifier 1NG2 (Groemping et al., 2003). The figure was 
prepared using the program ISIS draw.
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and flexibility) for the formation and stabilisation o f the superSH3 domains in the active 
and auto-inhibited states.
1.6.2 The GWW motif
The second feature that appears to be crucial for the formation o f the superSH3 
domain is the presence o f a ‘G W W ’ m otif in either SH3 domain. This m otif is located 
in the n-Src loops, the region where the two domains come closest and contact each 
other across the domain interface. The role o f  each residue in this m otif is discussed 
below. The location o f the m otif is 192G W W 194 in SH3Aand 262G W W 264 in SH3b.
1.6.2.1 The role of G192A and G262B (GWW)
The crystal structures o f the auto-inhibited and p22phox-bound p47phox show that 
G 192a and G 262 b make van der W aals contacts with main chain atoms o f the opposing 
n-Src loops. However, they are not involved in binding to either the polybasic region or 
the p22phox peptides (Groemping et al., 2003). Furthermore, the structures suggest that 
substitution o f G192A and G 262 b with any residue larger than a glycine would cause a 
steric clash with the opposing n-Src loop, and thereby disrupt the binding interface o f 
the superSH3 domain (Figure 21). In order to investigate this hypothesis, Groemping 
and colleagues made glycine to serine mutants (G192SA and G 2 6 2 S b), and performed 
binding measurements using ITC (Groemping et al., 2003). These studies showed that 
mutation o f either glycine resulted in proteins that were less soluble than the wild-type 
protein, and that the double mutant was completely insoluble, suggesting that G192A 
and G 262b are critical for correct protein folding. Furthermore, binding studies using 
the individual mutant proteins showed a dramatic reduction in the affinity for the 
polybasic region and p22phox-derived peptides, clearly indicating that the formation o f 
the superSH3 domain is compromised. This observation is further emphasised by a form 
o f CGD, in which patients carry glycine to serine mutations in exactly these positions 
(Noack et al., 2001). Based on these observations, it was suggested that the role o f 
G 192 a and G 262 b is to allow the correct orientation o f  the SH3 domains with respect to 
each other, and to enhance the structural integrity o f the protein.
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n-Src loops
Ser
62
Asp261
p47phox
Figure 21: G192A and G262B in the superSH3 domain. The n-Src loops at the interface between
SH3a and SH3B. The modelled mutation o f G192SA results in steric clashes with main chain atoms from 
the n-Src loop of SH3B. The blue sphere represents the van der Waals surface of CP o f S I92, and the red 
spheres those of main chain Cps in the n-Src loop of SH3B. Illustration courtesy of Groemping et al., 
2003.
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1.6.2.2 The role of W193A and W263B (GWW)
The positions corresponding to W 193A and W 2 6 3 b are fully conserved among 
SH3 domains and are crucial for ligand binding (position 36(W )-Figure 13) (Larson and 
Davidson, 2000). Many studies have shown that W 193A plays a more important role in 
NADPH oxidase activity than W 2 6 3 b- The importance o f  W 193A can be rationalised by 
the fact that the interaction between p47phox and p22phox is dominated by SH3A. In fact, 
immunoblott assays (Sumimoto et al., 1996), in vitro binding assays (de M endez et al., 
1997) and quantitative binding studies (Groemping et al., 2003) have shown that 
isolated SH3A is able to bind to p22phox but isolated S H 3 b cannot. However, the 
presence o f  SH 3b (as a tandem) significantly increases binding (de M endez et al., 1997) 
and the affinity for p22phox (Groemping et al., 2003). Furthermore, mutation o f W 193A 
to arginine is shown to completely abolish binding o f the isolated SH3A domain to 
p22phox, as well as O2 ’ production and membrane translocation o f  the full-length mutant 
protein, where as mutation o f W 2 6 3 b only has a partial effect (de Mendez et al., 1997; 
Hata et al., 1998; Sumimoto et al., 1996). These data are further supported by the 
structure o f active p47phox bound to p22phox, which shows that W 193A makes more 
extensive contacts with the ligand than W 2 6 3 b These include a hydrogen bond with 
N154, as well as van der W aals interactions with P I 52 and P I 56 (Figure 22) 
(Groemping et al., 2003) Although W 2 6 3 b makes two hydrogen bonds with P I 56 and 
P I 57, it is not found within a similar hydrophobic environment as its counterpart 
W 193A.
Unlike p22phox which can bind isolated SH3A, the polybasic region requires the 
presence o f both SH3 domains for complex formation (Groemping et al., 2003). 
However, the precise role o f W 193A and W 2 6 3 b in the auto-inhibited state is unclear at 
present. The structure o f auto-inhibited p47phox shows that W 193A makes extensive 
contacts with the core binding m otif o f  the polybasic region. Specifically, it makes a 
hydrogen bond with G297 plus van der W aals and hydrophobic interactions with P299 
and R296. W 263 b on the other hand only forms one hydrogen bond with P299 and 
stacks against R301 (Groemping et al., 2003; Yuzawa et al., 2004a; Yuzawa et al., 
2004b). These biochemical and structural data suggest that although SH3A and SH 3b are 
required for the formation o f a high affinity ligand binding site, W193A may make a 
bigger contribution.
I l l
P155
R158
P157
W 204
Figure 22: The binding pocket formed by p22phox for W193A. The binding pocket is formed by
P I52, N154 and P I56 of the core peptide binding region of p22phox (grey sticks). W193A is shown in 
yellow which fits into the binding pocket. PDB identifier 10V3 (Groemping et al., 2003).
1.6.2.3 The role of W194A and W264B (GWW)
W 194a and W 264B are not involved in direct contacts with ligands. Instead they 
are located at the SH3 domain interface, making contacts across the interface and 
contribute to the stabilisation o f the superSH3 domain conformation (Figure 20). The 
crystal structure o f auto-inhibited p47phox shows that W 194A makes a hydrogen bond 
with L260b, and W 264B with E190A (Groemping et al., 2003; Yuzawa et al., 2004a; 
Yuzawa et al., 2004b). In the p22phox-bound state similar interactions are made, but due 
to slight rearrangements between the individual SH3 domains, these hydrogen bonds are 
bridged via water molecules (Groemping et al., 2003).
1.6.2.4 Other proteins that may form a superSH3 domain
Many proteins involved in signal transduction processes contain multiple SH3 
domains that are connected by linkers o f varying length. A subset o f these proteins 
contains a GWW m otif in adjacent SH3 domains (see SH3 family alignment from the 
SMART database, http://smart.embl-heidelberg.de/), including the adaptor proteins 
CIN85 and FISH. The most convincing case so far for another superSH3 domain- 
forming protein is that o f the non-phagocytic NADPH oxidase homologue N O X O l. 
This protein is only capable o f binding ligands in the presence o f its tandem SH3 
domains (Dutta and Rittinger, unpublished data). In addition, there are also biochemical 
data available for CIN85 as well as FISH that strongly suggest that a subset o f  the SH3 
domains present in these proteins cooperate for ligand binding (Abram et al., 2003; 
Kowanetz et al., 2003). Further studies are now required to determine whether the 
superSH3 domain may indeed be a novel signal transduction module.
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1.7 Aims of the project
The activity o f the NADPH oxidase is regulated by a complex set o f protein- 
protein and protein-lipid interactions. A central player in the activation and assembly o f 
this enzyme is p47phox, whose activity is regulated by protein-protein and protein-lipid 
interactions. The aim o f this project is to investigate the conformational changes or 
changes in protein-protein and protein-lipid interactions that take place in p47phox during 
the activation and assembly process.
Most studies have focused on the effects o f  phosphorylation o f serine residues 
located within the polybasic region o f p47phox (S303, 304, 315, 320 and 328), on 
NADPH oxidase activation. It is not clear whether the C-terminal serine residues (S359, 
370 and 379) contribute to this activation process. Here, experiments are described 
investigating whether phosphorylation o f the C-terminal serine residues act 
synergistically with phosphorylation o f the polybasic region, to promote the interaction 
with p22phox, as well as the effects on binding to p67phox In addition, the effect o f  p47phox 
C-terminal phosphorylation on lipid binding will be explored (chapter 3).
The superSH3 domain has been proposed to be a novel protein-protein 
interaction module, and key to its formation is believed to be the covalent linker 
between the two SH3 domains, and a ‘G W W ’ m otif located in the respective n-Src 
loops o f  either SH3 domain The aim o f this study is to investigate the structural 
requirements with respect to these two features, for the formation o f the superSH3 
domain in the active (p22phox-bound) and auto-inhibited (polybasic region-bound) states 
o f p47phox (chapter 4). This may enable us to determine which other proteins may 
behave in a similar fashion.
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CHAPTER TWO
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2.0 Materials and Methods
All standard chemicals used in this work were obtained from Sigma, BDH and 
Bio-Rad, and were o f the highest purity commercially available. Details o f other 
reagents, cell lines, media, buffer compositions and gel compositions can be found in 
the Appendix. Restriction enzymes were purchased from New England Biolabs, 
oligonucleotides from Oswel and DNA purification kits from Qiagen. PtdIns(3,4)P2 was 
purchased from CellSignals and all other lipids from Sigma. PIP beads were purchased 
from Echelon Biosciences. All structural pictures were generated in PyMOL 
(http://www.pymol.org) unless otherwise stated.
2.1 General molecular biology procedures
2.1.1 Plasmid vectors and constructs
Recombinant proteins were expressed in the Glutathione S-transferase (GST) 
fusion vectors pGEX-6-Pl (p47phox) (refer to Table 6) and pG EX -4-Tl (p67phox) (refer 
to Table 7). Figure 23 shows a map o f the GST fusion vectors with the reading frames 
and main features. Expression o f  GST fusion proteins is under the control o f the tac 
promoter, which is induced by isopropyl p-D thiogalactoside (IPTG), a lactose 
analogue. The laclq gene, also present in pGEX vectors functions as a repressor, and 
binds to the operator region o f the tac prom oter to prevent basal expression until IPTG 
induction. Hence, the laclq gene maintains a relatively tight control over the expression 
o f insert.
2.1.2 Transformation of competent cells
50 pi o f competent E. coli cells (NovaBlue or BL21(DE3)) were thawed on ice. 
100 ng o f plasmid DNA was pipetted into the cells, gently mixed and incubated for 30 
mins on ice. The cells were subjected to heat shock at 42 °C for 1 min before returning 
to ice for a further 2 min. 300 pi o f  LB media (see Appendix: A2) (excluding 
ampicillin) was added to the sample, which was gently mixed and incubated at 37 °C 
for 1 hr. 20-200 pi o f the sample were spread onto an LB agar plate containing 100
pg/ml ampicillin and incubated overnight at 37 °C.
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PGEX-6P-1 (27-4597-01)
TM PreScission Protease
L e u  Glu Val Leu Phe Gln^Gly P ro l  Leu Gly Ser  Pro Glu Phe Pro Gly Arg Leu Glu Arg Pro His
CTG GAA GTTCTG TTC CAG GGG CCC CTG GGATCC CCG GAATTC CCG GGT CGACTC GAG CGG CCG CATi 1 i u  u ui i—i---------- 1
BamH I EcoR I s m a  I Sal 1 Xho I Not 1
PGEX-4T-1 (27-4580-01)
_ _ _ _ _ _ _ T h rom bin_ _ _ _ _ _
L e u  Val Pro  A rg^G ly  S e r  I Pro  Glu P h e  P ro  Gly Arg Leu Glu Arg Pro His Ara  Asp 
CTG GTT CCG CGT.GGA TCCCCG.GAA TTC, CCG GJST CGA CTC GAp CGG CCG CAT CGTGAC TGA
' BamH I ' EcoR 11 S m a  , J  Sal 11 Xho , 1 Not I ' S to p  c o d o n s
Tth 111 I 
! Aat IBal
Ptai 
BspM I ,
Pst
pG EX
-4900 bp
Nar
AlwN IEcoR V p4.5
BssH
Apa I
PBR322oilBstE II Mlu I
Figure 23: Map of the Glutathione S-transferase fusion vectors. The reading frames and main
features of the pGEX vector are indicated.
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2.1.3 Plasmid DNA purification
Plasmid DNA was purified from E.coli NovaBlue cells using the Qiagen Mini or 
Midi Prep Kits according to the m anufacturer’s protocol. Plasmids from Midi preps 
were further purified by mixing the eluted DNA (500 pi) with 20 pi o f 5 M NaCl and 
1.3 ml o f 100 % ethanol. The samples were centrifuged at 13,000 rpm for 20 mins and 
the supernatant carefully removed. The DNA pellet was washed with 500 pi o f 70 % 
ethanol and centrifuged at 13,000 rpm  for 5 mins. The supernatant was removed and the 
pellet washed with 100 % ethanol in the same way. The pellet was dried at 37 °C for 10 
mins and re-dissolved in a suitable volume o f TE buffer (10 mM Tris.Cl (pH 8.0), 1 
mM EDTA). DNA concentration was determined by UV spectrophotometry at 260 nm 
(Beckman DU640).
2.1.4 Polymerase chain reaction (PCR) amplification
PCR reactions were carried out in sterile 500 pi eppendorf tubes. A typical 
reaction was prepared as listed in Table 1. The sample was placed in a thermal cycler 
(MJ Research) and 25 PCR cycles were carried out after an initial incubation at 94 °C 
for 10 mins (hot start). The method allows full denaturation o f  the template DNA and 
reduces non-specific priming. The fragments were purified using the Qiagen PCR 
Purification Kit according to the m anufacturer’s protocol.
94 °C 10 mins (Initial incubation)
Per cycle
94 °C 2 mins (DNA denaturation)
55 °C 2 mins (Primer annealing)
72 °C 2 mins (Primer extension)
After 25 cycles
72 °C 10 mins (Final extension)
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Table 1: Typical reagent mixture for a PCR reaction.
Reagent Volume (pi)
10 X PCR buffer (1.2 M Tris-HCl (pH 8.0), 100 mM KC1,
C
60 mM (NH4)2S04, 1 % Triton X-100, 0.01 % BSA)
D
MgCl2 (25 mM) 2
dNTP mixture (8 mM total, 2 mM each) 5
Template DNA (0.5-1 pg total) 1
Oligo 1 (20 pM) 1
Oligo 2 (20 pM) 1
K o d polymerase (2.5 U/pl) 1
dH20 34
TOTAL 50
2.1.5 Agarose gel electrophoresis
DNA was analysed using a 1 % agarose gel containing 0.1 pg/ml ethidium 
bromide (see Appendix: A3). 2-5 pi o f  sample was mixed with 3 pi 6X loading buffer 
(see Appendix: A3) and subjected to electrophoresis in lx  TAE buffer at 80 V for 30-40 
mins, and visualized on an UV-transilluminator (BDH).
2.1.6 Restriction enzyme digests
DNA fragments and vectors were digested using appropriate restriction enzymes 
(see Tables 6 and 7) at 37 °C for 3 hrs. A typical reaction mixture is shown in Table 2. 
The digested DNA was subjected to electrophoresis on a 1 % agarose gel as described 
in section 2.1.5. The required bands were excised from the gel using a sterile scalpel 
blade and purified using the Qiagen Gel Extraction Kit, according to the manufacture’s 
protocol.
2.1.7 Ligation reaction
A 1:1, 1:3 or 3:1 m olar ratio o f vector:insert DNA is recommended for 
successful cloning o f fragment DNA into a plasmid vector (Sambrook et al., 1989). The
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following example uses a 1:1 vector: insert ratio, where typically the ligation reaction 
uses 100-200 ng o f vector. The conversion o f mole ratios to mass ratios for a 3 kb 
plasmid, and 0.5 kb insert can be calculated by the following equation (Promega).
ng vector x kb size o f  insert x molar ratio o f insert = ng o f insert [3] 
kb size o f vector vector
Ligation reactions were carried out at 16 °C overnight. A typical ligation reaction is 
shown in Table 3. Ligated samples were transformed into NovaBlue competent cells as 
described in section 2.1.2.
Table 2: Typical reaction mixture for a restriction enzyme digest.
Reagent Volume (pi)
DNA (50-100 ng) 5
10 X reaction buffer (6 mM Tris-HCl (pH 6), 6 mM MgCl2, 150 mM 
NaCl, 1 mM DTT) (appropriate to restriction enzyme used, refer to 
manufacturers instructions)
2
Restriction enzyme 1(10 U/fil) 1
Restriction enzyme 2(10 U/pl) 1
BSA (1 mg/ml) 2
dH20 9
TOTAL 20
Table 3: Typical reaction mixture for a ligation.
Reagent Volume (pi)
Vector (pg) X
Insert (pg) Y
T4 DNA 10 X ligase buffer (300 mM Tris/HCl (pH 
7.8), 100 mM MgCl2, 100 mM DTT and 5 mM ATP)
2
T4 DNA ligase (3 U/pl) 1
dH20 Z
TOTAL 20
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2.1.8 Site-directed mutagenesis
Mutations were introduced into p47phox using the Quik-Change Site-Directed 
Mutagenesis Kit (Stratagene, UK). This method is used to make point mutations and 
delete or insert single or multiple nucleotides. The basic procedure is summarised in 
Figure 24. The plasmid containing the gene for the target site mutation (p47phoxWild- 
type) is denatured. Two complementary oligonucleotide primers with the desired 
mutation are annealed to the plasmid. Pfu DNA polymerase (Stratagene) was used to 
extend the mutagenic primers, resulting in nicked circular strands. The methylated non­
mutated parental DNA template is then digested using Dpn\, and the nicked dsDNA is 
transformed into NovaBlue competent cells where the nicks in the mutated plasmid are 
repaired. The primers containing the desired mutation were designed to be between 25- 
45 bases in length and chosen such that the annealing temperature (Tm) o f  the primers is 
10 °C above the extension temperature (Tm = 81.5 + 0.41 (% GC) -  675 / N - % mismatch, (N = 
primer length, b.p)).
The mutagenesis PCR reaction was prepared as shown in Table 4. 12-14 PCR 
cycles were carried out after an initial denaturation at 95 °C for 30 sec (12 cycles for 1 
point mutation, 14 cycles for 2-3 point mutations), using the following program:
95 °C 30 secs (Initial denaturation)
12-14 cycle 
95 °C 30 secs
55 °C 1 min
68 °C 1 min/kb of plasmid length
After 12 cycles
10°C 10 mins (Cooling)
(DNA denaturation) 
(Primer annealing) 
(Primer extension)
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Step 1
Plasmid Preparation
Step 2
Temperature Cycling
Mutagenic
primers
Step 3 
Digestion
Step 4
Transformation
Mutated plasmid
(contains nicked circular strands)
LEGEND
— Parental DNA plasmid
✓ Mutagenic primer
— Mutated DNA plasmid
Figure 24: Overview of the Quik-Change Site-Directed Mutagenesis method. Taken and
adapted from the Quik-Change Site-Directed Mutagenesis Kit Instruction manual, 1996.
Table 4: Composition of a typical mutagenesis reaction.
Reagent Volume (pi)
10 X PJu reaction buffer (100 mM KC1, 60 mM 
(NH4)2S04, 200 mM Tris- HC1 (pH 8.0), 20 mM 
MgCl2, 1 % Triton X-100)
5
Oligo 1 (125 ng/pl final concentration) 1
Oligo 2 (125 ng/pl final concentration) 1
p47phoxWild-type DNA (50 ng/pl final concentration) 1
10 mM dNTP mix (2.5 mM each NTP) 1
Pfu DNA polymerase [2.5 U/pl] 1
dH20 40
TOTAL 50
The amplified PCR sample was treated with 0.8 pi Dpn\ endonuclease (10 U/pl), and incubated at 37 °C 
for 1 hr. The DNA was transformed into NovaBlue competent cells. Midi preps of four colonies were 
carried out using the Qiagen Midi Prep Kit according to the manufacturer’s protocol. All mutations were 
confirmed by DNA sequencing performed by IC Consultants, Imperial College, London.
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2.2 Generation of specific plasmids
All plasmids employed in this study are listed in Tables 6 and 7. The cloning of 
plasmid pGEX-p47phoxS8E is described in detail below in section 2.2.1. The plasmid 
containing the PH domain o f the TAPP1 protein was kindly donated by Dr. M aria Deak 
(Thomas et al., 2001), and details about the plasmid can be found beneath Table 7.
2.2.1 Cloning of p47phos S303, 304, 315, 320, 328, 359, 370 and 
379E (pGEX-p47phoxS8E)
P47p contains eleven phosphorylation sites o f  which eight have been shown to 
be required for NADPH oxidase activation. Five o f these serine residues; S303, 304, 
315, 320, 328 are located within the polybasic region, and the remaining three serine 
residues; 359, 370, 379 are located in the C-terminal portion o f the protein. At the start 
o f this project two full-length plasmids had already been constructed, in which 
phosphorylation had been mimicked by substitution o f serine residues to glutamate (in 
pG EX -6-Pl) (Table 6). The plasmids were pGEX-p47phoxS5E (polybasic region mutant) 
and pGEX-p47phoxS3E (C-terminal region mutant) (Table 6). These were used to 
generate a construct, which combined all eight serine to glutamate mutations in a single 
plasmid (pGEX-p47phoxS8E) (Table 6) (Figure 25a). Briefly, restriction enzyme digests 
o f pGEX-p47phoxS5E and pGEX-p47phoxS3E plasmids were carried out using the Smal 
restriction enzyme, and the fragments separated on a 1 % agarose gel. The desired 
fragments were excised and purified using the Qiagen Gel Purification Kit according to 
the manufacturer’s protocol. As Smal digests result in blunt ended DNA fragments, self­
ligation o f the pGEX-p47phoxS5E in pG EX -6-Pl vector had to be prevented by de­
phosphorylation (using phosphatase alkaline shrimp enzyme) (Table 5). The two 
digested products were mixed and incubated at 37 °C for 30 min and the reaction was 
terminated by incubating at 65 °C for 15 min and then placed on ice. The de- 
phosphorylated DNA plasmid was purified using the Qiagen PCR Purification Kit 
according to the m anufacturer’s protocol. The vector and insert were ligated (section 
2.1.7) and transformed into NovaBlue competent cells (section 2.1.2). Plasmids from six 
clones were purified using the Qiagen Midi Prep Kit according to the m anufacturer’s 
protocol. In order to verify the correct insertion and orientation o f the 6 plasmids,
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EcoRI
BamHI
Figure 25a: Schematic outline of the construction of pGEX-p47phoxS8E. The pGEX-p47phoxS5E
plasmid is shown in green (a) and pGEX-p47phoxS3E plasmid shown in pink (b). Incubation of ‘a’ and ‘b ’ 
with the Smal restriction enzyme (c) gives two products i) the vector backbone plus N-terminal p47phox 
(base pairs 1-1020) and ii) a smaller fragment containing the C-terminal region of p47phox (base pairs 
1021-1170). The vector backbone plus p47phox from ‘a ’, was ligated with the smaller fragment from ‘b \  
to produce a single plasmid containing all eight phosphorylation sites (pGEX-p47phoxS8E) (d). Dark 
circles indicate phosphorylation sites.
restriction enzyme digests were carried out using the Notl and BamHl restriction 
enzymes. If  the insert is in the correct way around then a band o f 559 b.p. should be 
excised upon digestion with Notl/BamHl, and if  it is inserted the wrong way around 
then a band o f 427 b.p. should be observed. The digested samples were separated on a 1 
% agarose gel and those samples showing the correct insertion were sent for DNA 
sequencing (IC Consultants, Imperial College, London).
Unfortunately, the protein produced from this plasmid was a mixture o f full- 
length protein and a C-terminally deleted variant (possibly caused by the presence o f 
E.coli proteases in the culture m edium (see section 3.1.2.2). Therefore, PCR was used to 
engineer a hexahistidine tag (His6) at the C-terminus o f  the p47phox construct to aid 
purification o f the protein using Ni-NTA chromatography (Table A5) (Figure 25b). The 
PCR product was digested with EcoRl/Notl restriction enzymes, ligated into an 
EcoRl/Notl cut pGEX-6-Pl vector, and then transformed into NovaBlue competent 
cells. Plasmids from five colonies were purified using the Qiagen Midi Prep Kit 
according to the m anufacturer’s protocol. To test if  the colonies contained the insert, 
restriction digests using EcoRl/Notl restriction enzymes was performed. The digested 
DNA was subjected to electrophoresis on a 1% agarose gel and those clones containing 
the insert were tested for protein expression.
Table 5: Composition of a typical de-phosphorylation reaction.
Reagent Volume (pi)
Phosphatase alkaline shrimp enzyme (0.2 units) 0.5
DNA (1.0 pmol) 30
10 X SAP buffer (200 mM Tris-HCl (pH 8.0), 100 mM MgCl2) 5
dH20 14.5
TOTAL 50
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Figure 25b: Schematic outline of the construction of pGEX-p47phoIS8E-His6. Sense (e) and
antisense (f) primers were used to engineer a hexahistidine tag (His6), onto the C-terminus o f pGEX- 
p47phoxS8E (g), to generate the His6 fusion construct (i). The pGEX-6-Pl vector (h) as well as the His6 
fusion construct were digested with EcoRl/Notl restriction enzymes, and ligated to produce the pGEX- 
p47phoxS8E-His6 plasmid (j). For purposes of simplicity the pGEX-p47phoxS8E-His6 plasmid is hereafter 
referred to as the pGEX-p47phoxS8E plasmid. Dark circles indicate phosphorylation sites.
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Table 6: Cloning and protein expression details of p47phox proteins. The molecular weights,
isoelectric points (pi), extinction coefficients, protein yields, solubility and restriction enzymes used for 
the cloning of p47phox proteins. All clones were constructed using the pGEX-6-Pl vector. Indicated values 
are following 3C precision protease removal o f the GST tag. ‘1’ denotes plasmids that were kindly 
provided by Dr. Karine Lapouge, NIMR, London, and ‘2’ denotes those prepared de novo. All proteins 
are full-length proteins unless an amino acid range is stated in orange.
Cloned PGEX-p47pho1 
plasmid inserts
Restriction 
enzymes used 
for cloning
Mass (kDa) of 
expressed 
protein
pi
Extinction 
coefficient 
at 280 nm 
(M 'em 1)
Soluble
(S)/non-
soluble
(NS)
Yield 
per 1 
litre 
culture
(mg)
Wild-type 1 BamHl/EcoRl 44.9 9.12 57750 S 8
Tandem SH3 domains
(156-285) 1
EcoRl/Notl 15.3 4.28 37410 S 5
S359E 1 BamHl/EcoRI 45.0 9.04 57750 S 5
S370E 1 BamHl/EcoRl 45.0 9.04 57750 s 6
S379D 1 BamHl/EcoRl 44.9 9.04 57750 s 5
S359/370E 1 BamHl/EcoRI 45.0 8.93 57750 s 5
S379E2 BamHl/EcoRl 45.0 9.04 57750 s 5
S3E 1 BamHl/EcoRl 45.0 8.82 57750 s 6
S5E 1 BamHl/EcoRl 45.0 8.82 57750 s 6
S8E 2 EcoRl/Notl 46.6 7.01 57750 s 0.8
E218A (156-285) 2 EcoRl/Notl 15.3 4.31 37410 s 4
E220A (156-285)2 EcoRl/Notl 15.3 4.31 37410 s 4
D221A (156-285)2 EcoRl/Notl 15.3 4.31 37410 s 4
D/E3A (156-285) 2 EcoRl/Notl 15.2 4.40 37410 s 9
D/E3A (156-340) 2 EcoRl/Notl 21.6 9.35 38690 NS 0
W 193 RA( 156-285)2 EcoRl/Notl 15.3 4.35 31720 s 1.2
W194Ra (156-285) 2 EcoRl/Notl 15.3 4.35 31720 NS 0
W194Aa (156-285)2 EcoRl/Notl 15.3 4.35 31720 s 0.5
W263Rb (156-285) 2 EcoRl/Notl 15.3 4.35 31720 s 3.5
W264Rb (156-285)2 EcoRl/Notl 15.3 4.35 31720 NS 0
W264AB (156-285)2 EcoRl/Notl 15.3 4.35 31720 s 0.4
AT (156-285) 2 EcoRl/Notl 15.3 4.28 37410 s 2.3
A l+(156-285)2 EcoRl/Notl 15.5 4.28 37410 s 1.3
A2+ (156-285)2 EcoRl/Notl 15.5 4.28 37410 s 2.3
3PA (156-285)2 EcoRl/Notl 15.3 4.28 37410 s 2.7
3PA (156-340)2 EcoRl/Notl 21.9 8.0 38690 NS 0
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Table 7: Cloning and protein expression details of p67phox proteins. The molecular weights,
isoelectric points (pi), extinction coefficients, protein yields, solubility and restriction enzymes used for 
the cloning of p67phox proteins. All clones were constructed using the pGEX-4-Tl vector Indicated 
values are following thrombin removal o f the GST tag. ‘ 1 ’ denotes plasmids that were kindly provided by 
Dr. Karine Lapouge, NIMR, London. All proteins are full-length proteins unless an amino acid range is 
stated in orange.
Cloned pGEX-p67ph01 
plasmid inserts
Restriction 
enzymes used 
for cloning
Mass (kDa) of 
expressed 
protein
Pi
Extinction 
coefficient 
at 280 nm 
(M',cnTl)
Soluble
(S)/non-
soluble
(NS)
Yield per 
1 litre 
culture 
(mg)
Wild-type 1 BamWMXhol 59.7 5.88 68560 S 2
(SH3)b (243-297)1 BamHl/Xhol 8.8 4.32 6970 S 11
Details about the PH dom ain:
The plasmid containing the PH domain o f TAPP (tandem PH domain containing 
protein) 1 was provided by Dr. Maria Deak, University o f Dundee, Scotland (Thomas et 
al., 2001). It is cloned into the pGEX-4-Tl vector using the restriction enzymes 
BamHl/BamUl. The over-expressed protein was purified as a GST-fusion protein 
without further removal o f the GST-tag (section 2.2.3).
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2.3 Protein purification
All plasmids were transformed into E.coli BL21(DE3) competent cells for 
recombinant protein expression (see Appendix: A2 for genotype). The proteins were 
purified by the general methods described below. The composition o f the buffers used 
for purification can be found in Appendix: A4. The characteristics o f each protein 
purified are listed in Tables 6, 7 and 9
2.3.1 Growth and induction of cells
After transformation into E.coli BL21(DE3) cells single colonies were picked, 
streaked onto a fresh LB agar plate and incubated overnight at 37 °C to produce a 
‘lawn’ o f cells (1 plate per 750 ml flask o f culture). The next morning the cells from 
each plate were resuspended in 5 ml o f terrific broth (TB) and pooled. 5 ml o f this 
starter culture mix was then used to inoculate 750 ml o f TB containing 100 |ag/ml 
ampicillin (2 litre flask). The cells were grown to mid log phase (abs at 600 nm = 0.6- 
0.8) at 37 °C with shaking at 260 rpm. 1 mM IPTG was added to induce recombinant 
protein expression, and the temperature lowered to 30 °C. After 3 hrs o f induction, the 
cells were harvested by centrifugation at 4000 rpm at 4 °C for 15 min in a Beckman J6 
centrifuge. The cell pellets were stored at -20 °C until required. Expression levels were 
quantified using SDS-PAGE. Typically cells from a 6 litre culture were used per 
purification preparation, but those proteins to remain as GST-fusions were expressed 
and purified on a smaller scale (1 litre o f  cell culture).
2.3.2 Preparation of bacterial lysates
The cell pellet was thawed on ice and re-suspended in approximately 250 ml of 
buffer A (buffer volume dependent on cell mass, 7 ml/g o f cells). The resuspended cells 
were sonicated on ice using a Branson Sonifier 450 (40 % output, 30 sec pulse plus 1 
min rest, x6) with stirring between pulses to ensure complete lysis. The lysate was 
centrifuged at 18,000 rpm at 4 °C for 45 min using a Beckman J25 centrifuge and the 
supernatant collected. The first step o f  protein purifications procedures was an affinity 
chromatography step using glutathione sepharose 4B resin.
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2.3.3 Glutathione sepharose affinity purification and cleavage of
fusion proteins
Typically a column was prepared using 10 ml o f the glutathione sepharose 4B 
resin (GE Healthcare) per protein preparation (typically for 4.5 - 6 litres o f cell culture). 
The column was first washed with ten bed volumes o f  M illiQ water to remove the 20 % 
ethanol storage solution, and then equilibrated with 10 bed volumes o f buffer A. The 
supernatant collected from the bacterial lysates was applied to the column using a PI 
pump (GE Healthcare) at 1 ml/min. The column was then washed at 1 ml/min with 10 
bed volumes o f buffer B, followed with 10 bed volumes o f buffer C.
All p47phox proteins were expressed in pG EX -6-Pl resulting in GST-fusion 
proteins with a recognition site for 3C PreScission Protease (3C) (GE Healthcare). The 
GST-tag was removed by incubating the glutathione sepharose 4B resin in 30-50 ml of 
buffer C containing 1 ml o f 3C protease (0.5 mg/ml) at 4 °C overnight. The protease 
recognises the amino acid sequence Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro and cleaves 
between the Gin and Gly residues (Figure 23). The amount o f cleaved protein was 
determined spectrophotometrically (Table 6). For the purification o f p47phoxS8E, DTT 
and EDTA in buffer C were substituted with 5 mM  p-mercaptoethanol, as it was later to 
be applied to a Ni-NTA resin for a second step o f  purification. EDTA would chelate the 
nickel on the Ni-NTA, whilst DTT can reduce Ni2+ ions at high concentrations thus 
rendering the resin ineffective.
All p67phox proteins were expressed in pG EX -4-Tl resulting in GST-fusion 
proteins with a recognition site for human a-throm bin (Cambridge Biosciences). The 
GST-tag was removed by circulating 20 ml o f buffer C containing 5 pi (7 mg/ml stock) 
o f a-throm bin at 4 °C overnight. Thrombin recognises the amino acid sequence Leu- 
Val-Pro-Arg-Gly-Ser and cleaves the sequence between the Arg and Gly residues 
(Figure 23). The amount o f cleaved protein was determined spectrophotometrically 
(Table 7). Depending on the purity o f  the cleaved proteins, they were further purified by 
ion-exchange, affinity chromatography or gel filtration (Table 8). Any proteins not 
mentioned in Table 8 that have been used, were kindly provided by Dr. Karine 
Lapouge, NIMR, London.
Those proteins required as GST-fusions were purified using 1 ml slurry o f 
glutathione sepharose 4B resin. The resin was washed and equilibrated as described 
above. Lysates were prepared as described above and the supernatant was incubated
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with the resin for 2 hr at 4 °C, washed with 10 ml o f buffer B and incubated with 3 ml of 
buffer C containing 15 mM reduced glutathione, for 2 hrs at 4 °C. The amount o f eluted 
GST-fusion protein was determined spectrophotometrically (Table 9).
Table 8 : Second stage of phox protein purification. The table shows the different types of
chromatography used to purify the proteins at the second stage. The proteins were full-length unless an 
amino acid range is stated in orange.
Protein
Chromatography 
column used
pH of 
Tris/HCl 
used
p47phox Wild-type Source S 8 . 0
p47ph«x Tandem SH3 domains (156-285) Gel filtration 7.0
p47ph°x S359E Source S 8 . 0
p47pho* S370E Source S 8 . 0
p4 7 pho* S379E Source S 8 . 0
p47phox S3E (S359  ^37Q and 379£) Source S 7.5
p4 7 pb°x S5 E (S303, 304, 315, 320 and 328E) Source S 7.5
p4 7 ph°x sgE ( S 3 0 3  3 0 4  3 1 5  3 2 0  3 2 8 , 3 5 9 , 370 and 379E) Ni-NTA 7.7
p4 7 ph°x E218A (156-285) Gel filtration 7.5
p4 7 pho* E220A (156-285) Gel filtration 7.5
p4 7 pho* D221A (156-285) Gel filtration 7.5
p4 7 ph°x D/e 3 a  (E218, E220, D221) (156-285) Gel filtration 7.5
p47ph0,A l‘ (156-285) Gel filtration 7.5
p47ph0XA l+(156-285) Gel filtration 7.5
p47ph0XA2+( 156-285) Gel filtration 7.5
p47pbox3pA ( 1 5 6 -2 8 5 ) Gel filtration 7.5
p47pboxW193RA (156-285) Gel filtration 7.5
p47phoxW194AA (156-285) Gel filtration 7.5
P47ph01 W263R„( 156-285) Gel filtration 7.5
p47ph0IW264AB (156-285) Gel filtration 7.5
P67phox Wild-type Source Q 7.5
p67ph°x (SH3)B (243-297) Gel filtration 7.5
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Table 9: Protein expression details of GST-fusions. The molecular weights, isoelectric points
(pi), extinction coefficients, solubility and protein yields of GST-fusions. Indicated values are following 
15 mM reduced glutathione elution. The proteins were full-length unless an amino acid range is stated in 
orange.
GST-fusion protein
Mass (kDa) of 
expressed 
protein
Pi
Extinction 
coefficient 
at 280 nm 
(M 'c m 1)
Soluble
(S)/non-
soluble
(NS)
Yields per 1 
litre culture 
(mg)
p47ph01 Wild-type 1 70.443 8.49 98430 S 23
P47phox S3E 1 70.569 7.98 98430 S 18
p47ph»* S5E i 70.653 7.22 98430 S 17
p47ph°i S8E 3 72.164 6.60 98430 S 11
p47ph°i pX domain' (4-122) 41.479 6.84 61310 s 11
TAPP1-PH domain *(7-112) 46.717 6.55 57180 s 10
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2.3.4 Ni-NTA affinity purification
P47ph0XS8E contains a C-term inal hexahistidine tag (His6) and was therefore 
further purified using Ni-chelating chromatography, to capture the full-length protein. 
His6-tagged proteins bind with high affinity to Ni 2+ ions immobilized on the 
nitrilotriacetic acid (NTA) group o f  the matrix. P47phoxS8E was eluted from the column 
using imidazole, which competes with the His6-tag for binding to the matrix (the 
imidazole ring is part o f the histidine structure (Figure 26). In addition, 10-20 mM 
imidazole was included in the buffers to reduce non-specific low affinity background 
binding.
The Ni-NTA resin was packed to final bed volume o f 10 ml. The resin was 
washed with 10 bed volumes o f sterile water to remove the storage solution and then 
equilibrated with 10 bed volumes o f buffer D. The buffer was applied at a flow rate o f 1 
ml/min using FPLC (GE Healthcare). The protein eluted from the glutathione sepharose 
4B resin was applied at 1 ml/min, and was washed with 10 bed volumes o f  buffer D 
until a stable baseline (A280) was obtained. The protein was eluted by running a linear 
gradient from 20 mM to 1 M imidazole (using buffers D and E). 1 ml fractions were 
collected and analysed by SDS-PAGE, and those containing pure protein were pooled 
and dialysed overnight at 4 °C into buffer C to remove the imidazole and p- 
mercaptoethanol.
Imidazole
H3@N -C H -C O O °
CH
NH
Histidine
Figure 26: The chemical structures of histidine and imidazole. The imidazole ring is part o f the
histidine structure. Taken and adapted from the Qiagen handbook for high-level expression and 
purification of 6XHis-tagged proteins, 2001.
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2.3.5 Ion exchange chromatography
For ion exchange chromatography, 50 ml Source S (cation exchanger) and 
Source Q (anion exchanger) columns were used (GE Healthcare). The columns were 
equilibrated with buffer F and the protein was applied at a flow rate o f 2 ml/min using 
an FPLC. The column was washed with buffer F until a stable baseline (A 280) was 
observed, and a linear gradient o f  50 mM -500 mM NaCl (using buffers F and G) was 
used to elute the protein. 1 ml fractions were collected and analysed by SDS-PAGE.
2.3.6 Gel filtration chromatography
Gel filtration was carried out on a HiLoad 26/60 Superdex 75 column (GE 
Healthcare). The column was washed and equilibrated with three column volumes of 
buffer H using an AKTA prime FPLC system (GE Healthcare). Prior to loading, the 
protein eluted from the glutathione sepharose 4B resin was concentrated to 
approximately 4 ml, using a suitable m olecular weight cut o ff (MWCO) Centricon 
centrifugal concentrator (Millipore). The protein was eluted at 2 ml/min, and the 
collected 2ml fractions were analysed by SDS-PAGE.
2.3.7 Storage of purified proteins
All the purified proteins were concentrated using a suitable MW CO Centricon 
centrifugal concentrator (Millipore) to concentrations between 500 pM to 1 mM. 
Proteins were aliquoted into 100 pi volumes, flash frozen in liquid nitrogen and stored 
at -80 °C.
135
2.4 Protein analysis
2.4.1 Determination of protein concentration and sample quality
Protein concentration was determined spectrophotometrically using a Beckman 
DU640 spectrophotometer at room temperature. The absorbance o f the protein solution 
was scanned from 240-350 nm and the concentration calculated using the extinction 
coefficients at 280 nm. The extinction coefficients are calculated based on the aromatic 
residue content o f each protein (1280 M -1cm -1 (Tyr), and 5690 M -1cm -1 (Trp)) (see 
Tables 6, 7 and 9). All purified proteins were verified by electrospray mass 
spectrometry (Steve Howell, NIMR, London).
2.4.2 SDS-PAGE
All proteins with molecular weights o f 15 kDa or less were analysed using 
NuPAGE Bis-Tris pre-cast gels (gradient 4 — 12 %) (Novex). All other proteins were 
analysed using 12 % SDS gels (see Appendix: A3). The samples were incubated at 100 
°C for 5 min with 4 X sample buffer (see Appendix: A3), and subjected to 
electrophoresis alongside suitable size standards at 35 mA constant current for 40 min 
(for 12 % SDS gels), or 200 V constant current for 1 hr (for NuPAGE pre-cast gels). 
Gels were stained using SimplyBlue SafeStain according to the manufacturer’s 
protocol.
2.4.3 Circular dichroism
Circular dichroism (CD) spectroscopy is a technique which measures the 
differences in the absorption o f  left and right handed circularly polarised light AA (= 
Auft -  ARight), which arises because o f structural asymmetry o f the chromophores 
(either peptide bonds or the aromatic amino acids). In a well defined ordered structure 
the spectrum produces positive and negative peaks, while in the absence o f an ordered 
structure the CD signal is zero. Although the technique only gives low-resolution 
structural information, it has the following advantages: CD spectra are very sensitive to 
changes in molecular conformation, only small amounts o f material are required, and a 
wide range o f  solvent conditions can easily be examined. CD spectroscopy can be used
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to investigate the secondary structure o f  proteins or to detect secondary and tertiary 
structural changes caused by variations in e.g. pH. It can also be used to monitor protein 
denaturation bought about by changes in temperature or addition o f chemical 
denaturants such as urea. To determine the secondary structure content o f proteins, CD 
is measured in the far-UV spectral region (190-250 nm) where the peptide bond is the 
major chromophore. The usefulness o f CD derives from the fact that the intense CD 
bands o f peptide bonds are very different in both shape and intensity for different 
secondary structural elements (Johnson, 1990; Rodger and Ismail, 2000; Sreerama and 
Woody, 2000).
The Beer-Lambert law for absorbance is:
A = s m* C * l  [4]
where A is the absorbance, £m is the molar extinction coefficient (M 1 c m 1), C is the 
protein concentration (M) and I is the path length (cm).
The CD equivalent o f this equation is:
AAA s = ------  [5J
m C * l
where Asm= (£ieft - £Rlght) is the molar CD extinction coefficient.
CD intensities in the far-UV region are usually presented on a mean residue 
basis as A c m r w ,  where A e m r w  is equal to A £ m divided by the number o f residues. 
Different secondary structures (a-helix, p-sheet and random coil) have different CD 
spectra. The a-helix has a positive peak at 197 nm and negative ones at 207 nm and 222 
nm. The p-sheet generally has a positive peak at 196 nm and a negative one at 210-218 
nm. The random coil has a weak positive peak at around 212 nm and a strong negative 
one at 195 nm. From the CD spectra, the fraction o f each o f the secondary structure 
elements present in a protein can be determined. However, although CD spectroscopy 
can determine the percentage o f the different secondary structures, it cannot determine 
which residues are involved in which specific secondary structure. The secondary 
structure content is estimated using a database o f CD spectra o f  known proteins (Yang
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et al., 1986), and secondary structure contents that were derived from their X-ray 
structures. The secondary structure content o f a protein is determined by fitting to the 
appropriate combination o f spectra o f  proteins with known structure.
In order to determine the thermal stability o f a protein, changes in the CD 
spectra with increasing temperature can be measured. Although measurements are 
generally performed by monitoring at a single wavelength, it can be useful to record 
spectra at higher temperatures to examine how much residual structure remains 
following unfolding.
For all measurements the protein samples were extensively dialysed overnight at 
4 °C in buffer H, and the protein concentration used per experiment was 0.15 mg/ml. In 
collaboration with Dr. Stephen. M artin, NIMR, London, CD spectra were measured 
between 190 nm -  260 nm on a Jasco J-715 spectropolarimeter using 1 mm fused silica 
cuvettes at 25 °C. Multiple scans were averaged and the appropriate buffer blanks were 
subtracted. The secondary structure contents were determined using the fitting programs 
CONTIN, SELCON, CDSSTR (Sreerama and Woody, 2000). Thermal denaturation 
curves were recorded by measuring the CD signal continuously at 224 nm over the 
ranges of 20 °C - 80 °C in sealed 1 mm cuvettes. The temperature was increased at 1 
degree/minute using the m anufacturer’s Peltier thermal controller. The curve was 
smoothed using a moving polynomial (Savitzky and Golay, 1964), and the Tm values 
were determined from the first derivative o f the smoothed unfolding curve.
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2.5 Western blotting
Proteins for western blotting were separated using SDS-PAGE and then 
transferred onto a suitable dim ension polyvinyidene difluoride membrane (pore size 
0.45 pM) (Millipore) by electroblotting in a tank (GE Healthcare) at 50 V for 1 hr in 
buffer 1. Once the transfer was complete, the membrane was blocked overnight in 20 ml 
o f buffer 3 at RT, washed twice for 5 mins in 20 ml o f buffer 2 at RT and then twice for 
5 mins in 20 ml o f buffer 4 at RT. The membrane was incubated in 20 ml o f buffer 2 
containing 1:20,000 dilution o f  the anti-GST HRP (horseradish peroxidase) conjugated 
antibody (Sigma) and then washed 5 times for 5 mins each in 20 ml o f buffer 2 at RT. 
The membrane was incubated for 5 mins in 5 ml o f a 1:1 ratio o f  the two solutions 
(enhancer solution and peroxide solution) provided in the W est Pico Chemiluminescent 
Substrate Kit (Pierce) and then developed using an X-ray film (Kodak).
Buffer 1 Buffer 2
10 mM CAPS (pH 11.0) 50 mM  NaCl
10 % methanol 20 mM Tris (pH 7.5) 
0.05 % Tween-20
0.2 % Triton X 100
Buffer 3 Buffer 4
Buffer 2 plus 3 % BSA 100 mM NaCl
10 mM  Tris (pH 7.5)
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2.6 Lipid sedimentation assays
2.6.1 Liposome production
All lipids used were bought as solids and solubilised in chloroform to a final 
concentration o f 10 mg/ml, apart from PtdIns(3,4)P2 which was made to a final 
concentration o f 1 mg/ml stock (due to the limited quantity provided by the 
manufacturer). All stocks were stored at -20 °C in glass vials (1.8 ml W heaton glass 
vial) which had been pre-rinsed with chloroform. Liposomes were prepared on ice by 
mixing lipids at the following concentrations: 50 % phosphatidylcholine (PC), 40 % 
phosphatidylethanolamine (PE), 5 % phosphatidylserine (PS) and 5 % PtdIns(3,4)P2 in 
a total volume o f 200 pi. 200 pi o f methanol was added to give a final reaction volume 
of 400 pi. Parallel to this, a control was prepared by omitting PtdIns(3,4)P2 and 
substituting the volume with chloroform. The lipid mixture was protonated prior to use 
by adding 1 M HC1 to a final concentration o f  0.1 % i.e. 400 pi chloroform, 400 pi 
methanol and 4.6 pi o f 1 M HC1. The samples were sonicated briefly for 5-10 seconds in 
a bath sonicator and allowed to stand for 15 mins at RT. The mixtures were dried under 
nitrogen to form a thin lipid film in the glass vial. The dried pellets were resuspended to 
a final concentration o f 1 mg/ml in filtered sample buffer composed o f 20 mM Hepes 
(pH 7.5), 100 mM NaCl, 1 mM DTT and 1 mM EDTA. The resuspended lipids were 
left to hydrate for 1 hr at RT, gently agitating by bath sonication every 10 mins for 5-10 
sec. The lipid mixes were further mixed in the bath sonicator until a homogenous 
suspension was formed (approximately 2-4 mins). To fully form the vesicles 4-6 brief 
pulses using a small 3.2 mm sonicator probe were applied (2 sec sonication and 2 sec 
rest).
2.6.2 Liposome binding assay
Reaction mixtures were prepared on ice in polycarbonate centrifuge tubes 
(Beckman). 50 pi o f the 1 mg/ml stock liposomes were mixed with 40 pi o f  the 
liposome buffer (sample buffer plus 1 mM MgCl2) and 5-10 pi o f the purified protein 
(15 pM final protein concentration). The samples were mixed repeatedly with a pipette 
and incubated on ice for 15 mins. The liposomes were sedimented by centrifugation at 
140,000 g (Beckman TLA 100 ultracentrifuge) at 4 °C for 15 mins. The supernatant was
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carefully removed and transferred to a separate vial, and the liposome pellets were 
resuspended in 100 pi o f liposome buffer (it is im portant to solubilise the pellet in an 
equal volume as the supernatant). 10 pi o f  sample were incubated with 5 pi o f 2 X SDS 
loading buffer and the samples were heated at 100 °C for 2 mins. Equal volumes of 
pellet and supernatant (15 pi) were loaded onto a NOVEX 4-12 % Bis-Tris SDS-PAGE 
gel and separated at 200 V constant current for 1 hr, then visualised with SimplyBlue 
SafeStain.
2.6.3 Adjustments to improve the lipid sedimentation assay
Due to problems with the experimental protocol various adjustments were made to 
maximise binding.
Adjustment 1: -Include 10 % cholesterol in liposome mix
-Use speedvac for further evaporation
Adjustment 2: -Use 5 % PA instead o f 5 % PS
-Use 2 ml glass vials for liposome production (Chromacol)
-Produce multilameller vesicles (M LV ’s) by vortexing instead o f 
sonication
Adjustment 3: -Increase PA and PtdIns(3,4)P2 concentration to 10 %
-Use 2 ml glass vials for liposome production (Chromacol)
-Use a freeze drier from E-C M odulyo for solvent evaporation
2.7 PIP (PtdIns(3,4)P2) bead binding assay
PIP beads are agarose beads that have PtdIns(3,4)P2 covalently attached. 50 pi 
slurry o f beads was pelleted at 1000 rpm for 1 min at 4 °C and the storage solution was 
discarded. The beads were washed in 50 pi o f binding buffer containing 10 mM Hepes 
(pH 7.4), 150 mM NaCl and 0.25 % NONIDET P-40 (NP-40). The supernatant was 
discarded and the beads were resuspended in 50 pi o f  the binding buffer. 5 pg o f protein 
was added and incubated at 4 °C for 3 hrs on a rocking device. The beads were washed 
five times with ten bed volumes o f  binding buffer by centrifugation at 1000 rpm for 1
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min at 4 °C. The beads were pelleted by centrifugation, the supernatant was discarded 
and an equal volume (50 pi) o f  2 X SDS loading buffer was added. The samples were 
mixed and incubated at 100 °C for 2 mins. 20 pi o f the samples were separated on a 
NO VEX 4-12 % Bis-Tris SDS-PAGE gel, at 200 V constant current for 1 hr. They were 
visualised with either SimplyBlue SafeStain or electroblotted for western blot analysis. 
Control PIP beads were also provided by the manufacturer without PtdIns(3,4)P2 
coupled and were run parallel to the assay to ensure that any binding observed was not 
due to non-specific binding to the agarose beads.
2.8 Fluorescence spectroscopy
Fluorescence spectroscopy experiments were carried out to determine binding 
affinities for complexes between a fluoresceine labelled p22phox derived peptide (peptide 
3, Appendix: A4) and p47phox proteins. Changes in peptide fluorescence were monitored 
at 525 nm upon excitation at 429 nm. In addition, binding affinities for complex 
formation between a 35-mer peptide derived from the polybasic region o f p47phox 
(peptide 1, Appendix: A4) and p47phox tandem SH3 domain proteins was measured by 
following changes in tryptophan fluorescence at 320 nm upon excitation at 295 nm.
Stocks o f the fluorescein labelled p22phox peptide and the p47phox 35-mer 
polybasic peptide were made in 20 mM  Hepes (pH 7.5). The protein samples and 
working solutions o f peptides were made in buffer H. The pH o f the buffers was 
adjusted depending on the pi o f the individual proteins to one unit above or below the 
pi. All experiments were carried out at 20 °C. For each experiment the peptide or 
protein to be placed into the cuvette was diluted to a final concentration o f 1.0 pM. An 
amount o f protein or peptide was also added to the component that was to be titrated to 
maintain a 1.0 pM  concentration o f  fluorescent material (to account for dilution effects). 
The sample was titrated into the cuvette and allowed to equilibrate for 3 min after each 
addition before the reading was taken. All experiments were repeated at least 3 times 
and the data were fitted to a quadratic equation (equation 12) using the program GraFit 
(version 5). Control experiments were performed where buffer H was titrated into 
component A, to ensure that the fluorescence observed in experimental assays was not 
due to artifactual background signal.
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2.9 Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were carried out to determine 
binding affinities for complexes between p47phox proteins and p67phox(SH3)e. Heat 
changes were monitored at 15 °C. In addition, complex formation for p22phox derived 
peptide (peptide 2, Appendix: A4) or the p47phox 35-mer polybasic region peptide 
(peptide 1, Appendix: A4) with p47phox tandem SH3 domain proteins were determined. 
Heat changes were monitored at 18 °C. Protein samples were dialysed overnight at 4 °C 
in buffer H using a dialysis membrane with an appropriate MWCO (Slide-a-Lyzer, 
Pierce). Due to the small molecular weights o f  the peptides used, dialysis was not 
feasible. In this case the peptides were diluted with the experimental buffer. The pH of 
the buffers were adjusted depending on the pi o f  the individual proteins and to one unit 
above or below the pi. The protein samples were centrifuged for 10 min at 4 °C to pellet 
any aggregated protein. The volumes o f  proteins required to load the instruments were 
2.2 ml for the cell, and 600 pi for the syringe, which were degassed under vacuum for 
10 min. The cell and syringe were washed thoroughly with filtered dH20 and then with 
buffer H. The cell was filled using a 2.5 ml syringe by carefully introducing the sample 
gradually from bottom to top, avoiding the introduction o f air bubbles. Typically 250 -  
400 pM o f ligand was titrated into 25 -  40 pM  protein in the cell (varied depending on 
the affinity o f the interaction). Heats o f dilution in control experiments were determined 
by titration o f the syringe component into buffer H. The heats o f dilution were 
subtracted from the raw data before fitting to the quadratic equation shown in equation 
19, using the evaluation software supplied by the manufacturer (M icrocal Origin 
version 5.0).
The parameters shown in Table 10 were employed for all ITC experiments 
undertaken. To compensate for losses/dilutions from the tip o f the syringe during the 
experimental set-up, the first injection o f  all ITC experiments was o f a smaller volume 
(2 pi). Data from this first injection were removed from the final curve fitting analysis 
and all experiments were repeated at least three times.
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Table 10: ITC experimental parameters.
Parameter Value
Number of injections 30
Cell temperature (°C) X
Reference power (pCal/sec) 15
Initial delay (sec) 300
Syringe concentration (mM) Y
Cell concentration (mM) Z
Stirring speed (rpm) 310
Injection volume (pi) 1 * 2 pi
2 9 . lOpl
Injection spacing (sec) 300
Feedback mode High
The reference power is a small amount o f power that is continuously supplied to the reference cell heater. 
The cell temperature is the temperature of the experiment. The initial delay is the time from the start of 
the experimental data collection time until the 1st injection. The injection spacing is the time between each 
injection and should be chosen such that the signal has returned to baseline before the next injection. A 
high feedback mode gives the fastest response time (VP-ITC user manual, 2004).
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2.10 Quantitative analysis of protein-ligand interactions
In principle there are two different approaches in which protein-ligand 
interactions can be quantified. The first approach measures the concentration o f bound 
and free ligand directly. Examples o f  such techniques include ultrafiltration, gel 
filtration, ultracentrifugation, flow and equilibrium dialysis. The second approach is 
based on inferring concentration changes in free or bound ligand from the variation in 
some physical property o f the system. Examples o f such techniques include optical 
spectroscopy (fluorescence, circular dichroism, and absorbance), NMR, and isothermal 
titration calorimetry. In these methods the measured signal is related to changes in 
concentration. The interaction o f  a protein with a ligand is represented as:
equations 7 and 8:
where P j is the total protein concentration (free and bound), and L j is the total ligand 
concentration (free and bound)
Substitution o f the expressions for P and L into equation 6 gives:
P  + L <=> PL w jth [P][L]
[PL]
[6]
Substituting the mass balance relationship, + and ^ T + gives
([Pr]-[PL])([Lr]-[PL])
[PL\ [7]
K d[PL] = PTLT ~[PL]([PT] + [LT]) + [PL] [8]
thus,
[PL]2 - [PL](Pt + Lt + K d) + PrLp = 0 19]
[PL] is given by the solution o f  the quadratic equation, where:
[PL] = [10]
2
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2.11 Quantitative techniques used in this study
In this study ITC was chosen as the principle method for characterising protein- 
protein and protein-peptide interactions. A single ITC experiment simultaneously 
determines a range o f parameters (binding affinity, stoichiometry and thermodynamic 
parameters), without having to modifying the proteins under investigation. However, 
the method requires large amounts o f proteins and in some instances using ITC was not 
a feasible option due to poor protein yield and stability. In this case fluorescence 
spectroscopy was used as an alternative technique.
2.11.1 Fluorescence spectroscopy
Fluorescence spectroscopy is a highly sensitive technique that only requires 
small amounts o f protein and therefore is often used to quantitate protein-ligand 
interactions. The fluorescence can arise from intrinsic natural fluorophores or extrinsic 
fluorescent probes. The fluorescence o f proteins can be characterised by their excitation 
and emission spectra, the quantum yield (ratio o f  photons emitted to those absorbed) 
and anisotropy or polarisation values. The spectral properties depend on the atomic 
environment o f the fluorophore and its accessibility to the solvent, which can change 
upon interaction with ligands. The changes measured can be used to quantify the 
interactions and determine binding affinities, as was done in this study. Thus, 
fluorescence spectroscopy provides a sensitive means to characterise proteins and their 
interactions (Lakowicz, 1999; Ninfa and Ballou, 1998; Szabo, 2000).
Substances which display fluorescence can be divided into naturally occurring 
intrinsic fluorophores and into extrinsic fluorophores that are added to otherwise non- 
fluorescent samples. Intrinsic fluorophores include cofactors such as NADH or FAD 
and proteins. Fluorescence observed in proteins derives from the aromatic side chains o f 
the amino acids: tryptophan, tyrosine and phenylalanine. The emission maximum of 
free tyrosine is ~ 303 nm and this is generally the same for tyrosine in a protein. In 
contrast, whilst the emission m axim um  o f free tryptophan is ~ 355 nm, a tryptophan in a 
protein can emit anywhere from 313-355 nm, depending on the polarity o f  the 
environment. In proteins containing all three amino acids, fluorescence is almost always 
dominated by tryptophan because its extinction coefficient is significantly higher than 
that o f tyrosine and phenylalanine. In addition, the fluorescence o f phenylalanine and
tyrosine can be quenched via energy transfer to tryptophan.
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The use o f intrinsic fluorescence for quantifying protein/protein or 
protein/peptide interaction is only feasible if  one o f the binding partners does not 
contain any tryptophan residues. I f  they are present in both, then titration o f the second 
component may lead to severe background fluorescence, which can be difficult to 
subtract. I f  this is the case then the use o f  extrinsic fluorescent probes for monitoring 
complex formation may be a better alternative. Frequently used extrinsic fluorescent 
probes include fluorescein and rhodamine. These extrinsic labels are most often 
covalently attached to either cysteine residues, to the amino groups o f lysine residues or 
to the N-terminus o f peptides. However, introducing these probes at a specific site in 
larger proteins can be difficult, as proteins often contain more than one cysteine or 
lysine residue. Although these excess residues can be removed by mutagenesis, the 
effect on stability and activity o f  the protein must be examined. Furthermore, if  extrinsic 
labels are introduced it has to be ensured that the label does not interfere with the 
interaction under investigation.
2.11.1.1 Physical principles
The production o f fluorescence is generally a three step process i) absorption, ii) 
vibrational relaxation back down to ground vibrational levels and iii) emission. This 
phenomenon is schematically described by the Jablonski diagram (Figure 27). 
Absorption o f energy takes the molecule from a low vibrational level o f  the ground 
electronic state (S0) to a higher vibrational level o f  the first excited state (Si) or a second 
excited state (S2). After reaching one o f the higher vibrational energy levels o f the 
excited state, the molecule loses excess vibrational energy by collision and falls to the 
lowest vibrational level o f that state (internal conversion). This loss o f energy through 
collision gives rise to the ‘Stokes shift’. From here the molecules eventually revert back 
to any o f the vibrational levels o f  S0, emitting energy in the form o f fluorescence. In 
addition to fluorescence, phosphorescence can take place where the molecules enter a 
triplet state (Ti) (Figure 27). The energy emitted from Ti to S0 as phosphorescence 
results in longer wavelengths relative to fluorescence. Fluorescence emission can take 
place within 1 O’9- 1 O’6 seconds, whereas phosphorescence emission takes place within 
10"4- 102 seconds.
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Figure 27: Jablonski diagram. This diagram shows the different energy levels and processes in
an electronically excited molecule. Indicated are the ground state (S0), first excited state (Si), second 
excited state (S2) and triplet state (Ti) (taken and adapted from Szabo, 2000).
2.11.1.2 Instrumentation
All experiments undertaken in this study were carried out using a PCI photon 
counting spectroflurometer (ISS, USA). Figure 28 shows a schematic diagram of a 
typical fluorescence spectrophotometer. The instrument contains a xenon lamp, which 
provides a high intensity light at wavelengths ranging from 200 nm-1000 nm. The beam 
splitter splits the light into two, where one beam passes through the sample and the 
other through a reference cell. The instrument also contains two monochromators, one 
o f which selects the appropriate excitation wavelength (>.ex) from the light source and 
the other the appropriate emission (A ,e m ) wavelength. The photon intensity is detected by 
a photomultiplier and converted into an electrical signal (Lakowicz, 1999).
2.11.1.3 Determining the spectral parameters for the binding experiment
In order to obtain data o f sufficient quality to quantitate a protein-ligand 
interaction, a significant change in the fluorescence signal is required upon complex 
formation. The largest change in signal may not necessarily occur at the emission 
maximum ( E max ) of the isolated protein or ligand, as this may shift upon complex 
formation. Therefore, correctly selecting the appropriate wavelength at which complex 
formation is followed is crucial. This selection can easily be made by recording spectra 
o f the protein or ligand on its own, and o f the protein/ligand complex. The emission 
wavelength should then be chosen such that the differences in signal between the free 
and bound state are maximal. A typical protein emission spectrum is shown in Figure 
29. The p47phox tandem SH3 domain protein (which contains five tryptophan residues) 
is present in the cuvette at a concentration o f 1 pM. Upon addition o f a 20-fold excess 
o f the p47phox 35-mer polybasic peptide (which contains no tryptophan residues), the 
fluorescence signal increases and the emission maximum shifts from 340 nm to 320 nm. 
The biggest increase is observed at 320 nm and therefore all titrations were carried out 
at this emission wavelength.
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Figure 28: A schematic diagram of a typical fluorescence spectrophotometer. L represents the
light source, ExM is the excitation monochromator, which selects the appropriate excitation wavelength. 
BS is the beam splitter which splits the light into two, where one beam passes through the sample and the 
other through the reference. F/P is the filter or polarizer (polarizers are used to measure the fluorescence 
anisotropy). Sa is the sample holder, EmM is the excitation monochromator which selects the appropriate 
emission wavelength. PMT are the photomultiplier tubes which detect photons and convert them to an 
electrical signal. SLe and SLx are the entrance end exit slits o f the monochromators; respectively. S and R 
are the sample and reference fluorescence signals; respectively (taken and adapted from Szabo, 2000).
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Figure 29: Change in fluorescence intensity and emission maximum upon complex formation
(intrinsic tryptophan fluorescence). P47phoxWild-typetandcm (aa 156-285) (black line) contains five 
tryptophan residues. Addition o f excess peptide (p47phox 35-mer polybasic region peptide) leads to an 
increase in fluorescence intensity by approximately 2-fold (red line) and the fluorescence maximum shifts 
from 340 nm to 320 nm upon complex formation (broken black line).
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2.11.1.4 Curve fitting
The concentration o f  com plex formed is given by the ratio o f  the m easured 
change in fluorescence to the amplitude:
[ PL] =  | ] ] |
( F - F  )v min max ’
where F is the measured fluorescence signal, Fmm is the minimal fluorescence signal 
and Fmax is the maximum fluorescence signal.
W hen equation 11 is substituted into equation 10, we get a form o f the quadratic 
equation (equation 12) that allows the calculation o f  a IQ from the measured 
fluorescence intensity (F) at different protein/ligand concentrations:
PT + L T + K d -  J (P T + L t + K , ) 2 -  4Pt Lt 
F = F  + (F  - F  ) —____-____ -__ * ____ -____ —________________________1121min V max min * p w  I I
Z [ r L \
2.11.1.5 Important parameters in fluorescence spectroscopy
Various factors need to be taken into consideration when planning a 
fluorescence spectroscopy experim ent (reviewed by Lakowicz, 1999 and Szabo, 2000). 
For example changes in tem perature affect the viscosity o f  the medium and hence 
collision o f fluorophore and solvent molecules. Therefore, fluorescence is tem perature 
dependent and it is essential that the reactant solutions used have reached their final 
temperature prior to the start o f  m easurem ents, especially those on ice. Therm ostatted 
cell holders are recom mended. As fluorescence titrations are an equilibrium  assay one 
needs to ensure that the samples are at equilibrium  i.e. the fluorescence signal remains 
constant during recording. It may be necessary to wait for a few minutes prior to 
recording the data. Furthermore, it is essential to determine the concentrations o f  both 
reactants precisely. The concentration o f  the cuvette reactant should be the lowest 
concentration possible, which reduces not only the material used, but also possible
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inner-filter effects. However, the concentration must not be too low as loss o f material 
through binding to the walls o f  the cuvette can occur.
Proteins should be a pure as possible to prevent non-specific interactions and 
samples should be free o f  im purities such as dust (samples should be filtered or 
centrifuged). In addition, buffers o f  the highest quality should be used, which do not 
absorb light in the w avelength range o f  the experiment.
If an unexpected decrease in fluorescence signal is observed, then it is important 
to check that long exposure to light (photobleaching) or mechanical stress due to stirring 
(stability) is not the cause. To check for photobleaching one can measure the signal first 
continuously without stirring and then mix the sample. This will lead to an increase in 
signal as new molecules will get into the light path, if  the fluorescence decrease is due 
to photobleaching. If photobleaching is a problem  this can be reduced by lowering the 
light intensity or by closing the shutter during measurements. If  photobleaching is ruled 
out then the decrease in signal could be due to mechanical stress, in which case the 
speed o f  the stirrer should be lowered. A nother possible reason could be loss o f protein 
due to adherence to the cuvette walls, in which case changing buffer conditions would 
be suitable or perhaps coating the cuvette with a detergent such as Tween 20 to 
m inim ise protein sticking.
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2.11.2 Isothermal titration calorimetry
Isothermal titration calorim etry (ITC) is a powerful technique used for the study 
o f  protein-ligand interactions and can be applied to interactions involving proteins, 
lipids, carbohydrates, nucleic acids, metal ions and others (reviewed in the VP-ITC user 
manual; (Ladbury, 2004; Leavitt and Freire, 2001; Perozzo et al., 2004; Pierce et al., 
1999). It is a therm odynam ic technique that m onitors the heat that accom panies a 
binding reaction. Upon com plex formation heat can either be released (exotherm ic 
reaction) or absorbed (endotherm ic reaction) and the am ount o f  heat released or 
absorbed is directly proportional to the amount o f bound ligand. A single binding 
experim ent sim ultaneously determ ines the therm odynamic properties including the 
binding constant (Ka), enthalpy change (AH°), and stoichiometry (n) (W isem an et al., 
1989). Using the determ ined values o f  AH and Ka, a full thermodynamic profile can be 
elucidated, where the Gibbs free energy o f  the reaction (AG°) and the entropy change 
(AS°) can be derived. The association constant Ka is related to the Gibbs free energy by 
the following relationship:
AG° = - R T \n K a [13]
where R is the universal gas constant (1.987 cal fC1 moT1), and T is the absolute 
temperature in Kelvin (0 °C  = 273.15 K).
AG° can also be expressed in terms o f  AH° and AS° by the relationship:
AG° = A H °-T A S °  [ |4 ]
I f  the experiments are repeated over a range o f different temperatures, the heat capacity 
associated (Cp°) with the reaction can also be determ ined since,
A Q °  = ^
dT  H 5 |
The Gibbs free energy change (AG°) is a measure o f the chemical potential o f  a
reaction and is a com bination o f changes in the enthalpy (AH°) and entropy (AS°)
during a reaction. AH° reflects the formation/breaking o f  hydrogen bonds, van der
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W aals interactions and salt bridges. These com ponents produce either favourable or 
unfavourable contributions to the free energy. Generally, AS° represents all the other 
positive and negative forces w hich contribute to the free energy. The total entropy 
change is expressed by several contributing effects, but m ainly solvation entropy 
(complex formation may be accom panied by desolvation, whereby water is released, 
resulting in favourable gains in AS). Conform ational entropy also contributes to the total 
entropy change, but usually contributes unfavourably (complex formation may reduce 
the rotational degrees o f freedom) (Perozzo et al., 2004). The therm odynam ic profile 
derived from ITC experiments can be used to com plem ent a crystal or NM R structure to 
characterise the activity and function o f  proteins and their ligands.
2.11.2.1 Instrumentation
All calorimetric experiments in this study were carried out using a M icrocal VP- 
ITC instrum ent (M icrocal Inc, N ortham ton USA). Figure 30 shows a schematic diagram  
o f  the VP-ITC unit. The instrum ent consists o f  two cells, the sample and reference cells. 
The sample cell holds the protein o f  interest and the reference cell holds either buffer 
solution or water. Both cells are kept at therm al equilibrium throughout the experim ent 
and are enclosed in an adiabatic outer shield (jacket). The spinning syringe contains the 
second component (ligand), which is injected serially into the sample cell to give a 
therm al titration curve. Figure 31 shows a typical output obtained for the titration o f  a 
peptide into protein. Enthalpic changes are m easured as heat change per unit time 
(pcal/s) that must be added to m aintain zero tem perature difference between the two 
cells, at the designated tem perature o f  the experiment. Reactions resulting in the 
evolution o f heat (exothermic) cause a negative change in DP power (differential pow er 
between the reference and sample cell), as less DP feedback is required to keep the cells 
at thermal equilibrium. The opposite is observed for endothermic reactions, where 
additional energy to the sample cell is required to maintain equal tem peratures in both 
cells. Each peak corresponds to the am ount o f  heating/cooling required to com pensate 
for the heat generated/absorbed upon each addition o f  the ligand. The heat 
absorbed/released upon each injection ( Qt ) is proportional to i) the am ount o f  ligand
that binds in that particular injection ( vxAL, )  and ii) the binding enthalpy for that
reaction:
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Figure 30: Schematic diagram of the VP-ITC Unit (Microcal). Taken and adapted from the
Microcal VP-ITC user manual, 2004.
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Figure 31: Example ITC data for the titration of 29 pM p47phoxE218EUlldein with 250 pM
p22pho1 peptide. The upper figure shows the power (pcal/sec) versus time. At each injection an 
exothermic spike is observed. The area under the spike is proportional to the heat o f binding. The lower 
figure shows the amount o f heat measured, normalized to the number o f moles o f injected p22phox peptide 
(kcal/mol) (peptide 2) versus the molar ratio o f cumulative p22phox peptide added to p47phoxE218Etandetn.
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Qi = v x AH  x ALi |16]
w here v is the reaction volume o f  the experimental cell.
The size o f  the peaks decrease as the binding sites on the m acrom olecule in the 
cell become saturated, and once the sample cell reactant is fully saturated by the ligand, 
then any heat observed is the heat o f  dilution. The integrated area under each peak gives 
the amount o f heat evolved during that particular injection. A binding isotherm is 
generated (Figure 31) by plotting the heat per injection ((? ,) against the m olar ratio o f
the ligand and macrom olecule ([L],0tai/[M],otai)- The isotherm is fitted using a linear 
least-squares method (Origin softw are provided by the manufacturer) from which AH, 
Ka and n are derived. AH is derived from y-axis intercept, n from the inflection o f  the 
binding isotherm at m olar equivalence, and Ka from the fit o f the curve. To determ ine 
the binding enthalpy accurately it is im portant that the first few injections define a 
baseline region where all the added ligand binds to the reactant. Furthermore, com plete 
saturation should be achieved to produce a well-defined sigmoidal curve, w hich is 
im portant to correctly determine Ka and the stoichiometry.
2.11.2.2 C urve fitting
Differentiation o f the quadratic expression for [PL] (equation 10) with respect to 
Ltot gives:
d[PL]  1 t \ -  (\ -  r) / 2 -  Lr / 2 
d \-L,,A 2 - _ 2 L r( \ - r )  + ( l - r ) 2
w here r is equal to K j/P T  and Lr is equal to Ltot/P,ot
The change in the concentration o f  PL can be related to the heat by:
dQ  = d [ P L ] x A H x v  [18]
w here AH is the enthalpy o f  binding, v is the reaction cell volume and Q is the heat 
change evolved from  the reaction.
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Then substitution o f equation 17 into 18 yields the final equation:
= AH\ -  +
2 j L r2 - 2 L r( l - r )  + (l + r ) 2 J
1 l - ( l  + r ) / 2 - L / 2
 — ■ [19]
H d Q / d L lot)
Equation 19 describes the curve, which represents binding isotherms for a single-site 
interaction (W iseman et al., 1989). The micro-calorim eter measures the differential heat
The concentration o f  the cell reactant required depends on the strength o f the 
interaction to be measured. The optim al am ount o f  cell reactant can be determined using 
the unitless C parameter. The C param eter is the concentration ratio o f the cell reactant 
divided by the Kd and defines the shape o f  the binding isotherm.
where Ka is the binding association constant, M,ot is the total macromolecule cell 
concentration, and n is the stoichiometry'.
It is crucial to determ ine the correct cell reactant concentration required for the 
experiment. If  the concentration is too low (C<1) the isotherm curve becom es very 
shallow, where the drop at equivalence point broadens and the intercept at the Y axis is 
lower than the true AH°. The sigm oidal curve loses its characteristic shape thereby 
making it extremely difficult to determ ine the Kd, molar ratio and AH° (Figure 32). If 
the concentration is too high ( 0 1 0 0 0 ) ,  the m olar ratio and AH° can be easily 
determined but the Kd cannot, as at the transition region the sigmoidal curve becom es 
rectangular in shape with too few points collected near equivalence. The height o f the 
curve corresponds to AH° and the sharp drop occurs at the stoichiometric equivalence 
point (n). Hence, reactions with large Ka values should be studied at low m acrom olecule 
concentration and the opposite is true for low Ka values. Ideally, one should use cell 
reactant concentrations where the C values are 10-500, and the syringe reactant 
concentration should be 10-20-fold greater than that o f  the cell concentration.
dQ/dL,ot-
2.11.2.3 Concentration requirements
C = K u[ M tol]n [20]
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Figure 32: Binding isotherms at various C parameter values. When the cell reactant is too low
(C<1), the data shape is shallow which makes it difficult to determine the IQ and AH° accurately. When 
the cell reactant is too high ( 0 5 0 0 )  then there is insufficient information at the transition region to 
determine the IQ. The optimal C values are between 10 and 500. Taken and adapted from the Microcal 
VP-ITC user manual, 2004.
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2.11.2.4 Important parameters in ITC
Various factors need to be taken into consideration when planning an ITC 
experiment. For example, it is essential that the cell and syringe solutions be precisely 
chem ically (pH and solvent com ponents) matched as even small differences can cause 
background heats o f  mixing, thereby m asking the heat o f  binding for the reaction. In 
order to avoid this, extensive dialysis o f both reactants is critical to match the 
components. Furtherm ore, all samples should be filtered or centrifuged to remove 
aggregate particles. Prior to loading the cell and syringe materials, both have to be 
degassed to remove residual air bubbles, as these can affect the baseline and interfere 
with the feedback circuit. In order to determine heats o f dilution, control titrations 
w here the syringe com ponent is titrated into the cell containing only buffer should be 
performed. Even at saturation, there is always ‘background’ heat at every injection. This 
should be subtracted from the final experimental isotherm. It is also im portant to 
determ ine the concentrations o f  the reactants accurately, as the accuracy o f  IQ and AH 
are directly dependent on this.
Many protein-ligand interactions are accom panied by the release or uptake o f 
protons. In the presence o f buffer these protons are either released or absorbed to 
m aintain a constant pH. Therefore, it is im portant to choose a buffer with a low heat o f 
ionization to minimize any artificial heats o f  buffer ionization (these heats are in the 
kcal/range). For example, Tris buffer should be avoided as it has a large proton 
ionization enthalpy (AHlon (25 °C) kcal/mol = 11.4), whereas a phosphate (AHlon (25 °C) 
kcal/mol = 0.9) or Hepes buffer (AHjon (25 °C) kcal/mol = 5.7) are well suited.
If no change in signal is observed during a titration this may be due to the 
affinity being too weak for the relative concentrations used. In this case, the reactant 
concentrations should be increased by ~ 10-fold to am plify the signal. Alternatively, the 
temperature can be changed by 5-10 °C in either direction, as AH is tem perature 
dependent and coincidently might be zero at a given temperature. If  the binding 
observed is too tight then lowering the reactant concentrations, particularly the cell 
reactant may be better. Alternatively, the tem perature can be increased as this often 
causes affinities to becom e weaker, which is particularly true for exothermic reactions. 
The opposite is true for endotherm ic reactions where decreasing the tem perature can 
weaken affinities.
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CHAPTER THREE
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3.0 Phosphorylation of p47phox and NADPH oxidase
activation
P47phox is phosphorylated on eleven serine residues o f which eight are required 
for activation o f the NADPH oxidase (Ago et al., 1999; el Benna et al., 1994; El Benna 
et al., 1996; Faust et al., 1995; Groem ping et al., 2003; Inanami et al., 1998; Johnson et 
al., 1998). Five o f  these serine residues are located within the polybasic region (S303, 
304, 315, 320 and 328), and the remaining three are located at the extreme C-term inus 
(S359, 370 and 379), a region that interacts with p67phox (Finan et al., 1994; Lapouge et 
al., 2002; Leto et al., 1994). M any studies have shown that phosphorylation o f  the serine 
residues within the polybasic region is im portant for the transformation o f  the inactive, 
auto-inhibited state into the active state (Ago et al., 1999; el Benna et al., 1994; El 
Benna et al., 1996; Groem ping et al., 2003). Although Ago and colleagues showed that 
phosphorylation o f the C-term inal serine residues S359, 370 and 379 do not directly 
promote binding o f p47phox to p22phox, it is not known whether they synergise with the 
polybasic region, to contribute to the interaction (Ago et al., 1999). In addition, the 
potential effects o f such phosphorylation events on the interaction with other oxidase 
components such as p67phox have not been directly characterised. Until now the effect o f 
these phosphorylation events have mainly been conducted with respect to superoxide 
production or membrane translocation o f  p47phox (Faust et al., 1995; Johnson et al., 
1998).
This chapter describes experim ents to investigate the effect that phosphorylation 
o f the C-terminal serine residues S359, 370 and 379 may have on the form ation o f the 
active conformation o f p47phox and the subsequent interaction with p22phox, the 
association with p67phox and on the interaction with phosphatidylinositols.
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3.1 The effect of p47phox C-terminal phosphorylation on
its interaction with p22phox
3.1.1 Overview and aims
As shown in Figure 7, serine residues 359, 370 and 379 are remote from the 
polybasic, auto-inhibitory region. Hence, phosphorylation o f these residues would not 
be expected to have a direct effect on the release o f the auto-inhibited conform ation as 
observed for serine residues 303-328. Interestingly however, a detailed quantitative 
analysis o f the interaction betw een p22phox and p47phox showed, that the binding affinity 
o f  a p22phox-derived peptide for a m utant in which all five serine residues in the 
polybasic region had been substituted with glutamates was 20-fold weaker than for the 
isolated tandem SH3 domains (G roem ping et al., 2003). This discrepancy could suggest 
that glutamate residues are not ideal mimics o f  phosphoserines and therefore cannot 
support the formation o f  the fully active form o f  p47phox. Alternatively though, this 
observation raises the possibility that phosphorylation o f  these serine residues alone 
may not support the fully active conform ation o f  the protein, and that phosphorylation 
o f  the remaining three serine residues in the C-terminal region o f  the protein may act 
synergistically and induce conform ational changes that promote the interaction with 
p22phox. This possibility was tested using mutants o f  p47phox in which a varying numbers 
o f  serine residues have been replaced by glutamates and their interaction with a 
fluorescein labelled p22phox-derived peptide was followed by fluorescence spectroscopy.
3.1.2 Results
Two plasm ids containing the serine to glutamate mutations S303, 304, 315, 320 
and 328E (pG EX -p47phoxS5E) and S359, 370 and 379E <pGEX-p47pho,1S3E), in the full- 
length construct were already available (Groemping et al., 2003; Lapouge and Rittinger, 
unpublished results). PGEX-p47phoxS5E mimics phosphorylation o f serine residues in 
the polybasic region, whereas pG EX -p47phoxS3E mimics phosphorylation within the C- 
terminal region. These m utant plasmids were used to construct a plasm id containing all 
eight serine to glutam ate substitutions (pG EX -p47phoxS8E) as described in section 2.2.1. 
The phosphorylation mimics p47phoxS8E, p47phoxS5E, p47phoxS3E as well as 
p47phoxW ild-type and the isolated tandem SH3 domains i.e. p47phoxWild-typetandcm (aa
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156-285) were purified to homogeneity. Their binding to a fluoresceine labelled p22phox 
derived peptide (hereafter called p22phox* peptide) was measured using fluorescence 
spectroscopy. In addition circular dichroism (CD) spectroscopy was used to determine 
if  the introduction o f these m utations had any effect on the secondary structure o f  the 
proteins or on their thermal stability. The methods used in these studies are described in 
chapter 2 o f  the M aterials and M ethod section.
3.1.2.1 Protein expression and purification
Proteins were expressed in a soluble form in E.coli under similar conditions and 
in similar amounts as p47phoxW ild-type, with the exception o f p47phoxS8E (see section 
3.1.2.2). They were purified by affinity chrom atography on glutathione sepharose, 
followed by either ion-exchange or size exclusion chromatography after protease 
cleavage o f the GST-tag. Figure 33 shows the purity o f the proteins used for the 
fluorescence titrations. All the proteins ran as single bands at their expected m olecular 
weights (~ 45 kDa), and could be easily concentrated to 500 pM  - 1 mM apart from 
p47phoxS8E, which aggregated above 250 pM. The identities o f  the purified proteins 
were confirmed by electrospray mass spectrometry.
3.1.2.2 Cloning and purification of p47phoxS8E
The full-length plasm id containing eight serine to glutamate m utations (pGEX- 
p47phoxS8E) was constructed as described in section 2.2.1. Initial attempts to express 
and purify the protein yielded a m ixture o f  the full-length protein (aa 1-390, 45 kDa) 
and a shorter, C-term inally deleted variant (aa 1-354, 41 kDa) (as determ ined by mass 
spectrometry, data not shown). The separation o f full-length and degraded protein 
proved impossible using anion exchange chrom atography, due to the similarities in pi 
(9.1 and 8.6, respectively) (Figures 34 A and B). Gel filtration chrom atography could 
also not be used to separate the two proteins, due to the small difference in m olecular 
weight. Therefore, to allow purification o f the full-length protein, a His6-tag was 
engineered onto the C-term inus o f pG EX -p47phoxS8E by PCR. The resulting protein 
was well expressed (Figure 35) in E.coli and largely soluble. A first purification step 
was carried out using glutathione sepharose 4B to capture the full-length as well as C-
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Figure 33: SDS-PAGE of proteins used for fluorescence spectroscopy experiments. Analysis
o f the purity of p47phoxWild-type and mutants o f p47phox that mimic serine phosphorylation. 5 pg of 
protein were loaded per lane.
M: Low molecular weight marker (GE Healthcare)
1: p47phox S8E (S303, 304, 315, 320, 328, 359, 370 and 379E) (46 kDa)
2: p47phox S5£ (S3Q3> 304 3 j 320  ^328E) (45 kDa)
3: p47phox S3E (S359, 370 and 379E) (45 kDa)
4: p4 7 pho* Wild-typeundem (aa 156-285) (15 kDa)
5: p47phox Wild-type (45 kDa)
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Figure 34: Purification of p47pholS8E by anion exchange chromatography. A. SDS gel. Lanes
1, 2 and 3 show the fractions collected during the NaCl gradient. Two bands are observed running at 45 
kDa (full-length p47phox) and 41 kDa (C-terminally deleted variant of p47phox). M: low molecular weight 
marker (GE Healthcare). B. Shows the corresponding chromatogram. Peaks 1, 2 and 3 correspond to 
lanes 1, 2 and 3 in Figure 29A.
Figure 35: IPTG induction of p47phoxS8E-His6. SDS-PAGE analysis o f cell lysates before and
after IPTG induction (2 different colonies). Lanes 1 and 3: cells before induction, 2 and 4: 3 hrs after 
induction with 1 mM IPTG. Molecular weight o f GST-p47phoxS8E-His6 is 72 kDa. M: low molecular 
weight marker (GE Healthcare).
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term inally degraded protein (Figure 36a). The protein was then further purified using 
Ni-NTA chromatography (Figure 36b). C-term inally deleted fragments do not possess 
the His6-tag and therefore do not bind to the Ni-NTA resin. The fractions containing the 
full-length protein were pooled, concentrated and analysed by SDS-PAGE at different 
protein concentrations to m onitor the purity o f  the final product (Figure 36c).
3.1.2.3 Binding of p47phox phosphorylation mimics to the p22phox peptide
In a previous study by our group, the interaction between p22phox and various 
m utants o f p47phox was quantified using fluorescence spectroscopy. The change in 
fluorescence o f a fluorescein labelled p22phox* peptide upon addition o f  increasing 
am ounts o f p47phox was followed. In contrast, attempts to measure this interaction by 
ITC were unsuccessful because the heat change upon complex formation proved too 
small to allow a reliable determ ination o f  the affinity and enthalpy o f the interaction 
(Groem ping et al., 2003). For this reason, the fluorescent approach was chosen in the 
present work to characterise the potential effect o f phosphorylation o f C-term inal serine 
residues on the interaction with p22phox (peptide 3, Appendix: A4). Results o f  the 
fluorescence spectroscopy experim ents are summarised in Table 11.
In accordance with earlier studies, titration o f  the p22phox* peptide with 
p47phoxWild-type did not result in any significant changes in fluorescence intensity, 
supporting the fact that wild-type protein cannot interact with p22phox. In contrast, 
titration o f the peptide with the p47phoxWild-typetandcm resulted in a binding affinity o f  
0.56 pM , which can be regarded to represent to fully active state, and p47phoxS5E bound 
to the peptide with an affinity o f  5.7 pM . All o f  these values are in good agreem ent with 
those previously reported (G roem ping et al., 2003) and were used as control 
experiments to ensure reproducibility and familiarity with the experimental system. 
Additional control experiments were carried out by titrating buffer into the p22phox* 
peptide, to ensure that the decrease in fluorescence observed was due to binding o f 
peptide to protein, and not an artefact.
To determine w hether phosphorylation o f  the p47phox C-terminal serine residues 
S359, 370, 379 alone had any effect on the interaction with p22phox, the peptide was 
titrated with the triple phosphorylation mimic p47phoxS3E. However, no change in 
fluorescence was detected, indicating that these mutations alone do not relieve auto­
inhibition. Nevertheless, it is conceivable that phosphorylation o f these residues may act
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Figure 36a: Purification of p47phoIS8E-His6 by affinity chromatography on glutathione
sepharose.
M: Low molecular weight marker (GE Healthcare)
1: Pellet
2: Supernatant
3: Flow through
4: Wash with high salt buffer B
5: Wash with low salt buffer C
6: GST beads before 3C protease cleavage
7: Elution after 3C protease cleavage
8: GST beads after cleavage
For composition of buffers refer to Appendix: A4
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Figure 36b: Further purification of p47phoxS8E-His6 using Ni-NTA chromatography.
A
M: Low molecular weight marker (GE Healthcare)
1: Load (protein eluted from the glutathione sepharose column)
2: Flow through
3: Wash with buffer D (containing 20 mM imidazole- refer to Appendix: A4)
4-9: Elution o f pure protein during a linear imidazole gradient (20 m M -1 M)
B
M: Low molecular weight marker (GE Healthcare)
1-9: Elution of pure protein (continues from Figure 3 lb,A)
M l  2 3 4  5 6 7 8 9
*
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Figure 36c: Purity of p47phoiS8E-His6. Analysis o f the purity o f p47phoxS8E-His6. Various
concentrations were loaded and a single band was observed at the expected molecular weight (45 kDa).
M: Low molecular weight marker (GE Healthcare)
1: 2 pg
2: 5 pg
3: 10 pg
N.B. For purposes of simplicity, p47phoxS8E-His6 hereafter will be referred to as p47ph0,S8E.
Table 11: Dissociation constants for the complexes formed between the p47phox
phosphorylation mimics and the 16-mer fluorescein labelled p22phox peptide.
p47phox protein K ^pM )
P47phox Wild-type >500
P47phox Wild-type,,ndem
0.56 ± 0.03 
0.40
P47phox S3E (S359,370, 379E) >500
p47ph°i S5E (S3Q3 3Q4 3 , 5 32Q 328£) 5.7 ±0.08 
8.0
p47phox S8E (S303, 304, 315, 320, 328, 359, 37 0 ,379E) 4.7 ±0.07
Fluorescence experiments were carried out in buffer H (pH according to the individual proteins, and to 
one unit above or below the pi). The p47phox proteins were titrated at increasing concentrations into the 
cuvette containing 1 pM of the fluorescein labelled p22phox peptide. Results shown in blue are those 
reported previously (Groemping et al., 2003). Values are the mean o f at least three independent 
experiments. The errors (±) are the standard deviation o f the mean. These errors are surprisingly small 
and while they attest to the high reproducibility o f the system, they nevertheless certainly underestimate 
the real error o f the experiments. For this reason it seems more realistic to assume an error o f at least 10 
% that is composed o f errors in the pipettes and the determination of protein concentrations.
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synergistically with phosphorylation o f serine residues in the polybasic region, to 
promote the interaction with p22phox. To investigate this possibility, binding studies 
using p47phoxS8E were carried out. However, this protein bound with an affinity o f  4.7 
pM  to the p22phox* peptide, w hich is not significantly different from that obtained for 
p47phoxS5E. Figure 37 shows representative fluorescence titrations for the binding o f the 
p47phox phosphorylation mimics to p22phox. These results suggest that phosphorylation o f 
the C-terminal serine residues S359, 370 and 379 do not synergise with phosphorylation 
o f the serine residues located within the polybasic region, to destabilise the auto­
inhibited conformation o f  p47phox.
3.1.2.4 Circular dichroism measurements of the p47phox phosphorylation
mutants
Circular dichroism (CD) spectroscopy was used to determine the secondary 
structure content and the therm al stability o f  the proteins under investigation, as 
described in section 2.4.3. Figure 38 shows the CD spectra for the different proteins, 
w hich are all similar to p47phoxW ild-type, thereby confirm ing that any changes observed 
in the binding affinities are not solely due to changes in secondary structure. Small 
variations in intensity were observed, probably deriving from small errors in the 
determination o f protein concentration and are not significant. The secondary structure 
content o f these proteins was calculated from the CD spectra using the methods 
described by Sreerama and W oody, 2000. For example, the secondary structure content 
o f  p47phoxS5E which is listed in Table 12 is similar to p47phoxW ild-type. The thermal 
stability o f  the proteins was assessed by measuring changes in ellipticity at 210 nm with 
increasing temperature (20 °C - 80 °C). Figure 39 shows the thermal scans for the 
different proteins. The p47phoxS3E mutant protein behaved similar to p47phoxW ild-type, 
while p47phoxS5E and p47phoxS8E showed unfolding/precipitation at lower tem peratures 
(6 - 8 °C) than p47phoxW ild-type. This suggests that these mutations somewhat 
destabilise the protein. However, the stability o f these mutant proteins is not changed in 
the temperature range in which they were used for binding studies (20 °C). All the 
reactions were reversible.
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Figure 37: Fluorescence titrations for the binding of p47phox phosphorylation mimics to the
fluorescein labelled p22pho* peptide. Similar to p47phoxWild-type, p47phoxS3E does not show any 
significant changes in fluorescence intensity upon addition o f the p22phox* peptide. Working solutions of 
protein and peptide were made in buffer H and all titrations were carried out at 20 °C.
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Figure 38: CD spectra of the p47phox phosphorylation mimics. Far-UV CD spectra of the
different phosphorylation mimics and p47phoxWild-type protein. The protein concentration was 0.15 
mg/ml and the experiments were carried out in buffer H.
Table 12: Secondary structure analysis of the CD spectra of p47phHX\ \  ild-type and
p47phoxS5E. Comparison o f the secondary structure content o f p47phoxWild-type (WT) and p47phoxS5E 
(S5E), as calculated using the programs CONTIN, SELCON and CDSSTR (Sreerama and Woody, 2000). 
The secondary structure content o f the other mutant proteins was similar to wild-type protein and within 
the acceptable 10 % error margin.
Program
a-helix (%) P-sheet (%) Turn (%) Random (%)
WT S5E WT S5E WT S5E WT S5E
CONTIN 14 17 37 35 23 26 26 22
SELCON 12.7 10 39 36 24.1 27.5 24.2 26.5
CDSSTR 13.8 17.7 36 37 25.2 22 25 23.3
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Figure 39: Therm al denaturation  curves for the p47phox phosphorylation mimics. The
ellipticity at 210 nm was continuously measured as the temperature was increased from 20 °C -  80 °C. 
The protein concentration was 0.15 mg/ml and the experiments were carried out in buffer H.
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3.2 The effect of C-terminal p47phox phosphorylation on
its interaction with p67phox
3.2.1 Overview and aims
The experiments described in the previous chapter provided evidence that 
phosphorylation o f the C-term inal serine residues S359, 370 and 379 does not synergise 
with phosphorylation o f  the polybasic region to promote the formation o f  active p47phox. 
Interestingly though, these residues are located in the region that mediates the 
interaction with p67phox with a binding affinity o f 20 nM (Finan et al., 1994; Lapouge et 
al., 2002; Leto et al., 1994) and hence it is conceivable that phosphorylation may affect 
com plex formation with p67phox instead. The aim o f this series o f experiments is to 
determ ine the effect o f  phosphorylation o f  serine residues 359, 370 and 379 on the 
interaction with p67phox.
3.2.2 Results
The overall approach taken for this study was similar to that described in the 
previous chapter, using substitution o f serine with glutamate residues to mimic 
phosphoserines. Various plasm ids containing serine to glutamate mutations in the full- 
length construct were already available at the beginning o f this study. These plasmids 
include the individual mutants; pGEX-p47phoxS359E and pGEX-p47phoxS370E, the 
double mutant; pGEX-p47phoxS359/370E, as well as those described in section 3.1. In 
addition, site-directed m utagenesis was used to construct the individual m utant pGEX- 
Ph°xs 3 7 9 E within the full-length construct. A full-length plasm id containing p67phox, as 
well as the isolated second SH3 domain o f  p67phox (p67phox(SH3)B) were also already 
available.
3.2.2.1 Protein expression and purification
All proteins were expressed and purified in a soluble form in E.coli under
similar conditions and in similar amounts as the wild-type protein (apart from
p47phoxS8E). The proteins were purified by affinity chromatography on glutathione
sepharose, followed by either ion-exchange or size exclusion chrom atography after
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protease or thrombin cleavage o f  the GST-tag. Figures 40 A and B show the purity o f 
the proteins used for the various ITC experiments. All the proteins ran as single bands at 
their expected m olecular weights and could be easily concentrated to 500 pM  - 1 mM 
other than p47phoxS8E. The identities o f  the purified proteins were verified by 
electrospray mass spectrometry.
3.2.2.2 Binding of C-terminal p47phox phosphorylation mimics to p67phox
The use o f  fluorescence spectroscopy to monitor complex formation between 
p67phox and p47phox was not feasible as both proteins contain tryptophan residues, which 
would interfere with the use o f  protein fluorescence as a signal. Similarly, the 
introduction o f an extrinsic fluorophore at a specific site in a protein the size o f  p67phox 
or P47ph0x is difficult and can give rise to numerous problems. For this reason ITC was 
chosen to characterise the interaction between the p47phox phosphorylation mimics and 
p67phox. This technique has the advantage that in addition to the binding constant, it also 
allows the determination o f  the stoichiom etry o f  the interaction as well as the 
therm odynamic parameters AG, AH and TAS. In previous studies where the interaction 
between p47phox and p67phox was investigated, the experiments were carried out in the 
following manner: full-length p47phox was placed in the syringe as it is very stable and 
can be highly concentrated, while full-length p67phox was placed in the cell (due to its 
lower protein yield and stability) (Lapouge et al., 2000). U nfortunately, such an 
experimental design was not possible in this case as p47phoxS8E also has problem s with 
poor protein yield and stability. To circum vent this problem it was decided to carry out 
all binding experiments using only the C-terminal SH3 domain o f  p67phox 
(p67ph0X(SH3)B), as it is well established that this domain is sufficient to fully 
reconstitute the interaction with p47phox (Kami et al., 2002; Lapouge et al., 2002). 
P 6 7 phox(SH 3)B can be produced in large quantities and is very stable at higher 
concentrations and was hence used as the syringe component. Control experim ents were 
carried out to ensure reproducibility and to confirm  that only p67phox(SH3)e is involved 
in the interaction. ITC experiments were performed in which wild-type p47phox was 
titrated with full-length-p67phox or isolated p67phox(SH3)e. The K<j values m easured were 
identical (38 nM for both), which supports the previous observations. The binding 
affinities and therm odynam ic param eters o f  complex formation between the different 
p47phox phosphorylation mimics and p67phox were measured at 15 °C. Results for the
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Figure 40: SDS-PAGE of proteins used for ITC experim ents. A. Analysis o f the purity of
p67phoxWild-type and p47phox Wild-type proteins, plus p47phox phosphorylation mimics. 3 fig were loaded 
per lane. B. Analysis o f the purity of p67phox(SH3)B. 4 fig was loaded.
M,:
M2:
Low molecular weight marker (GE Healthcare) 
High molecular weight marker (Sigma)
1: P47phox Wild-type (45 kDa)
2: p47phox S359E (45 kDa)
3: p47ph°x S37QE (45 kDa)
4: P47phox S359/370E (45 kDa)
5: p47phox S3?9E (45 kDa)
6: P47phox S3E (S359, 370 and 379E) (45 kDa)
7: p47phoxS5E (S303, 304, 315, 320 and 328E) (45 kDa)
8: P47phox S8E (S303, 304, 315, 320, 328, 359,370 and 379E) (46 kDa)
9: p67phox Wild-type (60 kDa)
10: P67phox (SH3)b (aa 243-297) (8.8 kDa)
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ITC experiments are summarised in Table 13. All binding reactions were exothermic 
with stoichiometries o f approxim ately 1:1.
Binding o f  the individual phosphorylation mimics p47phoxS359E and 
p47phoxS370E to p67phox(SH3)B both resulted in K<i values o f  81 nM, which is only 2- 
fold w eaker than for the wild-type protein (38 nM). These results suggest that 
phosphorylation o f these serine residues do not significantly interfere with the 
interaction with p67phox. However, the substitution o f both serine residues 
simultaneously (p47phoxS359/370E) had a stronger effect and weakened the affinity by 
12-fold to 0.48 pM. In contrast, the single mutation o f serine residue 379 
(p47phoxS379E) decreased the affinity to 1.0 pM , which is 26-fold w eaker than the wild- 
type protein, indicating that phosphorylation o f this serine residue makes a m ajor 
contribution to the weakening o f  the interaction with p67phox. The com bination o f all 
three mutations (p47phoxS3E) led to a further decrease in affinity to 2.4 pM , 63-fold 
weaker than between the wild-type proteins.
Although the interaction between p47phox and p67phox only involves the C- 
term inal region o f p47phox, it may be possible that phosphorylation o f serine residues 
within the polybasic region m ay induce conformational changes in the C-terminal 
region and thereby influence the affinity for p67phox. For this reason, the interaction 
between p47phoxS5E and p67phox(SH3)e was investigated. The two proteins interact with 
an affinity o f  61 nM, which is not significantly different from that o f  w ild-type protein 
(38 nM), suggesting that phosphorylation o f  serine residues 303, 304, 315, 320 and 328 
does not fundamentally effect the interaction with p67phox. To further investigate 
whether phosphorylation o f  these serine residues acts synergistically with the 
phosphorylation o f the serine residues located around the C-terminal proline rich region, 
binding o f P47phoxS8E to p67phox(SH 3)B was measured. A K<j value o f  2.9 pM  was 
obtained, which is almost identical to that o f p47phoxS3E, clearly indicating that the 
interaction with p67phox is only m odified by phosphorylation o f serine residues 359, 370 
and 379. Figure 41 shows representative titration curves for these interactions.
Interestingly, although the affinity o f  p67phox for p47phoxS359/370E and 
p47phoxS379E is lower than for wild-type p47phox, the enthalpy for complex formation 
actually increased for these two complexes, accompanied by com pensating less 
favourable entropy changes. That may suggest that additional interactions take place in 
these complexes that are not observed between the wild-type proteins and that restrict 
the conformational flexibility o f  the complex. However, a similar increase in AH is not
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Table 13: Thermodynamic values for the titration of p67pho,(SH3)B into p47phox
phosphorylation mimics.
p47ph°* protein K<i (nM) AH (kcal/mol) TAS (kcal/mol) AG (kcal/mol)
W T* 37 ± 4.1 -3.86 ±0.11 5.90 ± 0 .06 -9.78 ± 0 .45
WT 35 ± 3 .2 -6.2 ± 0.03 3.62 ±0.1 -9.82 ± 0 .05
S359E 59.7 ± 1.1 -6.02 ± 0 .19 3.54 ±0.03 -9.56 ± 0 .2
S370E 79 ±2.1 -6.51 ± 0 .02 2.85 ±0.1 -9.36 ± 0 .2
S359, 370E 475 ± 5 -7.72 ± 0 .06 0.62 ± 0.09 -8.34 ± 0 .05
S379E 965 ± 50 -8.37 ± 0 .27 -0.43 ±0.1 -7.94 ± 0.4
S3E 2450 ± 50 -5.63 ± 0 .33 1.76 ± 0 .2 -7.40 ± 0 .65
S5E 64.7 ± 3 .5 -6.25 ±0.01 3.21 ±0.11 -9.46 ± 0.42
S8E 2850 ± 5 0 -4.60 ± 0.06 2.71 ±0.08 -7.31 ± 0 .05
ITC experiments were carried out in buffer H (pH according to the individual proteins, and to one unit 
above or below the pi) at 15 °C. P47phox proteins in the cell were used at concentrations in the range of 
25-40 pM. P67phox(SH3)e was titrated at concentrations o f 250-400 pM. Titration o f full-length p67phox 
into wild-type p47phox protein is shown by an asterisk (*). The binding stoichiometry values (n) ranged 
from 0.9-1.1.Values are the mean o f at least three independent experiments. The errors (±) are the 
standard deviation o f the mean. As discussed in Table 11 the error values on these experiments are 
extremely low, due to the very good reproducibility o f the system. Nevertheless, it seems more 
appropriate to assume an error o f around 10 % that is contributed to mainly by pipetting errors during the 
determination o f protein concentrations.
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Figure 41: Complex formation between p67phox(SH3)B and different p47phox proteins. ITC
measurements o f complex formation between p67phox(SH3)B and p47phoxWild-type, p47phoxS3E 
(S359/379E), p47phoxS5E (S303/328E) and p47phoxS8E (S303/379E). Upper part, raw data o f the titration 
o f p47phoxWild-type (33 pM) with p67phox(SH3)B (321 |iM). Lower part, integrated heat changes corrected 
for the heats o f dilution and fitted curve, based on a single-site binding model. All experiments were 
carried out at 15 °C in buffer H.
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observed for binding o f the triple mutant, p47phoxS3E, which on the other hand 
somewhat questions this idea. Further studies such as the crystal structure o f the 
individual p47phox phosphorylation mutants in complex with p67phox(SH3)B are now 
required to further explain these observations.
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3.3 The effect of C-terminal p47phox phosphorylation on 
its interaction with PtdIns(3,4)P2
3.3.1 Overview and aims
The cytosolic NADPH oxidase proteins p40phox and p47phox each contain a PX 
domain in their respective N-termini. PX domains are lipid interaction m odules, which 
are found in a variety o f  proteins that associate with cell membranes (section 1.4.4). 
Unlike the p40phox PX domain, which specifically binds to PtdIns(3)P (Ago et al., 2001; 
Bravo et al., 2001; Ellson et al., 2001; Kanai et al., 2001), the p47phox PX dom ain can 
interact with a variety o f  phosphoinositides (Ago et al., 2001; Kanai et al., 2001; Zhan 
et al., 2002), but preferentially binds PtdIns(3,4)P2 (Kanai et al., 2001; Karathanassis et 
al., 2002). In addition, the p47phox PX domain has been proposed to contain a second 
lipid binding pocket, which is speculated to recognise anionic phospholipids such as 
phosphatidylserine (PS) or phosphatidic acid (PA) to increase membrane affinity 
(Karathanassis et al., 2002).
The interaction o f the p47phox PX domain with membrane phospholipids aids the 
association o f the cytoplasmic trimeric complex (p47phox-p67phox-p40phox) with the 
membrane to form the active NADPH oxidase complex. However, during the inactive 
state o f the enzyme, the p47phox PX domain only very weakly binds lipids, due to auto- 
inhibitory interactions o f the PX domain with the rem ainder o f the protein (Ago et al., 
2003; Karathanassis et al., 2002). Two studies have shown that mutant proteins in 
which phosphorylation o f various serine residues have been mimicked by glutamates, 
specifically o f  303, 304, 328 located in the polybasic region o f p47phox and o f  S303, 
304, 328, 359, 370 (Ago et al., 2003; Karathanassis et al., 2002) increase the lipid- 
binding capability o f  the PX domain. However, it is not clear w hether phosphorylation 
o f the C-terminal serine residues S359, 370 and 379 really contributes to this event. 
This chapter describes experiments aimed at investigating the effect that 
phosphorylation o f  the C-terminal serine residues may have on restoring lipid binding to 
the PX domain in the context o f  the full-length protein.
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3.3.2 Results
In order to determine the effects o f  p47phox phosphorylation on binding to 
PtdIns(3,4)P2, the following phosphorylation mimics were tested: p47phoxS3E, 
p47phoxS5E and p47phoxS8E. The full-length p47phox protein was used as a negative 
control, while the isolated p47phox PX domain was used as a positive control, which 
should show maximum binding. Parallel to this, the PH domain o f  the TAPP1 (tandem 
PH domain containing protein) protein was used as an additional positive control, as 
this PH domain is known to interact specifically with PtdIns(3,4)P2 with high affinity 
(Dowler et al., 2000; Kimber et al., 2002; Thomas et al., 2001). Two different protein- 
lipid pull down methods were used to determine lipid binding i) lipid sedim entation 
assays and ii) the use o f  PIP beads (PtdIns(3,4)P2 coated agarose beads). The methods 
used in these studies are described in chapter 2 o f the M aterials and M ethods section.
3.3.2.1 Lipid sedimentation assays
Initial binding experiments were carried out according to the protocol published 
by Karathanassis and colleagues, with m inor modifications. Briefly, lipid concentrations 
were used at 50 % PC, 40 % PE, 5 % PS and 5 % PtdIns(3,4)P2 The lipid mix was 
protonated with HC1, sonicated, dried under nitrogen, resuspended in buffer and then 
further sonicated to form the liposomes (Karathanassis et al., 2002). Subsequent 
modifications made to this protocol included omitting the protonation procedure as pre- 
protonated PtdIns(3,4)P2 were em ployed, and lipid concentrations were used at 42 % 
PE, 42 % PC, 6 % PS and 10 % PtdIns(3,4)P2. Initially only three different proteins 
were tested to establish the protocol, including full-length p47phox, isolated p47phox PX 
domain and p47phoxS5E (intermediate binding should be expected). However, no 
convincing binding for the p47phox PX domain and p47phoxS5E could be observed. 
Increasing the protein concentration also did not aid lipid binding (data not shown). Due 
to these problems Roger W illiams at the M RC-LM B, Cambridge, who published the 
above protocol was contacted, and it was decided to carry out the assay under his 
supervision. It was suggested to use the PH domain o f the TAPP1 protein as an 
additional positive control, as it specifically binds to PtdIns(3,4)P2 with a high affinity 
(Thomas et al., 2001). In addition, adjustment 1 to the protocol was made (section 
2.6.3). Negative controls were also performed i) using lipid samples in the absence o f 
PtdIns(3,4)P2 and ii) where the liposomes were omitted The results showed only
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minimal binding o f the PH dom ain o f  the TAPPI protein to PtdIns(3,4)P2 (Figure 42). 
No binding o f  the full-length p47phox protein to PtdIns(3,4)P2 was observed, as expected, 
and insignificant amounts w ere apparent in the negative control lanes. Nevertheless, no 
binding was observed for the isolated p47phox PX domain and only a small amount o f 
binding observed for the phosphorylation mimic p47phoxS5E. These results were in 
contrast to previous results, in w hich the isolated PX domain was fully lipid bound and 
hence in the pellet (Ago et al., 2003; Karathanassis et al., 2002). The experim ent was 
repeated back in the host laboratory using a new batch o f  purified p47phox PX domain 
protein to ensure that the previous problem s were not due to faulty protein preparation. 
However, no binding could be observed, not even for the PH domain o f TA PPI protein 
(data not shown). It was hypothesised that the thickness o f  the glass vials in which the 
liposomes were being produced (W heaton 1 ml vials) may not have allowed the pulses 
o f  the bath sonicator to penetrate through efficiently thus affecting vesicle production. 
Therefore, it was suggested to use thinner glass vials (Chromacol 2 ml vials), the same 
as those used in the LMB laboratory. However, upon repeating the experiment the assay 
once again proved unsuccessful (data not shown). The use o f  5 % PA in place o f  5 %  PS 
was tested as this may aid lipid binding, because PA is more negatively charged than 
PS, and therefore might bind to the ‘basic’ pocket o f  the p47phox PX domain more 
tightly. Again no binding o f  the isolated p47phox PX domain was observed (data not 
shown). An increase in centrifugation time to ensure that the vesicles are fully 
sedimented, again failed to show any binding o f the p47phox PX domain.
The lipid sedimentation assays described so far involved the production o f 
unilameller vesicles (SU V ’s), formed through lipid sonication. M ultilam eller vesicles 
(M LV ’s) produced through lipid vortexing are believed to sediment more efficiently, 
and therefore the use o f M LV ’s parallel to the use o f SU V ’s was also tested (adjustment 
2 o f the protocol, section 2.6.3), but again no binding was observed (data not shown). 
Further analysis o f the protocol suggested that drying o f  the lipids under nitrogen may 
not have been sufficient enough to remove all traces o f organic solvents, thereby 
affecting binding. A final experim ent was carried out (adjustment 3 o f  the protocol, 
section 2.6.3) using the isolated p47phox PX domain, with concentrations o f  PA and 
PtdIns(3,4)P2 increased to 10 %,
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Figure 42: Binding of p47ph,”‘ proteins to liposomes. Binding of p47phox proteins to PtdIns(3,4)P2.
15 pM total protein was incubated with liposomes containing PC:PE:PS: PtdIns(3,4)P2 (50:40:5:5), 
PC:PE:PS (50:40:5) and a negative control without PtdIns(3,4)P2. PtdIns(3,4)P2 indicated by an asterisk 
(*) was kindly donated by Roger Williams, MRC-LMB, Cambridge. The PH domain o f the TAPPI 
protein was used as a positive control. P and S indicate ‘pellet’ and ‘supernatant’ after centrifugation; 
respectively. Samples were analysed by SDS-PAGE and stained with the SimplyBlue SafeStain.
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and with the lipids further dried in a freezdryer for 2 hrs after initial drying under 
nitrogen. However, even after all these m odifications to the protocol described above, 
we still could not observe any evidence for an interaction between the p47phox PX 
domain and PtdIns(3,4)P2 (Figure 43).
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Figure 43: Binding of the p47pho* PX domain to liposomes. 15 pM protein was incubated with
vesicles containing PC:PE:PA:Ptdlns(3,4)P2 (40:40:10:10), PC:PE:PA (40:40:10) and a control test minus 
the vesicles. Lipid samples were dried under nitrogen and further dried in a freedryer for 2 hrs. M: 
molecular weight marker (SeeBlue marker, Invitrogen). P and S indicate ‘pellet’ and ‘supernatant’ after 
centrifugation, respectively. Samples were analysed by SDS-PAGE and stained with SimplyBlue 
SafeStain.
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3.3.2.2 PIP bead assay
A fter lipid sedim entation assays failed to show convincing binding to the 
positive controls p47phox PX dom ain and the TAPPI PH domain, agarose beads coated 
with PtdIns(3,4)P2 were used as an alternative method to detect protein-lipid 
interactions. However, binding o f  the p47phox PX domain, which has a m olecular weight 
o f  15.7 kDa could not be detected (positive control) (Figure 44, lanel). Similarly, no 
binding o f the phosphorylation mimic p47phoxS5E, which has a m olecular w eight o f  45 
kDa was detected (lane 4). Interestingly, a band running at an apparent m olecular 
weight o f  approximately 13 kDa (lanes 1-6) was observed in all the experiments apart 
from the control lanes containing the beads minus the PtdIns(3,4)P2, suggesting that a 
contaminant might be present on the PIP coated beads. In order to investigate this 
further, a clean sample o f the test beads was run on a Novex Bis-Tris SDS-PAGE gel 
(Figure 45) and analysed in a sim ilar manner. The gel clearly shows that the 13 kDa 
protein is present in the m anufacturer’s beads and therefore, not a possible degradation 
product or contaminant o f  the proteins used in the assay. After contacting the 
m anufacturer it was established that the agarose beads contained covalently linked 
streptavidin, which is used to bind PtdIns(3,4)P2. Streptavidin is a tetrameric protein 
with a molecular weight o f  52.8 kDa. Upon treatment o f the beads with a denaturant 
such as SDS the tetramer is dissociated, releasing a steptavidin m onom er with a 
m olecular weight o f 13.2 kDa, which corresponds exactly to the band observed.
The absence o f binding o f the p47phox PX domain to the PIP beads raised the 
question about the sensitivity o f  the assay. Although 5 pg o f  protein was used in each 
test o f which approxim ately 1 pg was loaded onto the SDS gel, possibly only a fraction 
o f  the proteins may have bound to the PIP beads. If  the affinity was weak then binding 
may have been too low to be detected using the SimplyBlue SafeStain. A lthough the 
m anufacturer’s protocol suggests that Coomasie staining can be used for protein 
visualization, we decided to measure the minimal amount o f  protein (p47phox full-length 
and the isolated p47phox PX domain) that can be detected with the SimplyBlue 
SafeStain.
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Figure 44: Binding of p47ph0* protein to PtdIns(3,4)P2 coated PIP beads. A band is observed
running at approximately 13 kDa for all the proteins (lanes 1-5) excluding the controls (lanes 6 and 7). 20 
pi o f samples were loaded per lane.
M: Molecular weight marker (SeeBlue marker, Invitrogen)
1: p47phox PX domain
2: p47phox full-length protein
3: p47ph0XS3E (S359,370 and 379E)
4: P47ph0XS5E (S303, 304, 315, 320 and 328E)
5: p47ph0XS8E (S303, 304, 315, 320, 328, 359, 370 and 379E)
6: Control beads plus the p47phox PX domain
7: Control beads plus the p47phox full-length wild-type protein
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Figure45: SDS-PAGE analysis of PtdIns(3,4)P2 coated PIP beads. 20 pi o f unused
PtdIns(3,4)P2 coated PIP beads were loaded onto a Novex Bis-Tris SDS gel. Lane 1: streptavidin 
monomer running at approximately 13 kDa. M: molecular weight marker (SeeBlue marker, Invitrogen).
0.1 0.2 ng 0.3 ng 0.4 ng 0.5 ng 0.7 ng 1.0 ng 2.0 n9
p47Phox fu||-|en gth | -—  ------ — » — — —  —
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Figure 46: p4 7 Pho* full-length and p47phox PX domain proteins at increasing concentrations.
SDS-PAGE analysis shows that both proteins can be visualised at concentrations as low as 0.2 pg by 
using the SimplyBlue SafeStain.
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The proteins were analysed on an SDS gel at increasing concentrations (0.1 pg - 2 pg). 
Figure 46 shows that both proteins can be detected using the SimplyBlue SafeStain at 
protein concentrations as low as 0.2 pg. This clearly indicates that even if  only a tenth 
o f  the isolated p47phox PX protein had bound to the beads, then this would have been 
apparent on the gel. Although it was dem onstrated that concentrations as low as 0.2 pg 
could be detected by SimplyBlue SafeStaining, to further investigate the binding o f  the 
p47phox proteins to the PtdIns(3,4)P2, the assay was repeated and analysed by western 
blotting, as this form o f  analysis is more sensitive. The proteins were purified as GST- 
fusions and visualised using an anti-GST HRP-conjugated antibody. The PH domain o f 
the TAPPI protein was used as a positive control. Figure 47 clearly shows that the PH 
domain bound to the beads as expected (lane 6-upperband). By com parison, only a 
marginal am ount o f binding was apparent for the isolated p47phox PX domain (lane 1), 
where maximum binding should be observed and the phosphorylation mutant 
p47phoxS5E (lane 4), where intermediate binding should be observed. No binding was 
observed for the phosphorylation mimic p47phoxS8E. This experiment shows that this 
assay works well for the PH domain, which has a high affinity for PtdIns(3,4)P2. 
However, it appears that the assay may not work well for proteins that have a lower 
affinity for lipids such as the p47phox proteins.
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Figure 47: Western blot analysis of the binding of p47pbox proteins to Ptdlns(3,4)P2 coated PIP
beads.
1: p47phox PX domain
2: p47phox full-length wild-type
3: p47pboxS3E (S359, 370 and 379E)
4: p47ph0XS5E (S303, 304, 315, 320 and 328E)
5: p47ph0XS8E (S303, 304, 315, 320, 328, 359, 370 and 379E)
6: PH domain o f TAPPI
7: Control beads containing the p47phox PX domain (minus PtdIns(3,4)P2)
N.B. The PH domain o f the TAPPI protein is temperature sensitive and degrades after thawing on ice
(lane 6, lower bands show the degraded protein).
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3.3.3 Summary of lipid binding assays
This lipid sedim entation protocol has been used by a number o f groups with 
minor modifications to study the interaction between p47phox and various lipids (Ago et 
al., 2003; Kanai et al., 2001; Karathanassis et al., 2002). After initial attempts to 
establish this technique proved unsuccessful, different adjustments to the protocol were 
made to reliably m onitor protein-lipid interactions. These included the use o f  different 
glass vials for sonication, the use o f protonated and un-protonated PtdIns(3,4)P2, 
addition o f  cholesterol, production o f  SU V ’s and M LV ’s and ultracentrifugation for 
extended periods o f time. D espite these changes the assays proved unsuccessful. After 
much discussion with experts in the field o f  protein-lipid interactions, it became 
apparent that lipid sedim entation assays are rather difficult to use and not as simple as 
often portrayed in the literature. This suggested to us that to use this technique 
successfully, further work to optimise the conditions would be required, which 
unfortunately was not possible due to time restrictions. The most likely explanation for 
the absence o f protein in the pelleted fractions is that the vesicles may not have formed 
efficiently, possibly due to insufficient sonification or the presence o f trace organic 
solvents. Alternatively, it is possible that binding did take place but that the vesicles did 
not sedimented efficiently, and would need to be made heavier, for example through the 
use o f brominated lipids or the inclusion o f sucrose into the vesicles.
Similarly, binding experiments using PtdIns(3,4)P2 coated agarose beads also 
proved unsuccessful. Phosphoinositide coated agarose beads have been used previously 
to detect lipid binding to PH domains (Rao et al., 1999) but not to PX domains. In 
accordance, control experiments with the TAPPI PH domain showed a clear interaction 
with the PIP beads. PH dom ains predominantly recognize the head group o f 
phosphatidylinositols, and do not require additional lipids for this interaction. In 
contrast, the PX domain o f  p47phox has been suggested to require the presence o f  PA or 
PS for maximum binding to occur (Karathanassis et al., 2002). This may explain why 
only extremely weak binding was observed in these experiments, and indicates that this 
technique is not suitable to detect PX domain-lipid interactions.
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3.4 Discussion
The activation and assem bly o f the NADPH oxidase is a complex process that is 
regulated by reversible protein-protein interactions, multiple phosphorylation events and 
association with membrane bound phospholipids. A central player in this regulatory 
network is the p47phox subunit, which is on one hand responsible for m aintaining the 
trimeric p40phox-p67phox-p47phox com plex cytosolic during the resting state, and on the 
other hand for translocating it to the membrane bound flavocytochrom e after 
appropriate activation. To perform  these tasks p47phox adopts two different 
conformations: a resting, auto-inhibited conformation and an active, open form. To 
switch between these two states, the protein undergoes a major conformational change 
that is induced by phosphorylation o f eight serine residues (Ago et al., 1999; el Benna et 
al., 1994; El Benna et al., 1996; Faust et al., 1995; Groemping et al., 2003; Inanami et 
al., 1998; Johnson et al., 1998). Five o f these serine residues, 303, 304, 315, 320 and 
328, are found in the auto-inhibitory polybasic region, while S359, 370 and 379 are 
located in the extreme C-terminus adjacent to a proline-rich motif. M ost studies have 
concentrated on the effect o f phosphorylation events in the polybasic region o f  p47phox 
(Ago et al., 2003; Ago et al., 1999; Groemping et al., 2003; Inanami et al., 1998; 
Karathanassis et al., 2002), and little attention has been paid to the phosphorylation o f 
those serine residues located adjacent to the proline-rich region. Here we investigated 
the effect o f phosphorylation o f  serine residues 359, 370 and 379 on the interaction with 
P22phox and p67phox as well as on binding to phosphatidylinositols.
Unfortunately, it is not possible to produce p47phox that is specifically 
phosphorylated at a given position, as most kinases that phosphorylate p47phox do so on 
multiple serine residues. Furthermore, these phosphorylation events are often not 
stoichiometric, and result in a mixture o f proteins with different degrees o f 
phosphorylation at different residues, that cannot be separated by chromatographic 
methods. For this reason it was decided to substitute those serines that become 
phosphorylated by glutamate residues, which are similar in charge and conform ation to 
a phosphoserine, and are often used as mimics o f  serine phosphorylation. The validity 
o f  such an approach is supported by a number o f studies, that have shown that these 
kind o f  mutant p47phox proteins can induce activation o f the NADPH oxidase (Ago et 
al., 1999; Groemping et al., 2003; Karathanassis et al., 2002).
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3.4.1 C-terminal p47phox phosphorylation does not affect the
interaction with p22phox
The isolated tandem SH3 domains o f p47phox (p47phoxW ild-typetandcm) are 
thought to represent the open, fully active conformation o f  p47phox, which is able to 
interact with p22phox with high affinity (Groemping et al., 2003). Experiments to 
investigate the contribution o f  individual serine residues within the auto-inhibitory 
polybasic region to the activation process, has shown that a protein in which all five 
serine residues have been substituted by glutamates is able to bind to p22phox. However, 
this interaction occurs 20-fold w eaker than the interaction with the tandem SH3 domain 
construct (Groemping et al., 2003). This discrepancy in affinity suggests that this penta- 
phosphorylated mutant does not represent the fully active state o f  p47phox. This could be 
simply due to glutamate residues not being ideal phosphorylation mimics. A lternatively 
though, it may suggest that phosphorylation o f  the C-term inal serine residues play a role 
in the activation process.
To investigate the latter possibility, it was first tested if  the triple mutant 
P47pho'S3E , in which S359, 370 and 379 had been simultaneously substituted by 
glutamate residues, is able to interact with the p22phox* peptide. However, no binding 
was observed, clearly indicating that phosphorylation o f the C-terminal serine residues 
is not sufficient to destabilise the auto-inhibited conformation o f the protein. Next, to 
determine whether phosphorylation o f the C-terminal serine residues acts in a 
synergistic fashion with serine residues within the polybasic region, binding 
measurements with a mutant that mimicks phosphorylation o f all eight serine residues 
were performed. However, this mutant displayed a similar binding affinity as 
p47phoxS5E, which clearly shows that phosphorylation o f the p47phox C-term inal region 
does not contribute to the interaction with p22phox. Therefore, the difference in binding 
affinity for p22phox between p47phoxS5E and p47phoxW ild-type-,andcm, is most likely due 
to the fact that glutamate residues are not fully effective in mimicking phosphorylation. 
This interpretation is further supported by the CD spectroscopy data, which show that 
p47phoxS5E and p47phoxS8E unfolded/precipitated at lower temperatures than 
p47phoxS3E, which behaved similar to the wild-type protein. This suggests that 
phosphorylation o f  the polybasic region has a destabilising effect on the protein, that is 
not replicated or increased by phosphorylation o f the C-terminal serine residues.
197
3.4.2 C-terminal p47phox phosphorylation weakens the
interactions with p67phox
The results from section 3.1 have clearly shown that phosphorylation o f the C- 
terminal serine residues (S359, 370 and 379) does not contribute to the formation o f 
active p47phox. However, their location within the p67phox-binding region (Kami et al., 
2002) suggests another function: the regulation o f complex formation with p67phox. To 
investigate this possibility, the relevant phosphorylation mimics were used to quantify 
the interaction with p67phox by ITC. M ost o f the binding measurements were carried out 
using the isolated p67phox(SH3)e domain instead o f  the full-length protein, as this 
fragment is more stable and hence better suited for ITC experiments. This is a valid 
approach as other studies (Lapouge et al., 2002) as well as control experiments carried 
out in this work, have shown that the interaction between p47phox and p67phox only 
requires the second SH3 domain o f  the latter, for the formation o f  a tight complex.
Substitution o f the individual serine residues only showed a significant effect on 
complex formation in the case o f  p47phoxS379E, which reduced the affinity for p67phox 
26-fold. This observation can be rationalised by the recently solved NM R structure o f 
p67phox(SH3)B in complex with the C-terminal region o f p47phox, which shows that S359 
and S370 are solvent exposed and do not form part o f the binding interface (Kami et al., 
2002) (Figure 48, A). Thus, phosphorylation would not be expected to directly affect 
the protein-peptide interface. In contrast, the hydroxyl group o f  S379 forms a hydrogen 
bond with the carboxyl group o f  glutamate 496. This thereby stabilises the com plex and 
suggests that introduction o f a negatively charged phosphate group at this position 
would lead to charge repulsion, and steric clashes (Figure 48, B). Interestingly, despite 
the absence o f a significant reduction in binding affinity for the individual 
phosphorylation mimics p47phoxS359E and p47phoxS370E, the simultaneous 
phosphorylation o f both residues (p47phoxS359/370E) weakened the interaction 12-fold. 
At present the reason for this is not clear, and we can only speculate that the sum o f two 
negatively charged residues may induce conformational changes in this region, and 
thereby interfere with com plex formation. A similar observation was made with the 
construct in which all three serine residues were substituted sim ultaneously 
(p47phoxS3E). This further supports the notion that simultaneous phosphorylation o f 
S359 or S370 may alter the conformation o f p47phox, and
198
A
p47ph°x c-term inal region S370
p67t*ox(SH3)B
Figure 48: The C -term inal region of p47phox interacts with p67phox(SH3)B. A. P67phox(SH3)B is
shown in blue and the C-terminal region of the p47phox in green. Phosphorylation sites (S359, 370 and 
379) are shown as yellow sticks. B. A magnification of the hydrogen bond interaction between S379 
(p47phox) and E496 (p67phox). The hydrogen bond distance is in A. PDB identifier 1K4U (Kami et al.,
2002).
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thus enhances the effect o f a phosphoserine at position 379. Furthermore, it has to be 
kept in mind that in these studies phosphoserines have been mimicked, and that under 
true conditions the effects may be larger and may possibly weaken the binding further. 
Although the polybasic region o f  p47phox is remote from the p67phox-binding site, we 
investigated if  phosphorylation o f  serine residues in this region may act in an allosteric 
fashion to induce a conformational change in the C-terminus o f the protein, and thereby 
further disrupt the interaction with p67phox. However, there was no evidence for such 
behaviour as p47phoxS5E bound with a similar affinity as p47phoxW ild-type, while 
p47phoxS8E showed a similar binding behaviour to p47phoxS3E. These results taken 
together with those from section 3.1, clearly show that phosphorylation o f the polybasic 
region is involved in the formation o f  the active p47phox, whereas phosphorylation o f  the 
C-terminal region weakens the interaction with p67phox, and importantly that there is no 
functional communication between the two sites.
During the completion o f this work a similar study on the effects o f 
phosphorylation on the p47phox-p67phox interaction, was published by M assenet and 
colleagues. However, in contrast to the data described here, that study reported much 
smaller effects o f phosphorylation on complex formation (M assenet et al., 2005). This 
discrepancy with our data is most likely due to differences in experimental methods: we 
used full-length proteins, in which phosphorylation was mimicked by glutamate 
substitutions, while M assenet and colleagues used p47phox-derived peptides, which 
either contained a phosphoserine (S379), or in which serine residues were substituted by 
aspartates. Aspartate residues are smaller than glutamates and therefore less suited to 
mimic a phosphoserine, possibly explaining the different results.
A nother study by M izuki and colleagues investigated the role o f  S379 in 
superoxide production. Interestingly, substitution o f this residue by alanine as well as 
glutamate severely reduced superoxide production (M izuki et al., 2005). This 
observation supports the im portant role o f Ser379 in complex formation with p67phox. It 
shows that disruption o f the Ser379p47-E496P67 hydrogen bond, either by removal o f the 
serine side chain or its phosphorylation, severely interferes with superoxide production 
thus consistent with our data. This is most likely due to interference with translocation 
o f p67phox to the membrane.
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3.4.3 Possible model for phosphorylation-induced changes in
NADPH oxidase assembly
M any researchers believe that during the inactive state o f the NADPH oxidase 
some p47phox exists in com plex with p67phox and p40phox as a tight hetero-trim er (Park et 
al., 1992; Someya et al., 1993; W ientjes et al., 1993), where the C-terminal region o f 
p47phox is bound to p67phox (Finan et al., 1994; Kami et al., 2002; Lapouge et al., 2002). 
However, more recently this model has been challenged, when it was reported that only 
p67phox and p40phox exist in a com plex, and that p47phox associates at a later stage with 
this dim er in what could be seen as the first step in the activation process (Brown et al.,
2003) (refer to section 1.3.2. for further details). This observation is rather surprising, 
given that in their un-phosphorylated forms, p47phox and p67phox interact tightly with an 
affinity o f 20 nM (Lapouge et al., 2002). In order to explain this observation, additional 
proteins or ligands or possibly posttranslational modifications that interfere with 
complex formation would be required. The results presented from our current study are 
extremely interesting in light o f these developments, and may help reconcile the 
conflicting data that are currently in the literature. In the resting state, the C-terminal 
region o f p47phox may have a basal level o f phosphorylation that interferes with the 
interaction with p67phox. This may occur either directly or possibly due to the 
recruitment o f another protein, that specifically binds the phosphorylated form. De­
phosphorylation o f p47phox by an as yet unknown phosphatase would then constitute the 
first step in the activation o f the NADPH oxidase, and allow the formation o f  the 
p4 7 Phox-p67phox-p40phox complex. This process may then be followed by phosphorylation 
o f  the remaining serine residues to form the active form o f p47phox, and induce 
translocation to the membrane where it binds to p22phox. This in turn may bring p67phox 
into close proximity to gp91phox and its binding partner Rac, to activate the production 
o f  superoxide radicals.
Such a role for phosphorylation o f S359, 370 and 379 seems more likely than 
the model suggested by Babior and co-workers, in which phosphorylation o f  S359 and 
370 preceeds all other phosphorylation events. It was suggested that this leads to 
translocation o f the cytoplasmic complex to the membrane, where phosphorylation o f 
the remaining serine residues would occur (Johnson et al., 1998). This model is at odds 
with all the available structural and biochemical data on phosphorylation induced 
changes in the conformation o f  p47phox and is very difficult to rationalize at present.
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4.0 The superSH3 domain as a novel protein-protein
interaction module
The tandem SH3 dom ains o f  p47phox (S H 3 a and S H 3 b) work in coordination to 
form a single ligand binding site o f  high affinity, for either the p47phox polybasic region 
or p22phox (Groemping et al., 2003; Yuzawa et al., 2004a; Yuzawa et al., 2004b). This 
conformation is known as the superSH3 domain and has been proposed to be a general, 
novel protein-protein interaction module (Groemping et al., 2003). The correct 
positioning o f S H 3 a and S H 3 b with respect to one another within the superSH3 domain 
is important for the formation o f  a high affinity ligand binding surface. The formation o f 
the p47phox superSH3 domain is dependent on two structural features, the covalent linker 
connecting the two SH3 domains and a conserved ‘G W W ’ m otif located in each n-Src 
loop and adjoining P-strands PC. This region is where the two SH3 domains are closest 
and make contacts across the domain interface (Groemping et al., 2003). There are a 
number o f proteins in the SM ART nrdb (http://sm art.em bl-heidelberg.de/) that contain 
multiple SH3 domains harbouring ‘G W W ’ motifs. So far, none o f  these proteins have 
been specifically tested for their ability to form a superSH3 domain. Nevertheless, for at 
least two o f  these proteins, FISH and CIN85, biochemical data have been published that 
suggest that adjacent SH3 domains in these proteins do cooperate in some form for 
ligand binding (Abram et al., 2003; Kowanetz et al., 2003). These observations support 
the proposal that the superSH3 domain may indeed be a novel signal transduction 
module.
This chapter describes experiments designed to better understand the structural 
features that allow a pair o f  adjacent SH3 domains to cooperate in a stable fashion and 
form a superSH3domain.
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4.1 Sequence requirements of the linker for the
formation of the superSH3 domain
4.1.1 Overview and aims
It has previously been shown by our group that the covalent linker between
SH3a and SH3B (213LDSPDETEDPEPNYA 227) is absolutely essential for the formation 
o f the superSH3 domain, as no interaction between the two individual domains is
detected in free solution (Groem ping et al., 2003). Furthermore, this linker makes a
num ber o f hydrogen bonds with the rem ainder o f the protein in the auto-inhibited state 
that are believed to be im portant for the structural integrity o f this conformation. Some 
o f  these interactions are made by backbone carbonyls and amide groups in the linker, 
whilst others are made by the carbonyls o f the side-chains o f E218, E220 and D221, and 
may hence provide specificity to the formation o f  the superSH3 domain. Other linker 
features that could be important for correctly orientating the SH3 domains for the 
interaction with their ligands are the specific length o f the linker (15 amino acids), and 
the presence o f three proline residues at positions 216, 222 and 224 that could provide a 
certain degree o f structural constraint.
An understanding o f the contribution o f these linker features to the formation 
and stabilisation o f the p47phox superSH3 domain, would not only be useful for a better 
general understanding o f this novel structural arrangement, but may also help to predict 
which proteins may behave in a similar fashion. Therefore, this study was aimed at 
describing how strict the structural requirements are in the context o f  linker length, 
flexibility and com position for the formation o f  the superSH3 domain in the auto­
inhibited and active states o f  p47phox.
4.1.2 Results
In order to determine the importance o f specific hydrogen bonds between the 
linker and the two SH3 domains, the hydrogen bond-forming residues E218, E220 and 
D221 were substituted by alanine (pGEX-p47phoxE 2 18A, pGEX-p47phoxE220A and 
pGEX-p47phoxD 221 A) using site-directed mutagenesis. In addition, a triple mutant 
containing all three substitutions was constructed (pGEX-p47phoxD/E3A) (refer to
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Figure 20 for interactions made by these residues). To investigate the effect o f linker 
length on the superSH3 domain, the length was decreased by removing amino acid 
A227 (pGEX-p47phoxA T), and increased by the addition o f  one (pGEX-p47phoxA l+) or 
two (pGEX-p47phoxA2+) alanine residues adjacent to A227. Flexibility o f  the linker was 
increased by substituting P 216, P222 and P224 with alanine residues, to make the triple 
mutant pGEX-p47phox3PA. All o f  these mutations were introduced in the tandem  SH3 
domains (aa 156-285), hereafter designated as e.g. p47phox3PAtandcnv The m utant proteins 
were tested in two different contexts: i) their interaction with the p47phox 35-m er peptide 
derived from the polybasic region, representing the auto-inhibited state and ii) their 
interaction with a p22phox-derived peptide (hereafter called p22phox peptide), representing 
the active state. Furthermore, the two triple mutations, pGEX-p47phoxD/E3A and pGEX-
p47phox3PA, were introduced into the construct representing the auto-inhibited core, 
com prising the tandem SH3 domains plus the polybasic region (aa 156-340), hereafter 
designated as p47phoxD/E3Aauto and p47phox3PAauto. These constructs were used to test 
w hether increasing linker flexibility, or removal o f stabilising hydrogen bonds could 
destabilise the auto-inhibited conformation, but still allow binding to the p22phox peptide 
(representing the active state).
ITC studies were performed to determine the binding affinities and 
thermodynamic parameters o f  complex formation. In addition, circular dichroism  (CD) 
spectroscopy was used to determine if  the mutations introduced any changes to the 
secondary structure o f  the mutant proteins. Furthermore, the thermal stability o f  those 
mutant proteins that showed the largest changes in binding affinity was determ ined by 
CD spectroscopy, to ensure that a reduction in binding is not due to increased instability 
o f the proteins under investigation. The methods for these techniques are fully described 
in chapter 2 o f  the M aterials and Methods section.
4.1.2.1 Expression and purification of p47phoxD/E3Aa„to and p47phox3PAauto
The auto-inhibited core construct containing the triple D/E to A mutations 
(p47phoxD/E3Aaut0) was grown and expressed under standard conditions (see M aterials 
and Methods). Although the protein was highly over-expressed, purification proved 
unsuccessful as the majority o f  the protein was insoluble (Figure 49A, lane 1). Growth 
and induction conditions were varied in an attempt to obtain soluble material. However, 
slower cell growth in LB m edia as apposed to TB, and growth and protein induction at
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Figure 49: Expression and purification of p47pho,D/E3A,
A: Purification using standard lysis buffer
M: Molecular weight marker (SeeBlue marker, Invitrogen)
1: Pellet
2: Supernatant
3: Flowthrough
B: Solubilisation of p47phoxD/E3A,M,„ using standard lysis buffer plus 5 % Y-PER or 0.1 % BOG
Molecular weight marker (SeeBlue marker, Invitrogen) 
Pellet
Supernatant 
Flow through 
GST beads 
Pellet
Supernatant 
Flow through 
GST beads
5 % Y-PER
0.1 % BOG
p47ph0XD/E3Aaut„(47.1 kDa)
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lower temperatures (16 °C and 20 °C) failed due to a lack o f protein expression (data 
not shown). Purification o f  p47phoxD/E3Aauto grown under standard conditions was then 
attempted using different additives in the lysis buffer to increase protein solubility i) 5 
% Y-PER yeast protein extraction reagent (Pierce) or ii) 0.1 % P-octylglucoside (BOG) 
(Anatrace). Both reagents were very efficient in solubilising the protein as shown in 
Figure 49B, lanes 1-4 and lanes 5-8. Since the use o f 5 % Y-PER was more effective 
than 0.1 % BOG, this reagent was chosen for subsequent purification trials. Despite this 
initial success in using Y-PER for protein extraction, the untagged protein in solution 
was very unstable, precipitating on the GST beads upon cleavage with 3C-protease 
(Figure 50, lane 8) with nothing eluted after cleavage (lane 7). Therefore, it was 
attempted to purify the mutant as a GST-fusion protein. However, as shown in Figure 
51, the protein again precipitated on the GST beads (lane 8), and nothing could be 
eluted with 15 mM reduced glutathione (lane 7). Similar results were observed with the 
use o f 0.1 % BOG (data not shown).
Unfortunately, the auto-inhibited core construct containing the triple proline 
mutations (p47phox3PAauto), behaved in a similar manner and purification was also 
unsuccessful despite similar optimisation and solubilisation attempts (data not shown). 
Based on the insolubility o f these auto-inhibited core region proteins, no attempt was 
made to make a linker length mutant in this construct as similar results were anticipated. 
Overall, these results show that increasing the linker flexibility and rem oving the 
stabilising hydrogen bonds has a detrimental effect on the stability and most likely the 
folding o f the superSH3 domain in the auto-inhibited state.
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Figure 50: Purification of p47pholD/E3Aaut0 using 5 % Y-per and cleavage with 3C protease.
M: Molecular weight marker (SeeBlue marker, Invitrogen)
1: Pellet
2: Supernatant
3: Flow through
4: Wash with high salt buffer B
5: Wash with low salt buffer C
6: GST beads before 3C protease cleavage
7: Elution after cleavage
8: GST beads after overnight cleavage
A: p47ph0XD/E3Aau,0-GST fusion (47.1 kDa)
B: GST (26 kDa)
C: p47phoxD/E3Aauto (21.6 kDa)
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Figure 51: Purification of p47ph0XD/E3A,uto as a GST-fusion.
M: Molecular weight marker (SeeBlue marker, Invitrogen)
1: Pellet
2: Supernatant
3: Flow through
4: Wash with high salt buffer B (pH 7.5)
5: Wash with low salt buffer C (pH 7.5)
6: GST beads before elution with 15 mM reduced glutathione
7: Elution with 15 mM reduced glutathione
8: GST beads after elution
A: p47ph0*D/E3Aau,0 GST-fusion (47.1 kDa)
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4.1.2.2 Expression and purification of p47phox linker mutants in the tandem
SH3 domains
Due to the unsuccessful attempts in purifying the constructs with triple 
mutations in the auto-inhibited core, these mutations were introduced into the tandem 
SH3 domain construct (aa 156-285): pGEX-p47phoxD/E3Atandcm and pGEX- 
p47Phox3PAtandcm- Furthermore, the following individual mutants were made: pGEX- 
p47phoxE218 A,andcm, pG EX -p47phoxE220Atandcm, pGEX-p47phoxD 221 Atandcm, pGEX- 
p4 7 phoxA r tandem, pGEX-p47phoxA 1 +tandcm, pGEX-p47phoxA2+tandcm. All o f the mutant 
proteins were expressed in a soluble form in E.coli, under similar conditions and in 
similar amounts as p47phoxW ild-typetandcm- They were purified by affinity 
chromatography on glutathione sepharose, followed by size exclusion chromatography 
after protease cleavage o f the GST-tag. Figures 52A and 52B show the purity o f the 
different mutant proteins used for the ITC experiments as determined by SDS-PAGE. 
All the proteins ran as single bands at their expected m olecular weights (15.2 kDa - 15.5 
kDa) and could be easily concentrated to 500 pM - ImM. The identities o f  the purified 
proteins were confirmed by electrospray mass spectrometry.
CD spectroscopy showed that the mutations did not affect the secondary 
structure o f  the proteins. Figure 53 shows a typical CD spectrum for p47phoxE 2 18 Atandcm, 
which is similar to that o f p47phoxW ild-typetandcm. The secondary structure content o f 
p47phoxE 218A,andcm is listed in Table 14 and is similar to p47phoxW ild-typetandcm 
(Sreerama and Woody, 2000) (refer to Appendix: A6 for the spectra o f the other mutant 
proteins). In addition, the therm al stability o f p47phoxD/E3Atandcm, p47phoxE 2 18Atandcm 
and p47phox3PAtandcm was checked by CD spectroscopy, which showed that the insertion 
o f  these mutations did not affect the structural integrity o f  the resulting proteins (also in 
Appendix: A6).
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Figure 52A: SDS-PAGE gel of p47pho1 linker mutants in the tandem SH3 domains. Analysis o f
the purity o f the p47phox linker proteins used for the ITC experiments. 3-5 pg were loaded and a single 
band is observed at the corresponding molecular weights.
M: Molecular weight marker (SeeBlue marker, Invitrogen)
1: p 47Phox W ild-typetandcm (15.4  kDa)
2: p47P A l tandem (15.3 kDa)
3: p47P A l tandem (15.5 kDa)
4: p47ph°XA 2+tandem (15.5 kDa)
5: p47P 3 P Atandcm (15.3 kDa)
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Figure 52B: SDS-PAGE gel of p47phox linker mutants in the tandem SH3 domains. Analysis o f
the purity of the p47phox linker proteins used for the ITC experiments. 3-5 fig were loaded and a single 
band is observed at the corresponding molecular weights.
M: Molecular weight marker (SeeBlue marker, Invitrogen)
1: p47phoxWild-typelandcm (15.4 kDa)
2: p47ph°*E218 Atandcm (15.3 kDa)
3: p47phoxE220AtandCm (15.3 kDa)
4: p47ph0xD 221A la0dcm (15.4 kDa)
5: p47phoxD/E3Alandcm (15.2 kDa)
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Figure 53: CD spectra of p47phoIWild-typetandem and p47phoxE218Atandem. Far-UV CD spectra of
P47phoxWild-typeundem and p47phoxE21 8 (aa 156-285). The protein concentration was 0.15 mg/ml, 
and the experiments were carried out in buffer H.
Table 14: Secondary structure analysis of the CD spectra of p47phoIWild-type,andem and
p47ph0XE218A,aBdem. Comparison o f the secondary structure content o f p47phoxWild-typelandem (WT) and 
p47phoxE218Atandem (E218E), as calculated using the programs CONTIN, SELCON and CDSSTR 
(Sreerama and Woody, 2000).
Program
a-helix (%) P-sheet (%) Turn (%) Random (%)
WT E218A WT E218A WT E218A WT E218A
CONTIN 6.1 6.3 41.5 34.9 26.6 22.6 25.8 36.2
SELCON 7.3 5.2 38.9 34.4 26.5 22.7 27.3 37.7
CDSSTR 6.9 7.6 40.6 32.9 26.2 23.1 26.3 36.4
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4.1.2.3 Binding of p47phox linker mutants to the p47phox polybasic region
peptide
Due to the insolubility o f the p47phoxD/E3Aauto and p47phox3PAauto constructs, the 
importance o f  linker com position for the stability o f the superSH3 domain in the auto­
inhibited conformation was investigated by measuring the ability o f  mutant tandem SH3 
domain constructs (p47phoxD/E3Atandem and p47phox3PAtandcm) to interact with a 35-mer 
peptide derived from the polybasic region o f p47phox (peptide 1, Appendix: A4). In 
addition, the individual linker m utant proteins were tested in the same experimental 
setup (described below). ITC was used to determine binding affinities and 
thermodynamic parameters o f  com plex formation and the results o f these ITC studies 
are summarised in Table 15. All the titrations demonstrated exothermic reactions and 
stoichiometries o f approximately 1:1.
The interaction between p47phoxW ild-typetandcm and the peptide was used as a 
reference titration. Complex formation occurred with an affinity o f 1.12 pM  and a 
binding enthalpy o f -17.8 kcal/mol, which is in close agreement with data previously 
reported by our group (Groemping et al., 2003) (Table 15). ITC experiments with the 
individual hydrogen bond forming mutants p47phoxE220Atandcm and p47phoxD 221 AtandCm 
gave Kd values o f 3.12 pM  and 2.69 pM , respectively, which are only ~ 2-fold weaker 
than p47phoxWild-typetandcm. P47phoxE 2 18Atandcm showed the most significant change o f 
all the individual mutant proteins with a reduction in affinity to 5.76 pM , approxim ately 
5-fold weaker than p47phoxW ild-typetandcm- Surprisingly though, the simultaneous 
replacement o f all three residues (p47phoxD/E3Atandcm) did not reduce the binding 
affinity any further (5.76 pM ). This suggests that slight structural arrangem ents may 
take place in this mutant protein, that could allow the formation o f other com pensating 
interactions.
The replacement o f  three proline residues in the linker (p47phox3PAtandcm) had a 
similarly minor effect on com plex formation with the polybasic peptide (2.0 pM ), just 
as the shortening or lengthening o f the linker. P47phoxA l'tandcm, p47phoxA 1 \ andcm and 
p47PhoxA 2+tandcm bound with Kd values o f 2.81 pM, 1.62 pM  and 3.32 pM , respectively, 
which is only 2-3-fold w eaker than p47phoxW ild-typetandcnv A typical titration curve for 
complex formation between p47phoxA T  tandem and the polybasic peptide is shown in 
Figure 54, and the therm odynamic parameters are listed in Table 15.
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Table 15: Binding affinities and thermodynamic parameters for titration of the p47phox linker
mutants with the p47phox polybasic region peptide.
Protein IM pM ) AH (kcal/mol) TAS (kcal/mol) AG (kcal/mol)
p47pl,ox Wild-type,,Bdem 1.12 ± 0.07 -17.8 ±0.56 -9.86 ±0 .5 -7.95 ±0.1
p47p‘,0XE218At,Ddem 5.76 ± 0 .2 -17.1 ± 1.0 -10.1 ±0.71 -6.99 ± 0.09
p47pl«ox E220AlandeilI 3.12 ±0.65 -19.1 ±0.55 -11.8 ± 0.5 -7.34 ± 0.05
p47ph0XD221AtlllldeiII 2.69 ±0.75 -14.5 ±0.05 -7.03 ±0.35 -7.45 ± 0 .39
p47phox D/E3A„ndeill 5.76 ±0.05 -15.5 ± 0.15 -8.54 ±0.15 -6.99 ±0.15
p47phox A l'taildeIIl 2.81 ±0.15 -11.3 ±0.65 -3.86 ±0 .3 -7.4 ± 0.09
p47phox A l+U„dem 1.62 ± 0.12 -12.1 ±0.09 -4.36 ± 0.05 -7.73 ±0.03
P47pboxA2+UlIdem 3.32 ± 0 .2 -11.9 ± 0 .2 -4.59 ± 0 .09 -7.31 ±0.08
p47ph0X3PAUlldein 2.0 ± 0 .03 -12.3 ± 0.1 -4.69 ±0.1 -7.6 ± 0.02
ITC experiments were performed in buffer H (pH according to the individual proteins, and to one unit 
above or below the pi) at 18 °C. Proteins in the cell (aa 156-285) were used at concentrations in the range 
o f 27-43 pM. The p47phox 35-mer polybasic region peptide was titrated at concentrations o f  250-400 pM. 
Values are the mean of at least three independent experiments. The errors (±) are the standard deviation 
o f the mean. The binding stoichiometry values (n) ranged from 0.9-1.1. As discussed in the previous 
tables, these errors are small due to good reproducibility o f the system. However, it seems more 
appropriate to assume an error o f around 10 % derived from pipetting errors during protein concentration 
determination.
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Figure 54: Characterisation of the interaction between the p47pho1 35-mer polybasic peptide
and p47pho*AI'Undem. The upper plot shows the raw data for the titration of the polybasic peptide (351 
pM) into p47phoxA r tondem (27 pM). The lower plot shows the isotherm after subtraction o f the heats of 
dilution. The data were fitted to a single-site binding model. Experiments were carried out in buffer H at 
18 °C.
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Interestingly, in spite o f  only minor changes in affinity and hence in free energy 
(AG), pronounced changes in the relative contributions o f AH and TAS were observed, 
particularly for p47phoxE220A,andcnv Substitution o f  glutamate 220 resulted in 
a gain in binding enthalpy, with a compensating less favourable change in the TAS 
value (Table 15). M oreover, an approximate 30 % loss o f binding enthalpy was 
observed for all the linker length mutants and the triple flexibility mutant (-11.3 
kcal/mol, -12.1 kcal/mol, -11.9 kcal/mol and -12.3 kcal/mol; respectively), which was 
compensated by an increase in entropy. Figure 55 shows that the AG values remained 
fairly constant for all the titrations, whilst the relative contributions o f AH and TAS are 
varied.
The results o f these binding studies were rather unexpected as the triple 
mutations in the auto-inhibited core construct (p47phoxD/E3Aauto and p47phox3PAaut0) 
produced insoluble protein (section 4.1.2.1). This indicates that the interactions between 
the linker and the tandem SH3 domains and polybasic region are very important for the 
structural integrity o f this conformation. However, given the titrations described above 
it appears that the structural requirements in terms o f  linker composition, length and 
flexibility are not rigid for the formation and stabilisation o f the auto-inhibited 
superSH3 domain, if  the interaction with the polybasic region occurs in an 
intermolecular fashion.
4.1.2.4 Binding of p47phox linker mutants to the p22phox peptide
To better understand the specific requirements in terms o f  length and 
composition o f the p47phox linker, for the formation and stabilisation o f  the superSH3 
domain in the active state, complex formation between the tandem  SH3 domain 
constructs and the p22phox peptide (peptide 2, Appendix: A l)  was studied by ITC. The 
results o f these titrations are summarised in Table 16. All the binding reactions were 
exothermic with stoichiometries o f  approximately 1:1.
As described previously, the binding o f p47phoxW ild-typetandcm to the p22phox 
peptide was used as a reference. Binding occurred with an affinity o f  0.14 pM  and a 
binding enthalpy o f -11.8 kcal/mol, which is in close agreement with data previously 
published by our group (Groemping et al., 2003). Binding experim ents using the 
individual hydrogen bond forming mutant proteins p47phoxE 2 18 Atandem, 
p47phoxE220Atandcm and p47phoxD221Atandem showed only marginal changes in binding
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Figure 55: Thermodynamic profile of the complexes between the p47pho* tandem SH3 domain
linker mutants and the p47ph01 35-mer polybasic region peptide. Graph illustrating that AG (red) 
values remain relatively similar for all the complexes, owing to compensating changes in the enthalpic 
(AH) (blue) and entropic (TAS) (green) contributions.
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Table 16: Binding affinities and thermodynamic parameters for the interaction of the p47phox
linker mutants with the 16-mer p22phox peptide.
Protein K e^M ) AH (kcal/mol) TAS (kcal/mol) AG (kcal/mol)
p47phox Wild-type, 0.14 ± 0 .04 -11.8 ±0.3 -2.65 ±0.35 -9.15 ±0.05
p47ph°» E 2, 8A(iitdtm 0.218 ±0.07 -13.0 ±0.25 -4.14 ±0.55 -8.90 ±0.13
p47pl,M E22DA„.Jm 0.211 ±0.03 -12.4 ± 0.15 -3.55 ±0.15 -8.90 ± 0.03
P47phorD22IA,„dra 0.219 ±0.07 -10.9 ±0.03 -2.03 ±0.17 -8.89 ± 0.09
p47phox D/E3A,,ddem 0.29 ±0.01 -11.2 ±0 .5 -2.45 ±0.5 -8.71 ±0.03
p47phox A r ISMten 0.54 ± 0.08 -10.5 ± 0 .09 -2.13 ±0.08 -8.36 ± 0 .08
P47ph0< A1 0.38 ± 0.06 -9.2 ± 0.05 -0.66 ± 0.05 -8.56 ± 0.06
P47pl,OIA2*llW,m 0.33 ± 0.05 -10.3 ± 0 .3 -1.66 ±0.35 -8.64 ± 0.05
p47pb0’‘3PA„.d,„ 0.56 ±0.05 -9.81 ±0.05 -1.48 ±0.09 -8.33 ± 0 .06
ITC Experiments were carried out in buffer H (pH according to the individual proteins, and to one unit 
above or below the pi) at 18 °C. Proteins in the cell (aa 156-285) were used at concentrations in the range 
o f 25-40 pM. The p22phox peptide was titrated at concentrations o f 250-400 pM. Values are the mean o f at 
least three independent experiments. The errors (±) are the standard deviation o f the mean. The binding 
stoichiometry values ranged from 0.9-1.1. As discussed in the previous tables, these errors are small due 
to good reproducibility o f the system. It seems more appropriate to assume an error o f around 10 % 
derived from pipetting errors during protein concentration determination.
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affinities (~ 0.2 pM ) compared to p47phoxW ild-typetandem (0.14 pM). Similarly, the triple 
mutant p47phoxD/E3Atandcm only showed a small decrease in binding affinity (0.29 pM). 
These results suggest that these hydrogen bond forming residues may not play an 
important role in the stabilisation o f  the superSH3 domain in the active state. Shortening 
the linker by one amino acid (p47phoxA l 'tandcm) had one o f the strongest effects on the 
interaction, and led to a 4-fold decrease in binding affinity (0.54 pM ). The titration 
curve for this reaction is shown in Figure 56. P47phoxA 1 +tandcm bound with an affinity o f 
0.38 pM, ~ 3-fold weaker than p47phoxW ild-typetandCm, while p47phoxA2+tandcm gave a IQ 
value o f  0.33 pM. Experiments using the triple flexibility mutant protein 
p47phox3PAtandcm weakened the affinity 4-fold to 0.56 pM. Overall, these data suggest 
that increasing or decreasing the length o f the linker by one or two amino acids, or 
increasing the linker flexibility has only a limited effect on the formation o f the active 
superSH3 domain. Intriguingly, the substitution o f either E218 or E220 
(p47phoxE 2 18Atandcm and p47phoxE220Atandcm) made complex formation between the 
mutant proteins and the p22phox peptide energetically more favourable (13.0 kcal/mol 
and -12.4 kcal/mol; respectively) (Figure 57 and Table 16), suggesting that slight 
rearrangements in these constructs may have allowed the formation o f novel hydrogen 
bonds.
As observed already for the intermolecular interaction o f these mutant proteins 
with the polybasic peptide, it appears that the structural requirements for the formation 
o f the superSH3 domain in the active state o f p47phox, in terms o f linker composition, 
length and flexibility are not very strict.
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4.2 The role of the GWW motif in the formation of the
superSH3 domain
4.2.1 Overview and aims
The GW W  motif, w hich is located in the n-Src loops and adjoining p-strand PC 
o f either p47phox SH3 domain, is believed to be central to the formation o f  the superSH3 
domain ( 192G W W 194 in SH3A and 262GW W 2M in SH3b). Figure 58 shows the 
involvement o f the GW W  m otif in formation o f the superSH3 domain in the active 
p22phox-bound state. A quantitative analysis by our group has already shown that the 
glycine residues in positions 192 and 262 in either SH3 domain, are absolutely critical 
to allow the two SH3 domains to come sufficiently close, to make contacts with one 
another across the domain interface (Groemping et al., 2003). The tryptophan residues 
adjacent to these glycines: W 193A and W 263b respectively are thought to be important 
for ligand binding, whereas tryptophans W 194A and W 264b, make contacts across the 
domain interface and thereby stabilise the superSH3 domain (Groemping et al., 2003; 
Yuzawa et al., 2004a; Yuzawa et al., 2004b). Although the role o f  a tryptophan residue 
in the position equivalent to W 193A and W 263b has been extensively studied in 
monomeric SH3 domains (Erpel et al., 1995; Liu et al., 1993; Terasawa et al., 1994), as 
well as in p47phox (de M endez et al., 1997; Nobuhisa et al., 2006; Sumimoto et al., 
1996), very little is known about the importance o f these tryptophan residues in the 
context o f the superSH3 domain. Therefore, the purpose o f this series o f  experiments 
was to understand the precise contribution o f  W 193A, W 263b, W 194a and W 264b to the 
stability and ligand binding properties o f  the p47phox superSH3 domain.
4.2.2 Results
The importance o f W 193A and W 263b in ligand binding is well docum ented in 
the case o f  single SH3 domains (de M endez et al., 1997; N obuhisa et al., 2006; 
Sumimoto et al., 1996). It is not known however if  they play the same role in the 
context o f  the superSH3 domain, and whether the presence o f  additional contacts 
outside the conserved ligand binding site (at least in the auto-inhibited state) may be 
able to compensate for the loss o f  this tryptophan. M ost previous studies investigated
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p 2 2 H*“
S H 3 b
S H 3 a
Figure 58: The GWW motif in the n-Src loops of p47phox is central to the formation of a
superSH3 domain. The p47phox superSH3 domain in complex with the p22phox peptide. The tandem SH3 
domains of p47phox are shown in blue, the linker in orange and the p22phox peptide in yellow stick format. 
P4 7 ph°x (yyyw motif residues involved in ligand binding (W193A and W263B) and stabilisation (W194A 
and W264b) are shown as green sticks. PDB identifier 10V3 (Groemping et al., 2003).
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the role o f  W 193a and W 263b in either superoxide formation or membrane 
translocation using a substitution with arginine (de M endez et al., 1997; Sumimoto et 
al., 1996). The same substitution was made here to maintain consistency and allow 
comparison o f our binding studies with the previous functional studies. All mutations 
were introduced into the tandem SH3 domain construct (aa 156-285). Expression and 
purification o f p47phoxW 193RA-tandcm and p47phoxW263RB-tandcm presented few problems, 
other than a lower yield o f  protein than for p47phoxW ild-typetandcm- In contrast, 
p47phoxW 194RA.tandcm and p47phoxW 264RB-tandcm were expressed in an insoluble form 
(data not shown). A possible explanation for this behaviour is that the long side chain o f 
the introduced arginine may cause a steric clash with the opposing SH3 domain and 
hence, disrupt the structural integrity o f the protein. These tryptophan residues were 
therefore substituted by alanine residues. Expression and purification o f the 
corresponding mutant proteins p47phoxW 194AA_tandem and p47phoxW 264A B-tandcm was 
successful, but with lower yields than p47phoxW ild-typetandem-
Fluorescence spectroscopy was chosen to determine binding affinities for 
complex formation between the proteins and peptides, as the overall yield o f these 
mutant proteins was rather low, making ITC an unsuitable technique. The mutant 
proteins were tested in two different contexts: i) their interaction with the p47phox 35- 
mer polybasic region peptide, to assess the formation o f the superSH3 domain in the 
auto-inhibited state, and ii) their interaction with a fluorescein labelled p22phox peptide 
(p22phox* peptide), to assess the formation o f the superSH3 domain in the active state. 
The interaction with the polybasic peptide was followed using the intrinsic fluorescence 
o f  tryptophan residues in the tandem SH3 domains (peptide 1, refer to Appendix: A4), 
as this peptide was not fluorescently labelled, nor contained tryptophan residues. The 
interaction with the p22phox derived peptide was measured following changes in the 
extrinsic fluorescein fluorescence (peptide 3, refer to Appendix: A4).
Furthermore, potential changes in the secondary structure content o f the mutant 
proteins were determined by CD spectroscopy. In addition, for those m utant proteins 
which showed the largest effects on binding affinity, the thermal stability was also 
determined to ensure that the reduction in binding was not due to increased instability o f 
the proteins under investigation. The methods for these techniques are fully described in 
chapter 2 o f  the M aterials and M ethods section.
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4.2.2.1 Expression and purification of the p47phox GWW motif mutants
The mutant proteins p47phoxW 193RA-tandcm, p47phoxW263RB-tandcm, 
p47phoxW194AA-tandcm and p47phoxW 264AB-tandcm were expressed in a soluble form, but at 
lower yields than p47phoxW ild-typetandcnv They were purified by affinity chromatography 
on glutathione sepharose, followed by size exclusion chromatography after protease 
cleavage o f the GST-tag. Figure 59 shows the purity o f  the proteins used for the 
fluorescence titration experiments, as determined by SDS-PAGE. All proteins ran as 
single bands at their expected molecular weights (~ 15.3 kDa), and their identity was 
verified by electrospray mass spectrometry. M oreover, CD spectroscopy showed that 
none o f the mutations had any affects on protein folding. Figure 60 shows a typical CD 
spectrum for p47phoxW263RB-tandcm, which is similar to that o f p47phoxW ild-type,andcm- 
Table 17 shows the corresponding secondary structure content o f p47phoxW263RB- 
tandcm,which is similar to p47phoxW ild-typetandem (Sreerama and W oody, 2000) (refer to 
Appendix: A6 for the CD spectra o f  the other mutant proteins). In addition, the thermal 
stability o f p47phoxW 193RA-tandcm and p47phoxW263RB-tandcm was checked by CD 
spectroscopy, which showed that the mutations did not affect the structural integrity o f 
the proteins (also in Appendix: A6).
4.2.2.2 Complex formation between the GWW motif tryptophan mutants
and the p47phox polybasic region peptide
The results o f the fluorescence titrations are summarised in Table 18. The use o f 
intrinsic fluorescence as a signal to monitor protein-ligand interactions is a powerful 
technique, that sometimes can provide structural clues about the com plex under 
investigation. The technique is extremely sensitive and as a consequence is also prone 
to artefacts, especially when ligand binding results in a decrease o f  the fluorescence 
signal. To ensure that the signal changes monitored upon addition o f  the peptide are 
only due to complex formation, the interaction between p47phoxW ild-typetandcm and the 
p47phox 35-mer polybasic region peptide was used as a control and reference 
experiment. Complex formation occurred with a binding affinity o f  1.1 pM , which is in 
close agreement with that previously reported by our group using ITC (1.5 pM) 
(Groemping et al., 2003). Titrations o f buffer into peptide were also perform ed as an
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Figure 59: SDS-PAGE of the p47pho1 GWW motif mutant proteins used for fluorescence
spectroscopy experiments. 4-12 % Bis-Tris Novex SDS-PAGE analysis o f the p47phox GWW (aa 156- 
285) motif tryptophan mutants used in these experiments. All proteins are approximately 15.3 kDa.
M: Molecular weight marker (SeeBlue marker, Invitrogen)
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Figure 60: CD spectra of p47phoxWiId-t>peUBdem and p 47pho*W263RB-tal,den, Far-UV CD spectra
of p47phoxWild-typetandem and p47phoxW263RB.iandem (aa 156-285). The protein concentration was 0.15 
mg/ml, and the experiments were carried out in buffer H.
Table 17: Secondary structure analysis of the CD spectra of p47pho,Wild-typetandem and
p47pht>1 W 263R B-iandem- Comparison o f the secondary structure content o f p47phoxW ild-typetandein (WT) and 
p4 7 phoxw 263RB-tandem (W263RB), as calculated using the programs CONTIN, SELCON and CDSSTR 
(Sreerama and Woody, 2000).
Program
a-helix (%) P-sheet (%) Turn (%) Random (%)
WT W263RB WT W263Re WT W263Rb WT W263Rb
CONTIN 6.1 5.3 41.5 32.8 26.6 23.5 25.8 38.4
SELCON 7.3 7.8 38.9 34.0 26.5 22.5 27.3 35.7
CDSSTR 6.9 7.2 40.6 31.7 26.2 22.9 26.3 38.2
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Table 18: Dissociation constants for the complexes formed between the p47phox GWW motif
tryptophan mutants and the p47phox 35-mer PB region peptide.
Protein Kd(pM)
p4 7 ph»* Wild-typetandem
1.11± 0.9
1.5 (ITC)
P47phoxW193RA.tandem
>500
> 500 (ITC)
P47phOX W 2 6 3 R B -,a n d e m 4.11 ±0.01
P47ph0XW194AA.tandem 2.62 ± 0.03
P47phOX W 2 6 4 A B -«andem 1.12 ±0.07
p47pl,0XSH3A No binding (ITC)
P47ph0XSH3B No binding (ITC)
Experiments were carried out in buffer H (pH according to the individual proteins, and to one unit above 
or below the pi) at 20 °C. The p47phox 35-mer polybasic region peptide was titrated at increasing 
concentrations into a cuvette containing 1 |iM o f either p47phoxWild-typetandcm, or the GWW motif 
tryptophan mutants (aa 156-285). Previous results from our group are shown in blue. P47phox SH3A (aa 
159-212) and p47phox SH3B (aa 228-284) are the isolated SH3 domains (Groemping et al., 2003). Values 
taken are the mean o f at least three independent experiments. The errors (±) are the standard deviation of 
the mean. As discussed in the previous tables, these errors are small due to good reproducibility o f the 
system. However, it seems more appropriate to assume an error of around 10 % derived from pipetting 
errors and protein concentration determination.
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additional control, to ensure that any changes in fluorescence observed were not an 
artefact. Titration o f the peptide into p47phoxW193RA-tandcm did not produce any 
significant changes in fluorescence intensity, suggesting that no binding takes place. On 
the other hand, mutation o f  this tryptophan residue in SH 3 b (p47phoxW 263Re-tandcm) 
resulted in a slight decrease in fluorescence, that was sufficient to determine a 
dissociation constant o f  4.1 pM , ~ 3-fold weaker than p47phoxWild-typetandcm- Figure 61 
shows the fluorescence titration curves for the titration o f p 47phoxW193RA-tandcm and 
p47PhoxW 263R A.tandcin with the polybasic peptide. As the measurements in this section 
rely on changes in tryptophan fluorescence, we thought it important to rule out the 
possibility that the absence o f a fluorescence signal for the p47phoxW193RA-tandcm 
titration, may be solely due to the removal o f  tryptophan residue 193. Therefore, 
additional ITC experiments were carried out to further investigate this interaction by 
titrating the polybasic peptide into p47phoxW 193RA-tandcm at 18 °C. However, the heat 
change o f this reaction was rather small (-2.31 kcal/mol) and the data quite noisy, 
thereby making the data difficult to fit reliably (data not shown). The experiment was 
repeated at 12 °C in the hope that the heat capacity o f  this binding reaction is such that 
AH might be bigger at this given temperature (section 2.11.2.4). Unfortunately, the heat 
change again was too small and the data quality not sufficient to allow a reliable fit (- 
3.32 kcal/mol, data not shown). Based on these titrations we estim ate the binding 
affinity to be more than 500 pM. This result further supports the fluorescence data and 
suggests that upon removal o f  W 193A binding to the polybasic peptide does not take 
place. Together, these observations suggest that in the context o f the inactive, auto­
inhibited state, W 193R a appears to be much more important for ligand binding than 
W 263R b . This is somewhat surprising given that unlike in the active state, neither SH3 
domain is capable o f binding to the polybasic peptide on its own (Groem ping et al., 
2003).
Mutation o f W 194A (p47phoxW 1 94Aa -tandem) only slightly disrupted the 
interaction with the polybasic peptide (2.6 pM ), while rem oval o f  W 264B 
(p47ph0XW 264AB -tandem) had no effect at all on complex formation (1.1 pM ). Figure 62 
shows the fluorescence titration curves for these interactions. These data indicate that 
W 194a and W 264B are not im portant in the stabilisation o f the superSH3 domain 
conformation in the inactive, auto-inhibited state.
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Figure 61: Fluorescence titrations of the interactions the between p47phoxW 193RA.Undem and
p47ph0XW 263R B.,!indein with the p47phox 35-m er PB region peptide. P47phoxW193RA_tandem shows no 
change in fluorescence intensity, indicative o f no binding. The titrations were carried out 20 °C in buffer 
H.
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4.2.2.3 Complex formation between the GWW motif tryptophan mutants
and the p22phox* peptide
The results o f the fluorescence titrations are summarised in Table 19. As before, 
the titration o f the p47phoxWild-typetandcm protein into the p22phox* peptide was used as a 
reference experiment. This complex represents the fully active state, and produces the 
highest affinity observed. The dissociation constant obtained (0.2 pM ) was reproducible 
and is in close agreement with that previously obtained by our group (Groemping et al., 
2003). In addition, control experiments were carried out where buffer was titrated into a 
solution o f  the p22phox* peptide, to ensure that the decrease in fluorescence intensity 
observed was due to peptide binding and not an artefact.
Titration p47phoxW 193RA-tandcm into the p22phox* peptide did not produce any 
significant changes in fluorescence intensity, indicating that no binding takes place. 
This result suggests that W 193A is also critical for ligand binding in the context o f  the 
active superSH3 domain and that the presence o f S H 3b is not sufficient to compensate 
for the loss o f  the interaction with W 193A. On the other hand, titration o f 
p47phoxW263RB.tandcm into the p22phox* peptide resulted in a dissociation constant o f  4.0 
pM , 20-fold weaker than p47phoxW ild-typetandem, but importantly closer to that observed 
for the binding o f the peptide to the isolated SH3A domain (7.0 pM  as determ ined by 
fluorescence spectroscopy and 3.4 pM  as determined by ITC) (G roem ping et al., 2003) 
(Table 19). Figure 63 shows the fluorescence titration curves for the binding o f 
p47phoxW 193RA.u,„dcm, and p47phoxW 263RB.,and™ to the p22phox* peptide. Together, these 
observations suggest that the role o f  the first tryptophan residue within the GW W  m otif 
is conserved and identical to that o f  this tryptophan in isolated SH3 domains (de 
M endez et al., 1997; N obuhisa et al., 2006; Sumimoto et al., 1996).
On the other hand, substitution o f W 194A and W 2 6 4 b had a sm aller effect: 
p47phoxW 194AA.tandcm interacted with the p22phox* peptide with a IQ o f  1.3 pM , which is 
only about 6-fold weaker than p47phoxW ild-typetandcm, while p47phoxW 264A B-tandcm 
bound 8-fold weaker with an affinity o f 1.6 pM. Figure 64 shows the fluorescence 
titration curves for the binding o f  p47phoxW 194AA.tandcm and p47phoxW264AB-tandcm to the 
p22phox* peptide. These data suggest that the individual removal o f  these tryptophan 
residues that are not directly involved in ligand binding, only partially disrupts the 
interaction between the two SH3 domains. However, some cooperativity between the 
domains is preserved as the interaction with the p22phox* peptide is still stronger than 
that o f isolated SH3A.
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Table 19: Dissociation constants for the complexes formed between the p47phox GWW motif
tryptophan mutants and the 16-mer fluorescein labelled p22phox peptide.
Protein IM p M )
p4 7 pho* Wild-typetandcm
0.21 ± 0.01 
0.19 (ITC)
0.4 (Fluorescence spectroscopy)
p47ph0* W 193 RA. tandem >500
p47ph0XW 263RA.tandem 4.01 ±  0.04
P47ph0,W 194AB-tandcm 1.33 ±0.07
p4 7 phox W 264AB-tandem 1.62 ±0.04
p47ph01 SH3a
3.4 (ITC)
7.0 (Fluorescence spectroscopy)
p47pho* S | | 3 b No binding (ITC)
Experiments were carried out in buffer H (pH according to the individual proteins, and to one unit above 
or below the pi) at 20 °C. P47phox Wild-type,^,.™ and the GWW tryptophan motif mutants (aa 156-285) 
were titrated at increasing concentrations into a cuvette containing a 1 pM solution o f the p22phox* 
peptide. Previous results from our group are shown in blue. P47phox SH3A (aa 159-212) and p47phox SH3B 
(aa 228-284) are the isolated SH3 domains (Groemping et al., 2003). Values shown are the mean of at 
least three independent experiments. The errors (±) are the standard deviation o f the mean. As discussed 
in the previous tables, these errors are small due to good reproducibility o f the system. It seems more 
appropriate to assume an error o f around 10 % derived from pipetting errors and protein concentration 
determination.
NOTE
The affinity o f p47phoxWild-typetandcm for the p22phox* peptide determined in these experiments is 
reproducibly higher than that observed in previous experiments (section 3.1.3.3). This is most likely due 
to the fact that the two different sets o f experiments were carried out using two different peptide stock 
solutions, derived from two different peptide syntheses. Importantly though, within each set of 
experiments the same peptide stock was used, and hence the differences in affinities observed are reliable 
and internally consistent.
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Figure 63: Fluorescence titrations of the interactions between p 4 7 phoxVV193RA.,andem and
p47p',o*YV263RB.,andem with the 16-mer fluoresceine labelled p22pho* peptide. P 4 7 phoxW 1 9 3 R A-tandem 
does not produce any significant change in fluorescence intensity of the p22phox* peptide, indicative of no 
binding. Titrations were carried out at 20 °C in buffer H.
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4.3 Discussion
The coordinated action o f  the p47phox SH 3a and S H 3b domains produce a single 
ligand binding site o f high affinity, and this conformation is referred to as the 
‘superSH3’ domain. Biochemical studies (Groemping et al., 2003) as well as structural 
data (Groemping et al., 2003; Yuzawa et al., 2004a; Yuzawa et al., 2004b) show that the 
linker connecting SH3A and S H 3 b, as well as the conserved ‘GW W ’ m otif located in the 
n-Src loops are central to the formation o f  this novel conformation (Figure 58). 
However, little is understood about whether certain linker features (length, flexibility 
and composition) contribute to the formation and stabilisation o f the p47phox superSH3 
domain. Furthermore, so far only the roles o f G192A and G 262 b in the GW W  m otif 
have been systematically studied.
Here it was investigated in detail whether there are any precise structural 
constraints in the linker, that have to be fulfilled to allow the formation and stabilisation 
o f  the superSH3 domain in the auto-inhibited and active states o f  p47phox. In addition, 
the requirements o f the tryptophan residues o f the GW W  m otif in this conformation 
were investigated. Various linker mutants were made in the context o f the auto-inhibited 
core, to test whether particular mutations could destabilise the auto-inhibited 
conformation, but still allow p22phox binding. In addition, linker and ‘G W W ’ m otif 
mutants were made in the context o f  the tandem SH3 domains and their ability to form a 
superSH3 domain and accommodate either the p47phox polybasic peptide or p22phox- 
derived peptide was also tested.
4.3.1 The structural requirements for the p47phox linker are
strict in the context of the auto-inhibited core
Linker length and flexibility have been shown to play im portant roles in systems 
where a tight control o f  protein activity is achieved through intram olecular protein- 
protein interactions. Examples o f  such proteins include the Src family o f  non-receptor 
protein-tyrosine kinases (Hofmann et al., 2005). The activity o f  Src kinases is regulated 
by two intramolecular interactions. These involve the binding o f the SH2 domain to a 
C-terminal phosphotyrosine and association o f the SH3 domain with the SH2-kinase 
linker (Sicheri et al., 1997; W illiams et al., 1997; Xu et al., 1997). Activation o f the
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enzyme is achieved in part by de-phosphorylation o f  the phosphotyrosine (as well as by 
competition with high affinity SH2 and SH3 domain ligands) and the subsequent 
disruption o f the SH2 domain mediated interaction. However, a study by Kuriyan and 
colleagues has shown that increasing the flexibility o f the SH2-SH3 domain linker can 
also relieve auto-inhibition and induce kinase activation. This highlights the importance 
o f the SH2-SH3 domain linker in maintaining auto-inhibition (Young et al., 2001).
In this study we w anted to test whether specific linker features are also 
important for maintaining the auto-inhibited conformation o f p47phox. The interactions 
made between the linker and the tandem SH3 domains as well as the polybasic region in 
the inactive state are much more extensive than those made in the active state with 
either SH3A or SH3b domains and the p22phox peptide (Groemping et al., 2003; Yuzawa 
et al., 2004a; Yuzawa et al., 2004b). This suggests that the linker requirements may be 
stricter in the auto-inhibited than in the active state. To test these possibilities, two 
different triple mutations were introduced into the auto-inhibited core construct i) 
mutations disrupting the formation o f specific hydrogen bonds (p47phoxD/E3Aauto) and 
ii) where the flexibility o f the linker is increased through the removal o f proline residues 
(p47phox3PAauto). Intriguingly, both o f the resulting mutant proteins were insoluble, 
strongly supporting the notion that maintaining a certain degree o f  constraint is 
important for the formation o f  the auto-inhibited superSH3 domain, and that an increase 
in linker flexibility may interfere with proper protein folding. Nevertheless, in contrast 
to our results there has been a previous report where partial purification o f the full- 
length protein with the following mutations in the linker region (D217A/E218A/E223A) 
appeared successful (Peng et al., 2003). However, it is important to note that only the 
substitution o f E218 is identical between the two constructs. The other two substituted 
residues, D217 and E223 do not form hydrogen bonds with the tandem SH3 domains. In 
fact, E223 is solvent exposed and its removal would not be expected to have any effect. 
Nevertheless, D217 forms a hydrogen bond with the backbone amide group o f  K317 in 
the polybasic region and its removal may weaken the intram olecular interaction. 
Although it is impossible to know for sure why the two constructs behave so differently, 
it is possible that the use o f  a baculovirus expression system, which was used by Peng 
and colleagues may be better suited for expression o f these mutants than the bacterial 
system used here. This may explain the different stabilities observed. Nevertheless, it 
seems likely that the removal o f five hydrogen bonds in our construct may have 
interfered with correct protein folding, possibly even in an insect cell-based expression 
system. Therefore, we believe that the results from our study strongly indicate that the
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structural requirements o f the p47phox linker are strict in the context o f the auto-inhibited 
superSH3 domain.
4.3.2 The structural requirements for the p47phox linker are
more flexible for binding to ligands in an intermolecular 
interaction
As it was impossible to produce soluble proteins to study linker mutants in the 
context o f  the auto-inhibited core construct, we decided to introduce the corresponding 
mutants into the tandem SH3 domain construct and investigate the interaction with the 
p47phox 35-mer polybasic peptide to mimic the auto-inhibited conformation. Somewhat 
unexpectedly, soluble protein was obtainable for all the mutants tested. Even more 
surprisingly, given the insolubility o f  the p47phoxD/E3Aauto and p47phox3PAauto 
constructs, complex formation between these mutants, and the polybasic peptide was 
only weakened to a relatively small degree, with a maximum 5-fold decrease in affinity 
for p47phoxE 218Atandcm and p47phoxD/E3Atandcm- A similar observation was made for the 
interaction with the p22phox derived peptide: neither mutation tested resulted in a 
significant loss o f binding affinity, and most mutants only reduced the strength o f 
complex formation 2-3 fold. The strongest effect observed for this interaction was with 
those mutants that had either a decreased linker length (p47phoxArtandcm) or increased 
flexibility (0.56 pM): both mutants bound the p22phox peptide only 4-fold weaker than 
p47PhoxWild-typetandcm- During the writing o f thesis a similar study on the effects o f 
varying the length o f p47phox linker on p22phox binding and superoxide production was 
published. Using pull-down assays, Nobuhisa and colleagues showed that shortening or 
lengthening the linker by 2-6 amino acids had little effect on complex formation with 
p22phox and NADPH oxidase activity. Similar results were obtained upon the removal o f 
the hydrogen bond forming residues E220 and D221 (Nobuhisa et al., 2006). This study 
unlike that by Peng and colleagues further supports our data, and clearly shows that 
mutating the linker has little effect on the formation and stabilisation o f  the superSH3 
domain in the active state o f  p47phox.
Taken together, these results clearly show that there is a significant difference o f 
the effect o f linker mutations depending if  the superSH3 domain is involved in an intra- 
or intermolecular interaction. In the case o f an interm olecular interaction, as 
exemplified by the complexes with the polybasic and p22phox-derived peptides, there
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seems to be a lot o f flexibility with regards to sequence and the linker appears to only 
play a role in physically connecting the two domains. At first, this seems somewhat 
surprising as the linker is involved in a number o f specific interactions with the two 
SH3 domains, especially in the auto-inhibited state (see Figure 20) and one would 
assume that the loss o f these interactions may seriously interfere with ligand binding. 
However, it is possible that in the case o f  an intermolecular interaction, there is 
sufficient flexibility in the system to allow the two SH3 domains to cooperate and form 
a superSH3 domain under a variety o f conditions. This is probably due to the fact that 
many other interactions take place between the tandem SH3 domains and the peptides. 
These may compensate for those interactions lost through mutations in the linker and 
may otherwise stabilise the superSH3 domain conformation. This does not appear to be 
the case for an intramolecular interaction. The insolubility o f the mutants tested strongly 
indicates that in such a case the structural constraints o f  the linker are much more rigid, 
and are likely important to allow the correct folding o f  the superSH3 domain containing 
protein. This is particularly interesting in light o f  the fact that the non-phagocytic 
p47phox homologue N O X O l does not contain the 3 proline residues present in the linker 
o f the phagocytic protein, nor the hydrogen bond forming residues E218 or D221. 
Indeed, this protein is currently not believed to adopt a similar auto-inhibited 
conformation. On the other hand, the interaction o f N O X O l with p22phox also appears to 
occur in the superSH3 domain conformation (Dutta & Rittinger, unpublished result), 
supporting the idea that the precise composition o f  the linker is not as im portant for an 
intermolecular interaction with an external ligand.
Altogether, these data suggest that the chemical nature o f  the linker is important 
in the context o f an intramolecular interaction, as interactions between the linker and the 
two SH3 domains may be required for the correct folding o f  the protein. On the other 
hand, linker requirements appear to be significantly less stringent for intermolecular 
interactions, where this increased flexibility may be important to allow the 
accommodation o f a number o f different targets.
4.3.3 W193a is more important for ligand binding than W263B,
in both the active and auto-inhibited states
The tryptophan residues o f each SH3 domain in positions 193a and 2 6 3 b are
fully conserved among the family o f SH3 domains and are directly involved in ligand
binding (Larson and Davidson, 2000). M utagenesis studies in p47phox have shown that
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W 1 9 3 a  plays a crucial role in p22phox binding. Substitution o f the tryptophan to arginine 
completely disrupts complex formation o f the isolated SH3A domain with p22phox and 
interferes with superoxide production plus membrane translocation o f the mutant, full- 
length protein. In contrast, m utation o f its equivalent residue in SH3B has little effect (de 
Mendez et al., 1997; Sumimoto et al., 1996). Here we have investigated the effect o f 
mutating these residues in the tandem SH3 domain construct on their ability to interact 
with the polybasic and p22phox-derived peptides. When interpreting the results from 
these studies it is important to keep in mind that isolated SH3A is able to interact with 
the p22phox peptide with an affinity o f 3.4 pM  (fluorescence spectroscopy), whilst SH3B 
cannot (Groemping et al., 2003). However, neither isolated SH3 domain can form a 
stable complex with the polybasic region (Groemping et al., 2003). Mutation o f W 193A 
(p47phoxW193RA_tandem) completely abrogated complex formation with the p22phox 
peptide, while the equivalent mutation in SH3B (p47phoxW263RB.tandem) reduced the 
affinity o f the mutant protein for p22phox to that o f  isolated SH3A. These results show 
that in the active superSH3 domain, both W 193A and W 263B behave the same as in the 
isolated SH3 domains (de M endez et al., 1997; Sumimoto et al., 1996). As binding to 
p22phox is dominated by the interaction with SH3A (for details see section 1.6.2.2), 
removal o f W 193A is detrimental to the interaction, while the equivalent mutation in 
SH3b merely reduces the affinity to that o f  isolated SH3A.
The precise role o f W 193A and W 263B in the auto-inhibited state is not clear at 
present. In this study we found the binding behaviour o f  the polybasic region to be 
similar to that o f p22phox, which was rather unexpected given that isolated SH3A is not 
able to interact with this region (Groemping et al., 2003). Substitution o f  W 193A to 
arginine abolished the interaction with the polybasic peptide, judging by the absence o f 
a change in intrinsic fluorescence. However, as the absence o f  a signal change could 
potentially be due to the removal o f W 193A, whose fluorescence may dominate the 
signal observed, the interaction was also probed by ITC. No convincing binding was 
observed, which is in good agreement with the fluorescence data. These results suggest 
that although the interactions between isolated SH3A and the polybasic region are not 
sufficient to allow the formation o f  a stable complex (Groemping et al., 2003), the 
hydrogen bonds and hydrophobic interactions made by W 193A are absolutely crucial for 
ligand binding in the superSH3 domain. In contrast, W 263B does not appear to 
significantly contribute to the ligand binding properties o f  the superSH3 domain, as its 
removal only weakened the interaction with the polybasic peptide 2-fold. These findings
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are extremely interesting as it suggests that SH3a plays a more dominant role in the 
auto-inhibited state than previously assumed.
4.3.4 W194a and W264B are only important for the stabilisation
of the superSH3 domain in the active state
Residues W 1 9 4 a and W 2 6 4 b are not directly involved in interactions with 
neither p22phox nor the polybasic region. Instead these residues have been proposed to 
contribute to the stabilisation o f the superSH3 domain through the formation o f  inter- 
SH3 domain hydrogen bonds in the auto-inhibited and active states (Groemping et al., 
2003; Yuzawa et al., 2004a; Yuzawa et al., 2004b). However, the data presented here 
show that removal o f  either residue has only a marginal effect on the interaction with 
the polybasic peptide, indicating that in the auto-inhibited state the loss o f an 
interdomain interaction can easily be compensated for by the extensive network o f 
interaction formed between the tandem SH3 domains, the linker and polybasic region o f 
the protein (Groemping et al., 2003; Yuzawa et al., 2004a; Yuzawa et al., 2004b). In the 
active state, both tryptophan residues form water-mediated hydrogen bonds across the 
domain interface, while many o f the additional interactions that stabilise the auto­
inhibited conformation are missing. Accordingly, substitution o f  either W 194A or 
W 2 6 4 b to alanine has a stronger effect and reduces the affinity for p22phox by 6-fold and 
8-fold, respectively. Interestingly, these binding affinities are closer to those observed 
for the wild-type isolated SH 3 a domain (Groemping et al., 2003) and suggest that either 
residue is required to ensure that a stable superSH3 domain is formed that can bind its 
target ligands with high affinity. Removal o f either tryptophan will induce sufficient 
flexibility into the system to disrupt some o f the cooperativity o f  the two domains, 
thereby creating a situation where the interaction with S H 3 a dom inates complex 
formation and the supporting effect o f SH 3 b is partially lost.
Taken together, these studies show that the two SH3 domains o f  p47phox that 
cooperate to form the superSH3 domain make different contributions to the ligand 
binding capability o f this domain. In both the auto-inhibited and the active states, SH3A 
plays a much more im portant role in ligand binding and accordingly the removal o f 
W 1 9 3 a, which is conserved in all SH3 domains (Larson and Davidson, 2000), has a 
major effect on affinity. The significance o f  tryptophans 194 and 264 depends more on 
the context o f  the interaction: in the auto- inhibited state, where a large number o f
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contacts are made between the tandem SH3 domains and the polybasic region outside o f 
the core binding region, either o f these tryptophans plays only a minor role in the 
stabilisation o f the superSH3 domain. However, in the active state, where many o f these 
interactions are lost, the interdomain contacts made by these tryptophan residues 
become more important and are required for the formation o f a high affinity ligand 
binding site.
4.3.5 Are there other proteins that may form a superSH3
domain?
The results from section 4.1 and 4.2 clearly indicate that the requirements for the 
formation and stability o f  a superSH3 domain in terms o f linker composition and the 
presence o f a ‘G W W ’ m otif are not overly stringent, suggesting that other proteins may 
also be capable o f forming such a conformation. The precise nature o f the linker appears 
to be more important for an intramolecular interaction and hence might limit the type o f 
proteins that are able to use the superSH3 domain to regulate protein activity through 
auto-inhibition. The linker appears to be less important for intermolecular interactions, 
which on the other hand may have stricter requirements for the presence o f  the ‘GW W ’ 
motif. Furthermore, our data also show the relative contribution o f the two SH3 
domains to ligand binding does not have to be equal thereby probably extending the 
type o f proteins that could adopt this conformation.
Interactions mediated by SH3 domains can be relatively weak and non-specific 
(Chen et al., 1993) and the superSH3 domain conformation might be a m echanism  to 
achieve additional specificity and affinity in these interactions while simultaneously 
retaining a certain degree o f flexibility for the accommodation o f  ligands with different 
binding properties. There are many other proteins such as CIN85 (Abram et al., 2003) 
and FISH (Kowanetz et al., 2003) that contain multiple, adjacent SH3 domains. These 
proteins often act as adaptors or scaffolds to allow the formation o f large, multi-protein 
complexes. Binding studies have shown that the SH3 domains o f  these proteins 
cooperate for ligand binding. For example, CIN85 contains three SH3 domains and 
although the individual SH3 domains are capable o f  binding their target ligands with 
micromolar affinities, the extended structure o f two or three SH3 domains significantly 
increases the affinity (Kowanetz et al., 2003). Further studies are now required to gain a 
better insight into the role o f  this novel protein-protein interaction domain in other 
biological systems.
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CHAPTER FIVE
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5.0 Final discussion and concluding remarks
This study focuses on two different aspects o f NADPH oxidase activity: i) the 
functional role o f phosphorylation o f serine residues in the C-terminal region o f  p47phox 
in the assembly process and ii) the structural requirements for the formation and 
stabilisation o f the superSH3 domain in the auto-inhibited and active states o f  p47phox.
5.1 p4 7 Phox phosphorylation and NADPH oxidase
activation
P47phox is the most extensively phosphorylated subunit o f the NADPH oxidase. 
A total o f  eleven serine residues have been identified as targets o f phosphorylation, o f 
which only eight appear to be required for enzyme activation (Ago et al., 1999; el 
Benna et al., 1994; El Benna et al., 1996; Faust et al., 1995; Groemping et al., 2003; 
Inanami et al., 1998; Johnson et al., 1998). Five o f these residues are located within the 
polybasic, auto-inhibitory region (S303, 304, 315, 320 and 328), while the remaining 
three are located adjacent to the C-terminal proline-rich region (S359, 370 and 379), the 
region which otherwise mediates the interaction with p67phox (Figure 19) (Finan et al., 
1994; Kami et al., 2002; Lapouge et al., 2002; Leto et al., 1994). Phosphorylation o f 
serine residues within the polybasic region, in particular o f S303, 304 and 328 relieves 
the auto-inhibited conformation o f  p47phox and allows binding to p22phox, thereby 
promoting superoxide production (Ago et al., 1999; Groemping et al., 2003). In 
contrast, phosphorylation o f  the C-terminal serine residues (S359, 370 and 370) alone 
appears not to be sufficient to promote an interaction between p47phox and p22phox (Ago 
et al., 1999). However, it has never been investigated if  phosphorylation events within 
the C-terminal region can synergise with phosphorylation o f the polybasic region, and 
thereby contribute to the disruption o f  the auto-inhibited state and promote NADPH 
oxidase assembly.
To address this issue phosphorylation mimics were produced (by the substitution 
o f serine for glutamate residues) and their ability to interact with a fluoresceine labelled 
p22phox-derived peptide was investigated. These experiments dem onstrated that a triple 
C-terminal phosphorylation mimic (S359, 370 and 379E) fails to relieve auto-inhibition 
and allow interaction with p22phox, in support o f the previous findings by Ago and 
colleagues. Furthermore, this study revealed that a mutant protein mimicking
245
phosphorylation o f the entire protein (S303, 304, 315, 320, 328, 359, 370 and 379E) 
behaves similarly with respect to the interaction with p22phox, to a protein where only 
phosphorylation o f the polybasic region has been mimicked (S303, 304, 315, 320 and 
328E). These results clearly demonstrate that phosphorylation o f  the C-terminal serine 
residues do not synergise with phosphorylation o f the polybasic region to weaken the 
intramolecular interaction between the tandem SH3 domains and the polybasic region, 
and allow an interaction with the flavocytochrome. This raises the question about the 
functional role o f these C-terminal phosphorylation events and their effect on 
superoxide production. It would be very interesting to directly compare these three 
different phosphorylation mimics in cell free activation assays, to test their ability to 
support the production o f superoxide. Should the p47phoxS5E and p47phoxS8E mutant 
proteins behave in a similar manner as observed in our binding studies, this would 
indicate that phosphorylation o f  the C-terminal serine residues may be an unspecific 
"by-product" o f  phosphorylation o f the auto-inhibitory region. On the other hand, 
should there be clear differences in the activity o f  these two proteins as very recently 
suggested by Mizuki and colleagues, then this would point towards a functional role that 
is currently not understood.
In respect to this, it is important to take into consideration that the C-terminal 
serine residues o f p47phox are located within a region that is known to bind with high 
affinity to the C-terminal SH3 domain o f p67phox (Finan et al., 1994; Kami et al., 2002; 
Lapouge et al., 2002; Leto et al., 1994). Hence, it is possible that C-terminal 
phosphorylation o f p47phox may be involved in regulating this interaction instead. The 
same approach o f employing phosphorylation mimics was used to test this hypothesis 
and it was shown that C-terminal phosphorylation o f p47phox indeed weakens the 
interaction with p67phox. In particular, phosphorylation o f  S379 appears to play a central 
role. However, as observed for the release o f the auto-inhibited conformation, there is 
no synergistic interplay between phosphorylation o f serine residues in the polybasic and 
the C-terminal region, suggesting that both events are functionally independent. During 
the completion o f this work, similar studies were published which support our findings 
and further show that phosphorylation o f S379 severely affects NADPH oxidase activity 
(Massenet et al., 2005; M izuki et al., 2005). The possibility that phosphorylation 
directly targets the p47phox-p67phox interaction is at first glance rather surprising, given 
that the translocation mechanism requires a tightly associated p47phox-p67phox-p40phox 
complex (Lapouge et al., 2002; Park et al., 1992; Someya et al., 1993; W ientjes et al., 
1993), to co-migrate as a whole to the membrane for enzyme activation. However, it
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may help to explain the recent findings by Brown and colleagues, that p47phox is in fact 
not associated with the p67phox-p40phox complex under resting conditions (Brown et al., 
2003). Based on these data we propose the following model for phosphorylation- 
induced changes in NADPH oxidase assembly (Figure 65). Briefly, in the inactive state 
o f the enzyme only p67phox and p40phox exist in a complex. The C-terminal region o f 
p47phox may have a basal level o f  phosphorylation, which prevents complex formation 
with p67phox and/or possibly provides a binding site for another, yet unidentified 
regulatory protein. De-phosphorylation o f the C-terminal region would constitute the 
first step in the activation process, allowing the formation o f the trimeric p47phox- 
p67phox-p40phox complex. This is then followed by phosphorylation o f the serine residues 
in the polybasic region to induce the active form o f p47phox, which can then migrate to 
the membrane, in complex with p67phox and p40phox and bind to p22phox (discussed in 
more detail in section 3.4.3).
The role o f p40phox in NADPH oxidase activity remains controversial (Ellson et 
al., 2006; Grizot et al., 2001; Kuribayashi et al., 2002; Sathyamoorthy et al., 1997; 
Tsunawaki et al., 1996). The p40phox SH3 domain has been reported to be another 
binding partner for the C-terminal proline-rich region o f  p47phox and was speculated to 
compete with the p67phox C-terminal SH3 domain for binding. However, the binding 
affinity o f the p47phox-p67phox interaction is much higher than that for the p47phox-p40phox 
interaction, which makes a direct competition very unlikely (Fuchs et al., 1996; Grizot 
et al., 2001; Lapouge et al., 2002; Wientjes et al., 1996). However, it is interesting to 
note that p40phox becomes phosphorylated on two sites: threonine 154, which is close to 
the SH3 domain and serine 315, which is located in the C-terminal portion (Bouin et al., 
1998). Although the role o f  these phosphorylation events has not been investigated so 
far, it is tempting to speculate that phosphorylation, particularly o f  threonine 154, may 
induce conformational changes within the SH3 domain, thereby raising the affinity o f 
p40phox for p47phox and allowing it to compete directly with p67phox. This could be 
investigated in future work by carrying out quantitative binding assays between 
phosphorylated p40phox and p47phox. P67phox is also phosphorylated on one m ajor site: 
threonine 233 (Forbes et al., 1999). Interestingly, this residue is located within a PR 
region adjacent to the N-terminal SH3 domain o f p67phox, both o f which have unknown 
functions in the regulation o f NADPH oxidase activity. Future work should now be 
directed towards determining whether phosphorylation o f this residue triggers any 
conformational changes within p67phox that may influence its interaction
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Resting NADPH oxidase---------------------► Active NADPH oxidase
Flavocytochrome b. Flavocytochrome b.
gp91P«»g p 91Bh««
Figure 65: Proposed model for NADPH oxidase activation. Resting state (1): during the resting
state o f NADPH oxidase the C-terminal serine residues of p47phox (S359, S370 and S379) have a basal 
level o f phosphorylation, possibly due to binding with a yet unknown protein (represented as X), which 
interferes with the interaction with p67phox. De-phosphorylation (2): p47phox C-terminal serine residues 
become dephosphorylated which constitutes the first step in the activation o f the NADPH oxidase. 
Complex formation (3): de-phosphorylation releases the unknown protein making p47phox available to 
bind the p67phox-p40phox complex to form the p47phox-p67phox-p40phox trimer. Phosphorylation (4): the 
process is then followed by phosphorylation of serine residues (S303, S304, S315, S320 and S328) within 
the polybasic region o f p47phox to give the active form of p47phox. Translocation (5): phosphorylation 
induces translocation of p47phox to the membrane where it binds to p22phox thereby bringing p67phox and 
p40phox into close proximity to gp91phox, and its binding partner Rac to activate the production of 0 2
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with other NADPH oxidase components, such as p47phox, p40phox or gp91phox. Such 
studies could help to produce a better and more complete understanding o f how 
phosphorylation regulates the assembly and ultimately activity o f  the multi-protein 
NADPH oxidase complex.
In the present study it was also attempted to investigate the effect o f  p47phox C- 
terminal phosphorylation on lipid binding to p47phox. In the resting state, the PX domain 
o f p47phox is not fully accessible for lipid binding due to an intramolecular interaction 
between this domain and an unknown region o f the protein (Ago et al., 2003; 
Karathanassis et al., 2002). The intramolecular binding target for the PX domain is most 
likely part o f the auto-inhibitory segment, as phosphorylation o f the polybasic region, 
particularly o f S303, 304 and 328, exposes the PX domain and restores maximum lipid 
binding (Ago et al., 2003; Karathanassis et al., 2002). It is not clear however, if  
phosphorylation o f  the C-terminal serine residues (S359, 370 and 379) plays a role in 
this event. In the present study this issue was addressed by testing various 
phosphorylation mimicking p47phox mutants, for their ability to bind to 
phosphatidylinositols. In these experiments two different protein-lipid pull down 
methods were tested: i) the use o f PIP beads and ii) lipid sedimentation assays. 
Unfortunately though, both assays proved unsuccessful. A lthough PIP beads have been 
successfully used to detect lipid binding to PH domains (Rao et al., 1999), they had 
never been used to study PX domains. This study suggests that this particular method is 
not suited to detect lipid binding to PX domains, possibly because unlike PH domains, 
PX domains require more than just the lipid head group to form a tight interaction. In 
contrast, lipid sedimentation assays have previously been used successfully for the study 
o f p47phox (Ago et al., 2003; Kanai et al., 2001; Karathanassis et al., 2002), so it was 
rather surprising when this assay failed to work in this study. The most likely 
explanation for this being, that the lipid vesicles may not have sedim ented efficiently. 
In future studies the vesicles should therefore be made heavier either by including 
sucrose (Suire et al., 2002) or using brominated lipids (Tortorella and London, 1994). 
Other experimental approaches that could be adopted, include lipid overlay assays 
(Dowler et al., 2000; Kanai et al., 2001) or possibly surface plasm on resonance 
(Karathanassis et al., 2002). The latter technique is known to be quite difficult to use, 
however, would have the m ajor advantage over all the other methods described here as 
it provides quantitative binding data.
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5.2 The superSH3 domain as a novel protein
interaction module
A number o f  studies have shown that, although p22phox can interact with the 
isolated SH3A domain o f p47phox (de Mendez et al., 1997; Groemping et al., 2003; 
Sumimoto et al., 1996), binding is significantly increased in the presence o f  S H 3 b (de 
M endez et al., 1997; Groemping et al., 2003). Biochemical and especially structural 
studies have uncovered that this high affinity is mediated by the formation o f a 
‘superSH3’ domain, where the conserved ligand binding sites o f SH3A and S H 3 b are 
juxtaposed and work in coordination, a conformation that is also observed in the auto­
inhibited state (Figures 8 and 10) (Groemping et al., 2003; Yuzawa et al., 2004a; 
Yuzawa et al., 2004b). It has been proposed that the linker connecting the two SH3 
domains and a ‘G W W ’ m otif located in each n-Src loop o f either SH3 domain are 
central to the formation o f this superSH3 domain, which is believed to constitute a 
general protein interaction module (Groemping et al., 2003). However, little is known 
about how stringent the structural requirements are for the formation and stabilisation o f 
this novel conformation, both in the auto-inhibited and active states o f p47phox. In the 
present study these requirements were investigated by introducing a number o f 
mutations into the tandem SH3 domains and testing their ability to interact either with a 
peptide derived from the polybasic region or a p22phox-derived peptide. Furthermore, a 
subset o f mutants were made within the auto-inhibited core construct o f  p47phox to 
mimic the behaviour o f full-length, auto-inhibited p47phox. These studies demonstrate 
that the chemical nature (length, flexibility and composition) o f the linker is critical in 
the auto-inhibited state, where the composition and length o f  the linker may be 
important for the correct folding o f the protein. In contrast, the structural requirements 
are significantly less stringent for the formation o f the superSH3 domain, when tested in 
the context o f  binding to the polybasic and p22phox-peptides. These data strongly suggest 
that the identity o f the linker is important in the context o f intram olecular interactions, 
but that more variations in the linker can be tolerated for the formation o f  intermolecular 
complexes. Such an increased flexibility may be important to allow a variety o f proteins 
containing tandem SH3 domains, to form a superSH3 domain and accommodate 
different targets. An interesting study at this point would be to ascertain what the 
minimum and maximum linker lengths and flexibility are for the formation o f this novel 
conformation. This could be conducted by using deletion mutants (o f greater length than
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those used in this study) and linker glycine mutants, in conjunction with quantitative 
binding assays.
Furthermore, in this study the precise role o f  the tryptophan residues in the 
GWW m otif for the stabilisation and ligand binding properties o f  the superSH3 domain 
was tested. The first tryptophan residue in this m otif is known to be absolutely crucial 
for ligand binding in isolated SH3 domains (de Mendez et al., 1997; Hata et al., 1998; 
Sumimoto et al., 1996). The results presented here indicate that it plays the same role in 
the active, p22phox -bound state where removal o f W 193a completely disrupts complex 
formation, while removal o f W 2 6 3 b reduces the affinity for the p22phox-peptide to that 
o f isolated SH 3 a - Similar effects on binding to the polybasic peptide were observed. 
These experiments showed that both in the auto-inhibited and active states o f p47phox, 
S H 3 a plays a more dominant role in ligand binding than SH 3b-
W 1 9 4 a and W 264B are believed to contribute to the stabilisation o f  the 
superSH3 domain due to the formation o f  interdomain hydrogen bonds (Groemping et 
al., 2003; Yuzawa et al., 2004a; Yuzawa et al., 2004b). Nevertheless, we show here that 
these interactions are not important for the stabilisation o f  the superSH3 domain in the 
auto-inhibited state. Upon removal o f either o f these residues the affinity for the 
polybasic region is maintained, possibly due to the large number o f stabilising contacts 
made outside the core binding region. In contrast, interactions made by W 1 9 4 a and 
W 2 6 4 b become more important in the active state, as many o f the stabilising peptide- 
tandem SH3 domain interactions seen in the auto-inhibited state are missing. Individual 
mutations o f these residues to alanine reduce the affinity for p22phox by 6-fold and 8- 
fold, respectively. An interesting experiment to do at this point would be to mutate both 
W 1 9 4 a and W 2 6 4 b simultaneously, to determine whether this may reduce the affinity 
for p22phox to that observed for the isolated wild-type SH3a domain.
Altogether, our data indicate that the requirements for the formation and 
stabilisation o f a superSH3 domain are not extremely strict, in terms o f linker 
composition and the presence o f the GWW motif. However, there are interesting 
differences in the requirements depending if  the superSH3 domain/target interaction 
occurs in an intra- or intermolecular manner. In the case o f an intramolecular 
interaction, the linker composition becomes more important, whilst the presence o f the 
tryptophans in the GW W  m otif is less important. In contrast, intermolecular interactions 
made by the superSH3 domain, allow a great deal o f flexibility in terms o f  linker length 
and composition, but rely more on interactions made by the tryptophan residues to 
achieve a high-affinity interaction. This suggests that other proteins that contain
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multiple SH3 domains, separated by variable linkers, may also form such a 
conformation to achieve additional specificity and affinity. It is now important to test 
some o f these proteins for their ability to adopt a superSH3 domain, in particular for 
those proteins where data have already shown that their SH3 domains cooperate 
somehow for ligand binding (Abram et al., 2003; Kowanetz et al., 2003). This would 
establish if  this domain arrangement is indeed a general novel protein-protein 
interaction module.
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APPENDIX
A1 General reagents
Table 20: General reagents and suppliers.
REAGENT SUPPLIER
40 % w/v acrylamide/bisacrylamide (37:5:1) Bio-Rad
Agarose Invitrogen
Ammonium persulfate (APS) Bio-Rad
Ampicillin Sigma
p-mercaptoethanol Sigma
Benzamidine Sigma
Bis/Tris pre-cast gels (NOVEX) Invitrogen
Bovine serum albumin (BSA) Sigma
Bromophenol blue BDH
CAPS Sigma
Chlorofom Sigma
DTT Sigma
EDTA Sigma
Ethidium bromide Bio-Rad
Ethanol Fisher scientific
Glutathione sepharose 4B resin Amersham biosciences
Glycerol BDH AnalaR
Hepes Calbiochem
HC1 Fisher Scientific
Imidazole Fluka
IPTG Biogene
Loading buffer (6 X) (for agarose gels) Novagen
Low molecular weight protein marker Amersham biosciences
MES SDS running buffer (10 X) Invitrogen
Methanol Fisher Scientific
Ni-NTA resin Qiagen
NP-40 Sigma
PCR marker Novagen
Protease inhibitor cocktail tablets (EDTA free) Roche
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Reduced glutathione Sigma
SDS running buffer (10 X) National diagnostics
SeaBlue Plus 2 marker Invitrogen
Shrimp alkaline phosphatase Roche
Simply blue safe stain Invitrogen
Sodium chloride BDH AnalaR
T4 DNA ligase Promega
TE buffer Qiagen
TEMED Bio-Rad
Thrombin Merck Biosciences
Tris BDH AnalaR
Triton X-100 Sigma
Tween-20 Aldrich
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A2 Media and cells
M e d i a
Luria-Bertani broth/agar (LB)
Bactotryptone 10 g/L
Yeast extract 5 g/L
NaCl 10 g/L
Distilled water 1 litre
Terrific broth (TB) Mix 900 ml o f  A with 100 ml o f  B
Part A Part B
Tryptone 12 g/L K2H P 0 4 (0.72 M) 12.5 g/L
Yeast extract 24 g/L KH 2PO 4 (0.17 M) 2 g/L
Glycerol 4 ml/L Distilled w ater 1 0 0  ml
Distilled water 900 ml
B a c t e r i a l  c e l l  s t r a i n s
All cell strains were purchased from Novagen. NovaBlue cells were used for 
initial cloning and plasm id purification and BLR21(DE3) cells were used for protein 
expression.
Table 21: Genotypes of E.coli cells strains.
E. coli cell strains Genotype
NovaBlue
BL21(DE3)
endA l hsdR17 (rKi2 m ia2+) supE44 thi-1 recAl gyrA96 relAl lac F ’[proA+B+ 
laclq ZA M 15::Tnl0(TcR)]
F' ompT hsdSB(rB'm B) gal dcm (DE3)
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A3 SDS-PAGE and agarose gels compositions
S D S  s e l s
4 X  sample buffer 
0.5 M Tris (pH 6.8)
Glycerol (40 % v/v)
10 % (w/v) SDS 
lO O m M DTT
0.05 % (w/v) bromophenol blue
Resolving buffer
1.5 M Tris (pH 8.8)
0 .15%  SDS
Table 22: Composition of a 12 % SDS gel.
Reagent Volumes for resolving gel Volumes for stacking gel
40 % Acrylamide Bis solution 3 ml 0.7 ml
Resolving buffer/stacking buffer 2.5 ml 1.25 ml
Distilled water 4.5 ml 3 ml
10%  APS 100 pi 50 pi
TEMED 10 pi 5 pi
A s a r o s e  s e l s
Table 23: Composition of a 1 % agarose gel.
Reagent Volume
Agarose 1 g
1 X TAE (40 mM Tris Acetate (pH 7.7), 1 mM EDTA) 100 ml
Ethidium bromide (10 mg/ml) 2 pi
Stacking buffer 
0.5 M Tris (pH 6.8) 
0 .1 5 %  SDS
285
A4 Buffers and peptides
B u f f e r  c o m p o s i t i o n s
The pH o f buffers was adjusted to be one unit above or below the pi o f the protein.
Buffer A 
50 mM Hepes 
300 mM NaCl 
4 mM DTT 
2 mM EDTA 
4 mM benzamidine
Buffer B 
50 mM Hepes
1 M NaCl 
4 mM DTT
2 mM EDTA
4 mM  benzamidine
Two protease inhibitor cocktail tablets (per 200 mi buffer)
Buffer C 
50 mM Hepes 
50 mM NaCl 
1 mM EDTA 
4 mM DTT
(Add 15 mM rcduced-glutathione for GST-fusion protein elution)
Buffer D 
50 mM  Hepes 
300 mM NaCl 
20 mM imidazole 
5 mM p-m ercaptoethanol
Buffer E Buffer F
50 mM Hepes 
300 mM NaCl 
1 M imidazole 
5 mM P-mercaptoethanol
50 mM  Hepes 
50 mM NaCl
1 mM EDTA
2 mM DTT
Buffer G 
50 mM Hepes 
500 mM NaCl 
1 mM EDTA
Buffer H 
50 mM Hepes 
100 mM NaCl 
1 mM EDTA
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P e p t i d e s
Dr. W. M awby, U niversity o f  Bristol, UK prepared the 35-mer peptide 
representing the p47phox polybasic region (peptide 1) (aa 296-330). An 18-mer peptide 
representing the proline-rich region o f  p22phox was prepared by Peter Fletcher (NIMR) 
(peptide 2), plus an identical peptide with a fluoresceine label attached (peptide 3) (aa 
149-166).
R G A PPR R SSIR N  A H S IH Q R S R K R L S Q D  A Y RRN S V R  (peptide 1)
K Q P P S N P P P R P PA E A R K K  (peptide 2)
fluoresceine K Q P P S N P P P R P P A E A R K K  (peptide 3)
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A5 Oligonucleotides
Table 24 shows the oligonucleotides used in this study. Substitution o f  a specific 
wild-type residue to a m utant residue e.g. Glu -> Ala at position 218 is shown as 
E218A.
Table 24: Oligonucleotides used for the cloning of p47phox mutants.
P47phox
mutants
Sense primer (5-3)
Antisense primer 
(3-5)
Codon substitution 
shown for sense strand
S8E-His6 CCAAGCGGAAGCTGGC ATAGTTTAGCGGCCGC Addition o f His6 tag onto
GTCTGCCGTCCACCACC TCAGTGGTGGTGGTGG the N-terminus o f full-
ACCACCACCACTGAGC TGGTGGACGGCAGAC length p47phox
GGCCGCTAAACTAT GCCAGCTTCCGCTTGG
S379E CTCATCCTGAACCGCTG
CGAGGAGAGCACCAAG
CGGAAG
CTTCCGCTTGGTGCTC
TCCTCGCAGCGGTTCA
GGATGAG
AGC->GAG
W193Ra GAAGAGCGAGAGCGGT
CGGTGGTTCTGTCAGAT
GAAAG
CTTTCATCTGACAGAA
CCACCGACCGCTCTCG
CTCTTC
T G G ^C G G
W194Ra GAGAAGAGCGAGAGCG
GTTGGCGATTCTGTCAG
ATGAAAGCAAAG
CTTTGCTTTCATCTGA
CAGAATCGCCAACCG
CTCTCGCTCTTCTC
TGG->CGA
W194Aa AGCGAGAGCGGTTGGG TTTCATCTGACAGAAC TGG-»GCG
CGTTCTGTCAGATGAAA GCCCAACCGCTCTCGC
T
CTTTCCTGATGACCCA
CCGGCCGTCCAGGAG
CTTG
W263Rb CAAGCTCCTGGACGGCC
GGTGGGTCATCAGGAA
AG
TGG->CGG
W264Rb CACAAGCTCCTGGACG
GCTGGCGAGTCATCAG
GAAAGACGACGTC
GACGTCGTCTTTCCTG
ATGACTCGCCAGCCGT
CCAGGAGCTTGTG
T G G ^C G A
W264Ab CTCCTGGACGGCTGGGC
GGTCATCAGGAAAGAC
GTCTTTCCTGATGACC
GCCCAGCCGTCCAGG
AG
TGG->GCG
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E218E
E220A
D221A
D/E3A
3PA
A1
A l+
CTGGACAGTCCTGACGC
GACGGAGGATCCTGA
GCCCAACTATGC
GGACAGTCCTGACGAG
ACCGCGGACCCTGAGC
CCAACTATGC
GGACAGTCCTGACGAG
ACGGAAGCCCCTGAGC
CCAACTATGC
CTGGACAGTCCTGACGC
GACGGCAGCCCCTGAG
CCCAACTATGC
CCCCTGGACAGTGCGG
ACGAGACGGAAGACGC
GGAGGCGAACTATGCA
GGTGAG
CCTGAGCCCAACTATGG
TGAGCCATACGTC
CCTGAGCCCAACTATGC
AGCAGGTGAGCCATAC
GTC
CCTGAGCCCAACTATGC
AGCAGCAGGTGAGCCA
TACGTC
GCATAGTTGGGCTCAG
GATCCTCCGTCGCGTC
AGGACTGTCCAG
GCATAGTTGGGCTCAG
GGTCCGCGGTCTCGTC
AGGACTGTCC
GCATAGTTGGGCTCAG
GGGCTTCCGTCTCGTC
AGGACTGTCC
GCATAGTTGGGCTCAG
GGGCTGCCGTCGCGTC
AGGACTGTCCAG
CTCACCTGCATAGTTC
GCCTCCGCGTCTTCCG
TCTCGTCCGCACTGTC
CAGGGG
GACGTATGGCTCACCA
TAGTTGGGCTCAGG
GACGTATGGCTCACCT
GCTGCATAGTTGGGCT
CAGG
GACGTATGGCTCACCT
GCTGCTGCATAGTTGG
GCTCAGG
GAG-»GCG
G A A ^G C G
GAC->GCC
GAG->GCG
GAA->GCG
G A C ^G C C
C C T ^G C G
CCT->GCG
CCC-»GCG
GCA->deletion
Addition o f two GCA’s
Addition o f two GCA
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A6 Circular dichroism results
C i r c u l a r  d i c h r o i s m  m e a s u r e m e n t s  o f  t h e  p 4 7 phox l i n k e r  a n d  G W W  m o t i f  
m u t a n t s
Figure 66 shows CD spectra for the various p47phox mutant proteins (tandem 
SH3 domain construct; aa 156-285) and p47phoxWild-typetandcm- All the spectra show a 
minimum at approxim ately 203 nm  and a maxim um  at approximately 223 nm, which is 
characteristic o f  a protein with a large p-sheet content. The secondary structure content 
o f these proteins was calculated using the methods described by (Sreerama and Woody, 
2000). Importantly, all the m utant proteins have a sim ilar secondary structure content to 
p47phoxWild-typetandcm (within the acceptable 10 % error margin) indicating that changes 
in ligand binding are not solely due to a loss in secondary structure.
In comparison to p47phoxWild-typetandcm, two triple mutant proteins: 
p47phoxD/E3Atandem and p47phox3PAtandcm, and the individual m utant p47phoxE 2 18Atandem 
showed the largest changes in binding affinity, upon binding to the p47phox 35-mer 
polybasic region peptide and/or p22phox peptide. Similar was observed for 
p4 7 PhoxW 1 9 3 RA tandem an(j p47phoxW 263RB-tandcm on binding to the p22phox* peptide. 
Thermal unfolding o f these m utant proteins was m easured at 224 nm with increasing 
temperature (20 °C-80 °C). Figure 67 shows the therm al scans for p47phoxD/E3Atandcm, 
p47phox3PAtandem, p47ph0XE218Atandcm, p47phoxW 193RA-tandcm and P47phoxW 263RB-tandem. 
All the proteins have a similar m id-point for unfolding o f  approxim ately 53 °C, which 
were all reversible. This suggests that the m utations do not have any major effects on 
the thermal stability o f the proteins.
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Figure 66: CD spectra of p47pho* tandem SH3 domain mutants. Far-UV CD spectra o f the
various p47phox tandem SH3 domain mutants and p47phoxWild-type,andein (aa 156-285). Spectra were taken 
in buffer H at a protein concentration o f 0.15 mg/ml.
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Figure 67: T herm al denatu ra tion  curves for p47phox tandem  SH3 domain m utants. The
ellipiticity of the mutant proteins and p47phoxWild-typetondem (aa 156-285) were continuously measured at 
224 nm as the temperature was increased from 20 °C to 80 °C. The scans were measured in buffer H at a 
protein concentration of 0.15 mg/ml.
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